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Fluorometabolite Biosynthesis in Streptomyces cattleya 
Steven J Moss 
Nature has evolved the ability to form a C-F bond, as exemplified by the bacterium 
Streptomyces cattleya, which elaborates fluoroacetate (FAc) and 4-fluorothreonine (4-
FT). The mechanism of this bond formation are unknown. This thesis probes the 
biosynthesis of fluoroacetate and 4-fluorothreonine and in doing so explores the C-F 
bond forming process. 
Feeding stable isotope enriched primary metabolites to S. cattleya, followed by 1 9F 
NMR and GCMS analysis of the resultant fluorometabolites, highlights the role of the 
glycolytic pathway in delivering a substrate for fluorination. 3-Fluoro-l-
hydroxypropan-2-one was synthesised and feeding studies eliminate this as the initial 
product of fluorination. 
Fluoroacetaldehyde was identified as a common fluorinated intermediate in the 
biosynthesis of both FAc and 4-FT. Whole cell studies demonstrate the rapid 
oxidation of fluoroacetaldehyde to FAc. 4-FT is produced in low quantities by S. 
cattleya incubated with fluoroacetaldehyde. The synthesis and feeding of [1 - H]-
fluoroacetaldehyde provide evidence that the resultant 4-FT is biosynthesised from 
fluoroacetaldehyde. The biotransformation from fluoroacetaldehyde to FAc was 
shown in cell free studies to be mediated by an aldehyde dehydrogenase, requiring 
N A D + as a co-factor. The substrate specificity of fluoroacetaldehyde dehydrogenase 
was probed by spectrophotometrically monitoring the production of NADH in the 
presence of different aldehydes. 
Further cell free experiments probed the biosynthetic origins of fluoroacetaldehyde. 
Glycolaldehyde phosphate and various phosphorylated glycolytic intermediates were 
incubated with cell free extracts of S. cattleya and a plethora of co-factors. In the 
absence of observing fluorination activity, it was shown that the cell free extract acts 
to dephosphorylate the substrates. The putative role of glycolaldehyde phosphate was 
explored by feeding isotopically labelled glycolaldehydes to whole cells of the 
bacterium. The results were not consistent with direct conversion from 
glycolaldehyde phosphate to fluoroacetaldehyde. 
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Now, ever since Perkin, failing to make quinine, founded the dyestuffs industry, the 
organic chemists have found the study o f 'natural products' an inexhaustible source o f 
exercises, which can be performed out o f pure curiosity even when paid for in the 
hope o f a more commercial reward. As a result, the organic chemist's view of nature 
is unbalanced, even lunatic, but still in some ways more exciting than that o f the 
biochemist. While the enzymologist's garden is a dream of uniformity, a green 
meadow where the cycles of Calvin and Krebs tick round in a disciplined order, the 
organic chemist walks in an untidy jungle o f uncouthly named extractives, rainbow 
displays o f pigments, where in every bush there lurks the mangled shape o f some 
alkaloid, the exotic perfume of some new terpene, or some shocking and explosive 
polyacetylene. To such a visionary, both the diatretynes are equal prizes, to be set 
together as 'natural products.' We shall do the same, but since to a more sober eye 
both are in a sense less 'natural' than, say, glycine or adenosine triphosphate, we may 
prefer the term 'secondary metabolites.' 
J. D. Bu'lock, Adv. Appi. Microbiol., 3 (1961), 293 
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Chapter 1 
Introduction 
Chapter 1: Introduction 
Over half a century has elapsed since the toxin fluoroacetate (1) was first identified as a 
natural product o f the South African plant Dichapetalum cymosum} Since then a 
further twelve naturally occurring compounds containing a C-F bond have been 
discovered. To date the mechanism and enzymology of Nature's fluorination reactions 
remain largely unknown. 2 To provide a framework for discussion o f fluoroacetate (1) 
and 4-fluorothreonine (2) biosynthesis, i t is first necessary to introduce the concept o f 
secondary metabolism and review to some extent the methods by which the other 
halogens are introduced into natural products. 
1.1 Secondary Metabolism 
1.1.1 Primary and secondary metabolism 
Metabolism is classically delineated into two general categories. Primary metabolism 
defines the metabolic pathways common to all l iving organisms, such as the pathways 
that produce and utilise carbohydrates, amino acids, nucleic acids and fatty acids. These 
pathways are similar, though not identical, across the wide genus and species spectrum. 
Primary metabolites are manipulated by both anabolic and catabolic processes.3 These 
synthesise and degrade, respectively, the primary metabolites and biopolymers (DNA, 
RNA, proteins, polysaccharides and lipids) derived from them. Primary metabolites are 
essential for the efficient functioning o f all organisms.4 
Many species also operate metabolic pathways other than those directly involved in 
primary metabolism. These pathways utilise primary metabolites to deliver often 
structurally unique compounds. Such natural products are termed secondary 
metabolites as the pathways that create them are peripheral to primary metabolism. The 
border between primary and secondary metabolism is ill-defined with no universally 
satisfactory definition. Rigid definitions tend to exclude known secondary metabolites 
and occasionally preclude primary metabolites. A generally accepted and useful 
definition is that secondary metabolites have a limited distribution, usually restricted to 
a genus or species.5 
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Microbial secondary metabolites display phase dependent growth and are irrelevant to 
the growth o f the organism (section 1.1.3).6 It is o f great interest that secondary 
metabolites do not appear to be essential for the survival o f the producer organism. The 
biosynthetic pathways to secondary metabolites tend to be long and complex, so the 
production o f a secondary metabolite must infer some selective advantage over 
nonproducing strains o f the same species for their biosynthesis to be conserved through 
evolution. 7 In antibiotic production, this may be easy to rationalise, however where 
physiological roles have not been assigned to specific secondary metabolites their 
raison d'etre is not so obvious. 
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Fig. 1.1: Penicillin G (3), coniine (4) and a-pinene (5). 
The structures o f secondary metabolites are characteristically ornate and this is reflected 
in their diversity o f biological functions and uses by man. 8 They may have, for 
example, antibiotic activity, high toxicity or pheromonal action such as in penicillin (3), 
coniine (4) and a-pinene (5) respectively. Due to their diverse biological activities 
secondary metabolites have been used by man as poisons, narcotics, stimulants, 
flavours, fragrances and pharmaceuticals. Crude preparations o f secondary metabolites 
have been used in folklore medicine and much has been learnt through 
ethnopharmacology (studying the crude plant preparations used by indigenous people 
for their biological activity; be it medicinal, poison or hallucinogenic). 9 1 0 It is 
envisaged that secondary metabolites w i l l continue to supply new lead compounds for 
the pharmaceutical industry, through both the identification o f new natural product 
chemotypes and through biotechnological exploitation o f existing natural products." 
Secondary metabolites have had a large impact on contemporary society, both positively 
through pharmaceuticals, flavours and fragrances and negatively through their use and 
associated crime in the illegal drugs market, which is largely based on natural products. 
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The reason why an organism produces secondary metabolites has been much debated. 
Even though many secondary metabolites have physiological roles assigned to them, 
these are pharmaceutical descriptors {e.g., antibiotic) and may not reveal the 
fundamental role o f the metabolite. I t has been noted and accorded some significance 
that many secondary metabolites have activities in species other than the producing 
organism. However, i t may be that secondary metabolites originally had a role in the 
internal physiology o f the producing organism. This ancestral function may now be 
disguised by evolutionary development where such compounds have refined specialised 
interactions wi th other species.12 
Secondary metabolites are broadly classified by their biosynthetic origin. Fatty acids 
and derivatives {e.g. polyacetylenes and prostaglandins) originate f rom the condensation 
f rom acetate (6) (see section 1.1.2). Similarly, polyketides originate f rom acetate (6) 
and partial reduction o f the resultant 'polyketone' chains that may condense and cyclise. 
Shikimate (7) provides a start point for the biosynthesis o f many phenols, lignans and 
flavanoids. Alkaloids originate f rom the amino acid pool, as do the non-ribsomal 
peptides. The isoprenoids (terpenes and sterols) are derived f rom deoxyxylulose-5-
phosphate and mevalonic acid (8) in two separate pathways. I n Fig. 1.2 the relationship 
between these key intermediates and primary metabolism is demonstrated. Primary 
metabolism supplies the necessary intermediates through glycolysis (minimally 
represented here by the conversion o f glucose (9) to pyruvate (10), via glyceraldehyde-
3-phosphate (11) and phosphoenol pyruvate (12)) and subsequent incorporation o f 
acetyl-SCoA (13) into the tricarboxylic acid (TCA) cycle. The diagram has been 
modified ( f rom Mann, 8 1994) to show a newly realised pathway to the isoprenoids via 
1-deoxyxylulose phosphate (14), which operates independent o f the well established 
mevalonate pathway. 1 3 1 4 In the fol lowing section fatty acid biosynthesis and p-
oxidation w i l l be discussed in some detail as these pathways are relevant to the origin o f 
some o f the known fluorinated metabolites. 
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Fig. 1.2: The major secondary metabolic precursors. The arrows represent multiple step 
transformations. 
1.1.2 Fatty acid biosynthesis and ft-oxidation15 
Fatty acids are biosynthesised by the repeated decarboxylase condensation o f malonyl-
SCoA (15), extending the chain by two carbons with each condensation. The resultant 
(3-ketothioester is reduced by a series o f enzymes to C H 2 before the next condensation 
cycle starts (see Fig. 1.3). The starter unit is generally acetyl-SCoA (13), although not 
exclusively so. In a variety o f secondary metabolites, particularly in bacteria, other 
carboxylic acids can become incorporated as their coenzyme A ester. P-Oxidation is 
essentially the reverse o f this process (though it is mediated by different enzymes and 
cofactors and in eukaryotes it occurs in a different cellular location). P-Oxidation is the 
process o f fatty acid catabolism and generates acetyl-SCoA (13). 
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Fig. 1.3: Fatty acid biosynthesis and P-oxidation. 
1.1.3 Microbial secondary metabolism 
Phase dependent biosynthesis is a characteristic of microbial secondary metabolism. In 
bacterial systems there are well-defined stages of growth and these correlate wi th the 
organism's biosynthetic capabilities.1 6 I f cell growth in a complex medium is 
considered, the cells in the initial innoculum may not be fu l ly established in primary 
metabolism. There is a lag period before cell growth commences. The rate o f growth 
then becomes exponential as healthy cells divide. During this phase primary 
metabolism dominates as the cells maximise use of available resources. This is known 
as the trophophase, and continues until there is a deficit in nutrients. At this point cell 
growth ceases and cell death begins as the organism takes steps to maximise its chance 
of survival. Two characteristics of this next phase, the idiophase, are secondary 
metabolism and sporulation. Sporulation is a mechanism by which the microorganism 
generates heat resistant cells. Spores can remain dormant until such a time as they are 
once again in a favourable environment for growth. Concurrent wi th sporulation is the 
onset o f secondary metabolism. 
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It is perhaps poignant that secondary metabolism occurs so late in the l ife cycle o f 
microorganisms and this led to the early hypothesis that some secondary metabolites 
were merely 'shunt' metabolites, secreted to prevent the accumulation o f potential toxic 
primary metabolites.6 This is no longer a generally accepted argument. The complexity 
of the signalling required to initiate secondary metabolite biosynthesis suggests a level 
o f sophistication that would rule out a mere accumulation. Also the biosynthesis o f 
aerial mycelium (sporulation) requires a level o f primary metabolism that would prevent 
this accumulation. 1 7 The concurrent events o f secondary metabolism and sporulation 
may indicate a dedicated defence system for the organism. There is evidence in 
Streptomyces spp. that the concurrent activities o f secondary metabolism and 
sporulation are not linked by chance, but that these events are controlled by the same 
genes, referred to as pleiotropic switches. Therefore, the organism prepares to enhance 
its long-term survival by producing heat resistant spores, whereas natural product 
biosynthesis may protect the organism during its idiophase. 
The accumulation o f secondary metabolites after the cessation o f cell growth provides 
another definition o f secondary metabolism. As primary metabolites generally do not 
accumulate, and are in a low steady state concentration, any metabolite that does 
accumulate after the cessation o f growth may be defined as a secondary metabolite. 
Interestingly this definition includes many bona fide primary metabolites, e.g. citrate, 
malate and shikimate. Perhaps a better definition o f microbial secondary metabolism 
was proposed by Duclaux (1925) 1 8 that the accumulated metabolites are 'produits de 
souffrance', that is secondary metabolites are produced when the organism is under 
stress, a state other than its physiological optima. 
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1.2 Elucidation of Metabolic Pathways 
Following structural elucidation it is usually possible to propose a biosynthesis for a 
given secondary metabolite, often by analogy to other known natural products. To set 
about establishing a biosynthetic pathway a variety o f techniques are available. Two 
general strategies are adopted. Either putative intermediates are fed carrying an isotopic 
label, to the producing organism to determine i f it is carried through to the final product. 
Alternatively the pathway may be blocked, by mutation, to observe the accumulation o f 
any intermediates. Although these studies require a synergy o f biological and chemical 
techniques, the former is largely chemical and the latter, biological. 
1.2.1 Biological methods 
1.2.1.1 Mutant studies 
Consider a hypothetical biosynthetic pathway to D, through the putative intermediates 
A, B and C, catalysed by the enzymes a, b and c. 
There are two general methods o f blocking individual steps to observe accumulation o f 
intermediates. Either the enzyme is prevented f rom being expressed at the genetic level 
or its action is inhibited by the addition o f a chemical inhibitor. Chemical inhibitors 
used in vivo are generally not so effective as the inhibitor may interfere wi th other 
metabolic processes.19 On the other hand, preventing the production o f the enzyme, by 
mutation, can be an effective tool. I f the culture is irradiated with U V or X-rays, or 
treated with a chemical mutagen, then random genetic mutations w i l l occur. I f these 
mutations affect the expression o f enzymes involve in primary metabolism then the 
growth o f the organism w i l l be adversely effected. I f however the mutation affects the 
expression o f an enzyme involved in secondary metabolism then the organism w i l l grow 
and any novel metabolites that accumulate can be analysed.2 0 Approaches using this 
method have become increasingly sophisticated. The genes that encode for the enzymes 
required for the production o f certain secondary metabolite are often clustered. This is 
especially the case in the polyketide antibiotics. The function o f many of these genes 
can be proposed by sequence homology to enzymes of known function. By introducing 
a mutation directly into a gene, the substrate for the enzyme that it encodes can be 
identified as it accumulates. Not only is this powerful methodology furthering the 
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knowledge o f individual biosynthetic pathways, but it also produces novel, potentially 
biologically active compounds, for pharmaceutical screening. 
1.2.1.2 Inhibition of protein biosynthesis 
Cycloheximide (16) has been used to inhibit the production o f enzymes necessary for 
secondary metabolism. 1 9 This compound inhibits protein biosynthesis, and i f added just 
prior to the onset o f secondary metabolism it can influence the expression o f target 
pathways. Such studies have demonstrated that enzymes o f secondary metabolism are 
not constitutive and that there is a chemical signal that initiates gene expression. 
Conversely secondary metabolite production in the presence o f cycloheximide (16) 
show that the required enzymes are constitutive and have been biosynthesised prior to 
the onset o f secondary metabolism. 
1.2.1.3 Cell free studies 
Once key steps in a biosynthetic pathway have been identified then in vitro studies can 
provide further information, for example, on substrate specificity or cofactor 
requirements. These experiments can be conducted on crude cell free extracts prepared 
by disrupting the cell walls by pressure, sonication or lytic enzymes. Such studies 
constitute part o f this thesis. 
1.2.2 Chemical methods 
The use o f both stable and radioactive isotopes, in the elucidation o f metabolic pathways 
is well established. The main isotopes used in this context are listed in below (Table 
1.1). 
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Isotope Relative natural abundance, % Radiation 
emitted 
Half- l i fe Spin 
2 H 0.015 stable 1 
3 H P 12.1 years Vi 
l 3 C 1.1 stable V* 
, 4 C P 5700 years 
, 5 N 0.37 stable 
, 8 0 0.20 stable 
32p 
P 14.3 days 
Table 1.1: Properties o f isotopes used in biosynthetic studies. 
1.2.2.1 Radioisotopes 
Radioisotopes have been used to great effect in understanding some o f the fundamental 
pathways in primary metabolism. The application of radioisotopes to biochemistry was 
pioneered in the 1920's by Hevesy (Copenhagen) and 1940's by Schoenheimer (New 
York). Their work led to the fundamental realisation that biomolecules are in a constant 
state o f f lux, being produced on demand.2 1 Using M C 0 2 Calvin showed that the first 
stable intermediate of C 0 2 fixation in plants was 3-phosphoglyceric acid (17). The use 
o f radioisotopes can require degradation studies to deduce the regiochemistry o f 
labelling. This was elegantly used by Cornforth et al22'n to demonstrate that cholesterol 
(19) is biosynthesised ultimately f rom acetate, by tracing the path o f [1- I 4C]-acetate (18) 
through the mevalonic acid pathway into the lipid. 
cholesterol 
O 
> 
biosynthesis 
H 
O 
18 H H 19 
• = I4C HO 
Fig. 1.4: Cholesterol (19) biosynthesis, topological mapping by [1- I 4C]-acetate (18). 
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A disadvantage o f using radioisotopes, beyond radiation exposure issues, is the 
approach offers limited regiochemical information, unless chemical degradation studies 
are employed. 
1.2.2.2 Stable isotopes 
Stable isotopes are now used widely and effectively as a biosynthetic tool. Advances in 
spectroscopic methods over the last thirty years, particularly 1 3 C and 2 H N M R , have 
ensured that stable isotope feeding experiments cannot only demonstrate incorporation 
o f putative intermediates but can also resolve regiochemical and stereochemical issues.24 
One of the many benefits o f using radioisotopes was accurate incorporation 
determination. This accuracy is now possible with stable isotope incorporation through 
GC-MS and l 3 C N M R analysis.2 5 
There are many different types o f feeding experiment that can be conducted. Initial 
studies into the biosynthesis o f a secondary metabolite usually focus on understanding 
the construction o f the carbon skeleton. This is carried out, most straightforwardly, by 
feeding isotopically labelled primary metabolites, such as [l- 1 3C]-acetate (20). Once an 
understanding of the connectivity o f the carbon skeleton has been gained then more 
specific labelling strategies are employed, usually requiring synthetic chemistry to 
prepare appropriate precursors. 
1.2.2.3 Single label feeding experiment studies2* 
The analysis o f feeding putative precursors containing only a single stable isotope 
generally relies on the assessment o f enrichments in the N M R spectrum relative to that 
o f the unlabelled compound. This is particularly relevant for l 3 C and 2 H labelling. I t is 
becoming increasingly common now to investigate the incorporation o f low levels o f 2 H 
due to its low natural abundance (0.01 % ) 
1.2.2.4 Double label feeding studies: 'bond labelling'252* 
Double label feeding experiments are particularly powerful as they directly demonstrate 
bond connectivity. For example, in [l,2- l 3C 2]-acetate (21), the two carbon nuclei couple 
to each other, and i f the bond is not broken through the biosynthetic pathway the 
coupling is retained in the isolated metabolite. This technique is widely applied as an 
initial experiment in many biosynthetic investigations. Other connectivities can be 
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demonstrated, by an extension o f this strategy, either by coupling between magnetically 
active nuclei or by observing a heavy atom induced upfield shift o f e.g. 1 8 0 or 2 H 
bonded to 1 3 C. As the isotopes used in such labelling studies are heavier than their 
'natural' counterparts, the bonds that they form are slightly shorter than those in the 
unlabelled isotopomer, and therefore the chemical environment o f neighbouring nuclei 
is perturbed. In a 1 3 C N M R spectrum a heavy isotope bonded to l 3 C w i l l shift its 
resonance to a lower frequency. Using these techniques the fol lowing bonds can be 
mapped through biosynthesis: 1 3 C - I 3 C , 1 3 C - 1 2 C - 1 3 C , 1 3 C - 1 5 N (by observing coupling); 
, 3 C - 2 H (by observing coupling and an upfield shift); 1 3 C - 1 2 C - 2 H , 1 3 C - I 8 0 (by observing 
the an upfield shift). 
The magnitude of the upfield shift is dependent on the stable isotope and its distance 
f rom the observed 1 3 C nuclei. Some of the largest 1 3 C-NMR shifts to lower frequency 
are observed with a-deuteriums, which can be of ~ 0.6 ppm in magnitude for each 
deuterium. 
Recently 3 H labelling has had a resurgence due to increased access to 3 H N M R . As 3 H 
is not quadrupolar the line broadening inherent in 2 H N M R is absent and the extremely 
low natural abundance of 3 H allows very low levels o f incorporation to be studied. 2 0 
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1.3 Halogenated Secondary Metabolites 
1.3.1 Distribution of halogenated metabolites 
Halogenated secondary metabolites were considered to be somewhat rare in Nature. A 
comprehensive review 2 6 in 1968 listed no more than 30 naturally occurring 
halometabolites, however now the total number o f halometabolites exceeds 2900. 2 7 
Chlorine is the most common halogen found in secondary metabolites,2 8 although there 
are metabolites reported for all o f the stable halogens.29 The thyroid hormone thyroxine 
(22) is one o f the few examples involving iodine. 3 0 Brominated metabolites are 
relatively sparsely distributed, although there are many in the marine environment and 
some have been generated by the replacement o f chloride by bromide in culture media. 3 1 
Chlorinated metabolites, perhaps not surprisingly considering the bioavailability o f 
chloride, in e.g. seawater, are produced in both great number and large amounts. It is 
estimated that bacteria release ca. 5 x 106 tonnes per annum o f methyl chloride into the 
marine environment, compared with 2.6 x 104 tonnes per year f rom man-made sources.32 
A l l o f the classes o f secondary metabolites demonstrate the ability to use halogens in 
natural product biosynthesis, although plant alkaloids have very few examples. 
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Fig. 1.5: Thyroxine (22), vancomycin (23) & tyrian purple dye (24). 
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I t would appear that the ability to produce halogenated metabolites has survived the 
rigours o f natural selection by conferring a selection advantage to the producing 
organism. As wi th other secondary metabolites these compounds are often utilised by 
man. One important example is the glycopeptide vancomycin (23), a last resort 
antibiotic used in the treatment of methicillin-resistant Staphylococcus aureus, where 
the chlorine atoms are important in displaying this biological activity. 3 3 
1.3.2 Mechanisms for biohalogenation 
The biohalogenation of metabolites (primary and secondary) is generally thought to be 
catalysed by haloperoxidases. Haloperoxidases oxidise halide ions to form hypohalites, 
using hydrogen peroxide as the oxidant. 3 4 
haloperoxidase 
U202 + X- - = * " OX + R j O 
The activated ( OX) species then halogenates an organic substrate often in a rather 
indiscriminate manner. The haloperoxidases are classified with regard to their oxidising 
capabilities. Chloroperoxidases oxidise chloride, bromide and iodide, whereas 
bromoperoxidases oxidise bromide and iodide, and iodoperoxidases only oxidise iodide. 
They are further classified by their active site, as either haem-containing, vanadium-
containing or metal-free haloperoxidases.3' A study on metal free bacterial 
haloperoxidases has shown that the oxidising species is peracetic acid generated f rom 
hydrogen peroxide and acetate present in the buffer. In this respect the enzyme appears 
to act as a hydrolase. Peracetic acid can then diffuse away f rom the active site to 
oxidise a halide. 3 5 
Haloperoxidases are generally monitored by a straightforward spectrophotometric assay. 
This involves the halogenation o f synthetic monochlorodimedone (25) wi th the 
concomitant loss o f absorbance at X = 290 nm, by the removal o f the enolone moiety. 3 6 
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Fig. 1.6: Monochlorodimedone (25) assay for haloperoxidases activity. 
Using this assay many haloperoxidases have been identified and isolated and again this 
indicates both the broad substrate and regiospecificity o f haloperoxidases. 
A recent genetic analysis o f the chlorotetracycline (27) 3 7 and pyrrolnitrin (32) 3 8 gene 
clusters has failed to show the presence o f haloperoxidases in their biosynthesis. This 
has led to the demonstration o f an NADH-dependent halogenase, rather than 
haloperoxidase, activity in pyrrolnitrin (32) biosynthesis. I t is proposed that instead o f 
activating the halide (as in haloperoxidase catalysed biosynthesis) the organic substrate 
is activated as an epoxide, with nucleophilic attack o f a halide ion. 
NAD , -H,0 H H C O . H CCLH 
T T 
y N H 
T T 
S N H 
I 
NH, NH, 5^ N N 29 H O H 28 + HADH, OL, H 
CI", H 
H 
CCL H 
a . 
-fr 
S N H NIL N HO 
H 
30 CI 
H,0 
H C C O . H 
S N H LA FL N O - N N 
32 H H 31 C C 
Fig. 1.7: NADH-dependent halogenase in pyrrolnitrin (32) biosynthesis 
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1.4 Fluorinated Secondary Metabolites 
The occurrence o f organo-fluorine compounds is rare in Nature. In fact there are only 
thirteen known natural products containing a C-F bond, isolated primarily f rom tropical 
and subtropical plants, but also microorganisms.2 There are no known examples of 
organo-fluorine compounds in the animal kingdom or f rom the marine environment. 
This dearth o f fluorometabolites is probably due to two main factors: the lack o f 
bioavailable fluoride and the chemistry and thermodynamics o f both fluoride and the C-
F bond. 
1.4.1 Fluorine bioavailability 
As the most abundant halogen in the earth's crust and the 13 t h most abundant3 9 o f all 
elements, the poor bioavailability of fluoride is perhaps paradoxical. However, the 
minerals (e.g. fluorspar) that contain fluorine in the earth's crust are largely insoluble. 
This is exemplified by comparing the amount o f fluoride and chloride in the earth's 
crust and its concentration in sea water. 
Concentration in the Earth's crust (ppm) Concentration in sea water (ppm) 
~F 544 13 
_C1 126 19 000 
Table 1.2: Fluoride and chloride concentrations in the Earth's crust and sea water. 3 9 
Despite this lack o f bioavailability some organisms have developed the capacity to 
tolerate and store large concentrations o f fluoride, including the genus Camellia.40 
Commercial tea (of that genus) contains 70 - 180 \xg g' 1 dry weight fluoride. Certain 
plant species growing on waste f rom fluorspar mining can accumulate fluoride to a 
concentration o f 10 000 ug g"1 dry weight 4 1 and the sponge Halichondria moorei can 
contain a remarkable 10 % of fluorine by dry mass, as potassium fluorosilicate. 4 2 
1.4.2 The Nature of the C-F bond 
In the context o f fluorinated secondary metabolites it is useful to discuss the nature o f 
the C-F bond and fluorine chemistry in general. Fluorine chemistry began in the second 
half o f the 18 l h Century, when Scheele produced a crude solution of hydrofluoric acid 3 9 
(Scheele also isolated the first pure natural products, including some o f the first 
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secondary metabolites), before that it was known to be a component o f the mineral 
fluorspar, f rom which it got its name (fluorspar was used as a f lux; latin fluor, f lowing). 
The element itself was not isolated for a further one hundred years when H . Moissan 
succeeded in the electrolysis o f a solution o f K H F 2 in HF. It was not until 1940 that F 2 
was prepared on an industrial scale, when it was required to produce UF 6 for uranium 
enrichment for the nuclear industry. 
When comparing the C-F bond with other C-X bonds it is noticeable how short, strong 
and polarised the bond is. In fact the C-F bond is the strongest single bond involving 
carbon, being 10 % stronger than the C-H bond. In Table 1.3 fluorine is compared with 
hydrogen and other halogens by way of some physical properties o f the element and the 
bond. 
X Bond dissociation energy, Bond Length, Dipole moment, C H } - Electronegativity 
C H 3 - X (kJmol') C-X (nm) X (Debye units) (Pauling scale) 
F 460 0.139 1.82 4.0 
CI 356 0.178 1.94 3.0 
Br 297 0.193 1.97 2.8 
I 238 0.214 1.64 2.5 
H 414 0.109 0 2.2 
Table 1.3: Physicochemical parameters o f the halogens. 
Fluorine is both the most electronegative and the smallest halogen, this leads to a large 
polarisation o f the C-F bond. The overall dimensions o f a C-F bond is in between that 
o f a C-H and a C-OH bond 4 4 (see Table 1.4) 
Substituent, X Bond length, C - X (nm) Van der Waal's radius (nm) 
H 0.109 0.120 
F 0.139 0.135 
O (in OH) 0.143 0.140 
CI 0.178 0.180 
S (in SH) 0.182 0.185 
Br 0.193 0.195 
I 0.214 0.215 
Table 1.4: Van der Waal's radius and bond length o f C-H and other substiruents. 
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Halogens other than fluorine are introduced biosynthetically via haloperoxidases. 
However, this method is not applicable to fluorination as the redox potential for fluoride 
is too great to be oxidised by peroxide reduction. This high redox potential is in part 
due to the high heat of hydration, which renders fluoride heavily solvated in aqueous 
media. Also being heavily solvated, fluoride emerges as a particularly poor nucleophile 
in aqueous media. 
X Heat o f hydration, X" (kJmol"1) Standard redox potential, E° (V) 
F 490 -3.06 
CI 351 -1.36 
Br 326 -1.07 
I 285 -0.54 
Table 1.5: Heat o f hydration and standard redox potential for the halogens. 
Fluoride is a poor leaving group due to the strength o f the C-F bond, however its ability 
to stabilise P-carbanions and the high heat o f hydration can assist in fluoride 
elimination. 
1.4.3 Fluorinated natural products in plants 
1.4.3.1 Fluoroacetate (1) 
O 
O 
F 
1 
Fig. 1.8: Fluoroacetate (1). 
By far the most abundant o f the fluorometabolites is fluoroacetate (1), a toxin found in 
several species o f tropical and subtropical plants.2 The South African plant 
Dichapetalum cymosum was known to be highly poisonous (known locally as Gifblaar, 
from Afrikaans: Gif - poison). In 1943 fluoroacetate (1) was identified as the toxic 
principle, 4 5 , 4 6 where it was shown to accumulate to 2500 p.g g' 1 dry weight in the young 
leaves o f the plant. Fluoroacetate (1) has now been identified in tropical and sub-
tropical plants in Africa, Australia, Asia and South America. 4 3 With the exception o f 
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Dichapetalum spp., fluoroacetate (1) production is confined to the Leguminales. Not 
only does the level o f fluoroacetate (1) vary greatly across all these species, but within 
each species there is variation depending on the geographic location, season and age of 
the plant. The changes with regard to geographical location could be due either to the 
availability o f fluoride or genetic variation across the species. The mechanisms behind 
the toxic ability of fluoroacetate (1) and rationales for resistance in fluoroacetate (1) 
producing organisms w i l l be discussed below (sections 1.4.4 and 1.4.5 respectively). 
1.4.3.2 ct)-Fluorinatedfatty acids 
The seeds of the fluoroacetate (1) producer Dichapetalum toxicarium are very toxic, but 
unlike the leaves, the seeds contain very little fluoroacetate (1). It has been shown that 
co-fluorooleic acid (33), makes up 3 % of the mass o f the seed oi l and accounts for 80 % 
of the organically bound fluorine. co-Fluoropalmitic acid (36), co-fluoromyristic acid 
(35) and co-fluorocapric acid (34) were also identified as components o f the seed o i l . 4 7 
A more recent study has confirmed that these and a number o f other fluorinated fatty 
acids are present.48 They include co-fluoroarachidonic acid, co-fluoropalmitoleic acid, co-
fluoroeicosenoic acid, co-fluorostearic acid and co-fluorolinoleic acid. Dichapetalum 
toxicarium also displays the ability to biosynthesise tf/reo-18-fluoro-9,10-
dihydroxystearic acid (37). This is likely to form via the epoxidation and hydrolysis of 
co-fluorooleyl-SACP. 
F 
n = 4 34 
n = 6 35 F 
n = 7 36 
Fig. 1.9: ©-Fluorinated fatty acids. 
The biosynthetic origin o f these a>-fluorinated fatty acids can be readily explained by 
fatty acid biosynthesis that utilises fluoroacetyl-SCoA (38) as a starter unit. As 
discussed previously fatty acid biosynthesis (section 1.1.2) proceeds f rom elongation o f 
an acetyl-SCoA (13) starter unit by condensation with malonyl-SCoA (15). In the 
18 
O 
O 
33 
OH 
O 
37 OH O 
terminal position the electronic effects o f the fluorine clearly do not effect the chain 
elongation and presumably the subsequent enzymes do not discriminate the non-
fluorinated f rom the fluorinated fatty acids and they are processed side by side. 
1.4.3.3 Fluoroacetone (39) 
The Australian species Acacia georginae had already been shown to produce 
fluoroacetate (1), although when researchers studied the amounts o f inorganic and 
organic fluorine they noticed a discrepancy,49 which suggested loss o f fluorine, possibly 
as a volatile. It was hypothesised that fluoroacetone (39) could be the volatile as i t had 
been previously identified as a metabolite o f fluoroacetate (1) in rat liver. 5 0 
Fluoroacetone (39) was identified as its dinitrohydrazone (DNP) derivative. The 
volatiles were passed through a DNP solution, which was analysed by paper 
chromatography. It was shown that the derivative co-eluted with the DNP-derivative o f 
synthetic fluoroacetone (39). However, the authors did state that the DNP-derivatives o f 
fluoroacetone (39) and acetaldehyde could not be separated by their system and so by 
the same token fluoroacetaldehyde (40) could not be ruled out. The authors suggested 
however that fluoroacetaldehyde (40) was unlikely to form due to its inherent 
instability. Results presented in this thesis, weaken this conjecture and therefore the 
possibility o f fluoroacetaldehyde (40) being the volatile produced in A. georginae 
remain. 
Assuming that fluoroacetone (39) is a bona fide fluorometabolite, then its bio-origins 
can be rationalised f rom fluoroacetate (1). Following the early stages o f co-fluorinated 
fatty acid biosynthesis, fluoroacetyl-SCoA (38) is condensed with malonyl-ACP (15) to 
form fluoroacetoacetyl-ACP (41). Hydrolysis and decarboxylation o f 4-
fluoroacetoacetate (41) would deliver fluoroacetone (39). 
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Fig. 1.10: Fluoroacetone (39), and its putative biosynthesis f rom fluoroacetate (1). 
1.4.4 Fluoroacetate (1) metabolism: (2R, 3R)-2-fluorocitrate (44) 
The plants that produce fluoroacetate (1) are highly toxic and are responsible for large 
scale cattle losses in Afr ica and Australia, an observation which prompted the original 
studies into the toxic components o f Dichapetalum spp. The toxicity o f fluoroacetate 
(1) led to its sodium salt being licensed as a rat poison and it is still used as such in 
North America and particularly Australia under the trade name 'compound 1080'. 
The physiological effect o f fluoroacetate (1) poisoning is depressed levels o f Ca 2 + , due 
to an increased level o f citrate that is known to bind o f Ca 2 + strongly. 5 1 The origins o f 
this toxicity may lie in the ability o f fluoroacetate (1) to inhibit the tricarboxylic acid 
cycle (TCA or Kreb's cycle). The TCA cycle is the end point o f the catabolic processes 
that yield energy f rom fuel molecules by the complete oxidation o f acetate (6) to C 0 2 . 3 
The T C A cycle is considered to be at the crossroads between catabolism and anabolism 
as it provides many precursors for both primary and secondary metabolism. 
Acetyl-SCoA (13) enters the TCA cycle f rom glycolysis by the oxidative 
decarboxylation o f pyruvate (10) (mediated by pyruvate dehydrogenase), before being 
condensed with oxaloacetate (42) to form citrate (43). Fluoroacetate (1) is involved in 
the 'lethal synthesis' 5 2 o f 2-fluorocitrate (44) by the analogous coupling o f fluoroacetyl-
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SCoA (38) w i th oxaloacetate (42). The 2-pro-R proton f rom fluoroacetate (1) is 
abstracted and condensation with oxaloacetate (42) (attacking the si face), proceeds with 
inversion at C-2." Therefore only (2^,3/?)-2-fluorocitrate (44) is biosynthesised,54 
synthetic studies have shown that the other three diastereoisomers are not toxic. 5 5 
O O H O X OH citrate synthase 
H O X H O X CO,H 
CO.H SCoA 
H„ H 
42 38 44 
Fig. 1.11: Lethal synthesis of (2i?,3^?)-2-fluorocitrate (44) f rom fluoroacetate (1), 
mediated by citrate synthase. 
I t appears that (2/?,3i?)-2-fluorocitrate (44) has the ability to inhibit the next step in the 
TCA cycle, the conversion o f citrate (43) to isocitrate (45) by aconitase (EC 4.2.1.3). 5 6 
Citrate (43) is dehydrated to form c/s-aconitate (46) before being rehydrated in an anti-
Markovnikoff fashion to yield isocitrate (45). (2R, 3Z?)-2-Fluorocitrate (44) is accepted 
as a substrate for aconitase, to form 2-fluoroaconitate (47). The enzyme then mediates 
an SN2' hydroxyl attack to the 5 position, with concomitant fluoride release, to form 4-
hydroxy-/ram ,-aconitate (48), which binds strongly to the enzyme in a non-covalent 
manner. Recent crystallographic evidence5 6 of the aconitase - 4-hydroxy-/ram ,-aconitate 
(48) complex indicates that short hydrogen bonds keep (48) in the active site as a 
transition state analogue. The double bond in this complex cannot be hydrated and 
therefore remains at the active site, released only by a great excess (> 10 4-fold) o f 
substrate (43). 
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Fig. 1.12: Metabolism o f (2R, 3i?)-2-fluorocitrate (44) to 4-hydroxy-^rara-aconitate 
(48). 
Aconitase inhibition may only contribute partially to 2-fluorocitrate (44) toxicity. It 
appears that the Kj for aconitase inhibition is o f the order o f 1 u M , but (2R, 3R)-2-
fluorocitrate (44) is toxic at the 10"4 u M level. 2-Fluorocitrate (44) has been implicated 
in inhibiting citrate (43) transport across the mitochondrial membrane.5 6 
CO„H 
H O X ^ . C O . H 
47 OH 
The toxicity o f the co-fluorinated fatty acids f rom D. toxicarium can also be explained in 
terms o f the lethal synthesis o f fluorocitrate (44), by p-oxidation (section 1.1.2) o f the 
co-fluorinated fatty acids. Through this process the co-fluorinated fatty acids are 
catabolised to acetyl-SCoA (13) and fluoroacetyl-SCoA (38). Neatly this provides 
independent evidence for P-oxidation. The co-fluorinated fatty acids tend to be more 
toxic than fluoroacetate (1) itself and this may be because fluoroacetyl-SCoA (38) is 
generated directly for 2-fluorocitrate (44) synthesis. Consistent with this only the co-
fluorinated fatty acids wi th an even number o f carbon atoms are toxic, i f an odd number 
is present then P-oxidation presumably yields the non-toxic fluoropropionyl-SCoA. 5 1 
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1.4.5 Resistance to fluoroacetate (1) poisoning 
Nature has developed a number o f strategies for resistance to fluoroacetate (1) toxicity. 
As fluoroacetate (1) itself is relatively benign the ability to convert the active and 
potentially toxic (through the lethal synthesis) fluoroacetyl-SCoA (38) to fluoroacetate 
(44) is an effective means o f resistance. A n in vitro activity has been identified in D. 
cymosum capable o f hydrolysing fluoroacetyl-SCoA (38), but not acetyl-SCoA (13). 
This suggests that such a hydrolytic enzyme may be responsible for plant fluoroacetate 
(1) resistance.57 I t has also been suggested that plants have the ability to segregate 
fluoroacetate (1) remote f rom the mitochondria, 5 8 so that it is not processed to (2R, 3R)-
2-fluorocitrate (44). It may be that some plant citrate synthases do not have the ability 
to process fluoroacetyl-SCoA (38) through to 2-fluorocitrate. 5 9 
Microorganisms that are symbionts on plants that produce fluoroacetate (1) have 
developed a defluorination activity. Studies on Pseudomonas spp. 6 0 ' 6 1 , 6 2 and the fungus 
Fusarium solan?3 have demonstrated the ability to defluorinate fluoroacetate (1) and 
this activity is inhibited by thiol blocking agents. It appears that a thiol group on the 
enzyme displaces fluoride to form a thioether (49), which is then hydrolysed to yield 
glycolate (50). When this hydrolysis is carried out in H 2 1 8 0 the resultant glycolate (50) 
incorporates oxygen-18. 6 1 
Enz—SH O 
O O 
Enz— S ^ J L Enz—SH O 
O O H,0 
OH 49 1 50 
Fig. 1.13: Proposed mechanism for microbial fluoroacetate (1) defluorination to yield 
glycolate (50). 
A different mechanism for microbial defluorination has recently been revealed in 
Moraxella Spp. 6 4 A fluoroacetate (1) dehalogenase has been shown to defluorinate 
fluoroacetate (1) via nucleophilic attack by a carboxylate group (from Asp 105 in the 
enzyme), to generate an intermediate ester. This ester is hydrolysed, assisted by His272. 
Multiple turnover o f the enzyme in the presence o f H 2 I 8 0 demonstrated that label was 
incorporated into the enzyme at position Asp 105, rather than the product, supporting the 
mechanism (see Fig. 1.14). 
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Fig. 1.14: Fluoroacetate (1) defluorination in Moraxella spp. B. 
A similar defluorination activity appears in plants and animals. In vitro experiments on 
liver homogenates o f the brush-tailed possum {Trichosurus vulpeculd) demonstrated a 
defluorination based on nucleophilic attack f rom the free thiol from glutathione rather 
than a thiol on an enzyme. 6 5 This generates ^(carboxymethy^glutathione which is 
metabolised to .S'-(carboxymethyl)cysteine. The presence o f S'-(carboxymethyl)cysteine 
fol lowing fluoroacetate (1) defluorination in mouse 6 6 and lettuce 6 7 suggest that this 
defluorination method operates in these systems. 
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1.4.6 Fluorometabolites from microorganisms 
To date there are only two examples o f microorganisms capable o f fluorometabolite 
biosynthesis, both o f which belong to the genus Streptomyces. 
1.4.6.1 Nucleocidin (51) 
Fig. 1.15: Nucleocidin (51). 
Nucleocidin (51) was isolated f rom the bacterium Streptomyces calvus, cultured f rom an 
Indian soil sample.6 8 I t demonstrated broad antibiotic and antitrypanosomal activity, 
although clinical use was curtailed due to its toxicity. Originally a partial structure was 
proposed f rom the empirical formula o f C n H i 6 N 6 S 0 8 , however during the late sixties the 
proposed structure was revised twice. In 1968, on the basis of new chemical and 
spectroscopic evidence, it was proposed that the nucleocidin structure was 9-(4-0-
sulfamoylpentofuranosyl)adenine (C, 0 H| 4 N 6 SO 7 ) , before the same research group 
revised the structure to 9-(4-fluoro-5-0-sulfamoylpentofuranosyl)adenine 
(C| 0 H, 3 N 6 SO 6 F) in 1969. 6 9 This structure has been confirmed through total synthesis.70 
Nucleocidin (51) is the only compound known to display a fluoro-sugar moiety and 
nothing is known about the biosynthesis o f this C-F bond. It is not obvious that 
fluoroacetate (1) could be involved in nucleocidin (51) biosynthesis, suggesting a 
unique C-F bond forming process. Unfortunately recent attempts to re-establish 
nucleocidin (51) production in Streptomyces calvus have failed 7 1 and there is not a 
biological system available to pursue a biosynthetic study on this metabolite. 
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1.4.6.2 Fluoroacetate (1) and 4-fluorothreonine (2) 
O OH 
CO 
O 
F 
1 
F + N H 3 
2 
Fig. 1.16: Fluoroacetate (1) and 4-fluorothreonine (2). 
Fluoroacetate (1) and 4-fluorothreonine (2) are produced by Streptomyces cattleya and 
are the subject o f this thesis. During fermentation studies7 2 on the P-lactam antibiotic 
thienamycin (52) in S. cattleya, it was noticed that an antimetabolite was co-produced. 
The isolation and structural elucidation o f this co-metabolite led to its identification as 
4-fluorothreonine (2) and subsequent l 9 F - N M R studies on the culture broth 
demonstrated the presence of fluoroacetate (1). 4-Fluorothreonine (2) was found to 
exhibit poor antibacterial properties and has an L D 5 0 o f 320 mg/kg (intravenous 
administration) in mice. This compares with an L D 5 0 o f 6.6 mg/kg for fluoroacetate (1) 
toxicity. Total synthesis has since confirmed that naturally occurring 4-fluorothreonine 
(2) is the (2S,3S)-4-fluorothreonine (2) isomer, wi th an identical stereochemistry to L -
threonine. 7 3 The short highly stereoselective synthesis involved the condensation o f 
fluoroacetyl chloride to a substituted imidazolidinone in an extention o f Seebach's 
methodology for preparing a-amino-P-hydroxy acids.7 4 
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1.5 Biological fluorination - proposed mechanisms 
Fluoride is heavily solvated and a poor nucleophile in aqueous media, but despite this 
the most probable mechanism for biological C-F bond formation is the nucleophilic 
attack of fluoride onto an activated carbon. Putative mechanisms for biological 
fluorination, specifically for the biosynthesis of fluoroacetate (1) in plants, have been 
proposed and are discussed below. 
7.5./ Addition to a carbon-carbon multiple bond 
1.5.1.1 Pyridoxal phosphate (53) assisted addition of fluoride 
Mead and Segal75 suggested that fluoroacetate (1) may be biosynthesised in a similar 
manner to P-substituted alanines in plants. The Leguminales, of which Acacia spp. are 
members, are capable of elaborating a variety of unusual P-substituted alanines. These 
amino acids arise by nucleophilic attack on P-position of serine (54) or cysteine (55), 
catalysed by pyridoxal phosphate (53). Seven such p-alanines (56 -» 61) have been 
isolated from Acacia spp.,76 including P-cyanoalanine (56) which was shown to be 
synthesised by this method.77,78 
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Fig. 1.17: Biosynthesis of p-substituted alanines (56 ->• 61) by the Leguminales. 
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The product of elimination of serine or cysteine pyridoxal phosphate adducts (62) is 
subject to Michael-type attack. Hydrolysis of the resultant adducts liberates the p-
substituted alanines as listed in Fig. 1.17. It is reasonable to suggest that a non-specific 
synthase catalyses this nucleophilic attack and may utilise fluoride as a nucleophile, to 
generate pyridoxal phosphate bound p-fluoroalanine (63). The biosynthesis of 
fluoroacetate (1) from this species could occur in one of two ways. Either P-
fluoropyruvate (65) is liberated by hydrolysis and fluoroacetyl-SCoA (38) synthesised 
by oxidative decarboxylation mediated by a pyruvate decarboxylase or the pyridoxal 
phosphate complex (63) undergoes decarboxylation and releases fluoroacetaldehyde 
(40) which could be oxidised to fluoroacetate (1) by an aldehyde dehydrogenase. 
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Fig. 1.18: Putative biosynthesis of fluoroacetate (1), Mead and Segal. 
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The authors cite relevant analogous reactions from within phytobiochemistry, mostly 
based on known S-methylcysteine metabolism.79,80 Mead and Segal examined the effect 
of fluoride and cyanide on extracts of Acacia georginae in order to test their 
hypothesis.81 Cyanide was found to inhibit the formation of pyruvate (10) from cysteine 
(55) (a process catalysed by pyridoxal phosphate (53)), and P-cyanoalanine (56) was 
synthesised in vitro. However, in the presence of fluoride ion there was no production 
of either P-fluoropyruvate (65) or p-fluoroalanine (64). p-Fluoroalanine (64) is unstable 
above pH 7.0, decomposing to liberate inorganic fluoride.82 Also, the pyruvate 
dehydrogenase complex (PDC) stoichiometrically defluorinates p-fluoropyruvate 
(65),83'84 a process mediated by pyruvate decarboxylase. Therefore in cell-free extracts 
at pH 8.5 p-fluoropyruvate (65) may have decomposed prior to detection. It is worth 
noting that the majority of fluoroacetate (1) producers are members of the Leguminales 
which demonstrate the phytobiochemistry necessary to produce P-substituted alanines, 
however Dichapetalum spp. to which many fluoroacetate (1) producers belong, falls out 
side of this group and generally they do not display P-substituted alanine chemistry. 
Interestingly callus tissue of Dichapetalum cymosum has been shown to convert p-
fluoropyruvate (65) to fluoroacetate ( l ) . 8 4 This activity was only demonstrated in cell-
free extracts of the callus tissue, in the presence of a PDC inhibitor, monomethyl 
acetylphosphonate (66),85 demonstrating that p-fluoropyruvate (65) is not 
decarboxylated by PDC itself and that there is a high degree of compartmentalisation to 
separate the two activities. This biotransformation perhaps implies a role for P-
fluoropyruvate (65) in fluoroacetate (1) biosynthesis in Dichapetalum cymosum. 
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Fig. 1.19: The decarboxylation of p-fluoropyruvate (65) by Dichapetalum cymosum. 
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1.5.1.2 Ethylene (67) and ethylene oxide (70) as putative precursors 
Ethylene (67) has been proposed as a potential precursor to fluoroacetate (1). The 
fluoroacetate (1) producer Acacia georginae has been shown to lose fluoride by 
producing a volatile organofluorine compound49 and also produces the plant hormone 
ethylene (67)86 (in bananas this hormone is responsible for the initiating ripening 
process,20 and is now used to artificially ripen bananas once imported). Peters87 
hypothesised that fluoroacetate (1) could be produced via fluoroethane (68) or vinyl 
fluoride (69), although he did not suggest a plausible mechanism. By association 
ethylene oxide (70) has been proposed as an intermediate also,43 which could generate 
fluoroethanol (71), prior to oxidation to fluoroacetate (1). However these routes are 
hypothetical and there is no experimental evidence to support these proposals. 
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Fig. 1.20: Putative pathways to fluoroacetate (1) from ethylene (67). 
1.5.1.3 Nucleophilic attack on a halonium ion 
When a haloperoxidase reacts with an alkene then the reaction product is dependent on 
the relative anion concentrations. Usually a halohydrin species is formed by reaction 
with hydroxide in the buffer, although if there is a relatively high concentration of 
halide ion a 1,2-dihalo species may be formed.88 
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Fig. 1.21: In vitro formation of a halonium ion and subsequent nucleophilic attack. 
Using this methodology Neidleman and Geigert88 prepared 2,3-fluoroiodopropan-l-ol 
(73), by the action of Horseradish peroxidase on allyl alcohol (72) and iodide in the 
presence of H 2 0 2 and fluoride, the first in vitro 'enzyme-associated' formation of a C-F 
bond. 
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Fig. 1.22: The in vitro synthesis of 2,3-fluoroiodopropan-l-ol (73). 
On the basis of this Neidleman and Geigert89 spectulated that fluoroacetate (1) could be 
biosynthesised by the iodofluorination of an ©-unsaturated fatty acid (74) which then 
undergoes de-iodoination and degradation to fluoroacetate (1) via (3-oxidation. 
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Fig. 1.23: The putative biosynthesis of fluoroacetate (1) via an co-fluorinated fatty acid 
(77). 
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The authors presented no supporting evidence for this hypothesis, although they did 
suggest studying the iodine content of fluoroacetate (1) producers. 
1.5.2 Fluorination via nucleophilic substitution 
It is unlikely that fluoroacetate (1) is produced directly by substitution on acetate (6) as 
the methyl group is not activated to such attack. Incubation of the leaves of the 
fluoroacetate (1) producer Dichapetalum cymosum with [2-14C]-acetate did not result in 
incorporation into the resultant fluoroacetate ( l ) . 9 0 This does not seem to inhibit the 
author of one secondary metabolite text9 1 from implying that the origin of fluoroacetate 
(1) is known to be acetate (6), and also to introduce trifluoroacetic acid (78) as a 
constituent of Dichapetalum spp. This latter aberration arose as trifluoroacetic acid (78) 
was used as the internal reference added in a l 9F NMR study in the citation quoted. 
The nucleophilic substitution of the hydroxyl group on glycolate (50) by fluoride to 
produce fluoroacetate (1), is an economical and attractive hypothesis. Due to the bond 
energy of the C-F bond in fluoroacetate (1), substitution could proceed under 
physiological conditions if it were coupled to a spontaneous reaction.92 It is unlikely 
however that hydroxyl would act as a leaving group in this case, but a more realistic 
hypothesis emerges i f it were activated, possibly by phosphorylation.43 
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Fig. 1.24: Nucleophilic substitution of a phosphate group by fluoride. 
The reverse of the reaction is well documented. Microorganisms that are capable of 
utilising fluoroacetate (1) as a sole carbon source have a haloacetate halidohydrolase 
that converts fluoroacetate (1) to fluoride and glycolate (50).60'61'63 The reaction 
proceeds by the nucleophilic attack of a enzyme bound thiol to liberate fluoride and 
produce a thioether bond, which is hydrolysed to yield glycolate (50) (section 1.4.5). 
However the reversibility of this reaction has been studied by the incubation of 
glycolate (50) and fluoride in the presence of H 2 I 8 0. Neither fluoroacetate (1) or 
glycolate (50) became labelled with oxygen-18. 
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1.6 Streptomyces cattleya and the fluorometabolites 
1.6.1 The Streptomycetes 
The majority of Streptomyces spp. are restricted to soil (usually under alkaline or neutral 
conditions)93 and are largely responsible for the 'earthy' smell of some soils as a 
consequence of the release of volatile metabolites such as geosmin (79).94 
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Fig. 1.25: Geosmin (79). 
The genus Streptomyces is associated with two phenomenon; sporulation and antibiotic 
biosynthesis.95 When grown on solid media mature Streptomycetes display 
differentiated morphologies, consisting of a lower branching vegetative mycelium on 
which aerial hyphae form spores or conidia. Closely linked with the onset of 
sporulation is secondary metabolite biosynthesis and the Streptomycetes produce a vast 
diversity of secondary metabolites. These include the polyether, macrolide, tetracycline, 
aminoglycoside and various P-lactam antibiotics. Many of the natural products isolated 
from Streptomycetes have become commercially important being used in medicine and 
in agriculture as feed stock additives. 
1.6.2 Streptomyces cattleya 
Streptomyces cattleya is the thienamycin (52) producing organism isolated by Merck in 
New Jersey, USA.96 Thienamycin (52) is a commercially important broad-spectrum 
antibiotic, active against many Gram-positive and some Gram-negative bacteria. It 
possesses a carbapenem ring system and as such is resistant to many p-lactamases 
which hydrolyse penicillins and cephalosporins. However, under physiological 
conditions, thienamycin is unstable, therefore the derivatives Imipenum (80) and 
Meropenam (81) are used in conjunction with Cilastatin which is an inhibitor of kidney 
dipeptidase, and so slows the degradation of the antibiotics.97 
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Fig. 1.26: Thienamycin (52), imipenum (80) and meropenam (81). 
Biosynthetic studies98 have shown that thienamycin (52) arises by a non-classical P-
lactam biosynthesis. Stable isotope incorporation studies suggest that the pyrrolidine 
ring is derived from glutamate, and the other two carbons of the P-lactam originate from 
an acetate (6) unit. The hydroxyethyl side group is delivered by the consecutive 
addition of two methyl groups from methionine (SAM) and the cysteaminyl side chain 
originates from cysteine. 
Streptomyces cattleya also produces the P-lactams cephamycin C (82) and penicillin N 
(83) and the metabolites 2-hydroxy-2-hydroxymethylcyclopent-4-ene (84) and 3-
ethynylserine (85). 
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Fig. 1.27: Cephamycin C (82), 2-hydroxy-2-hydroxymethylcyclo-pent-4-ene (84), 
penicillin N (83) and 3-ethynyl serine (85). 
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1.6.3 Fluoroacetate (1) and 4-fluorothreonine (2) 
4-Fluorothreonine (2) was isolated and identified during studies to optimise thienamycin 
(52) production when the soybean casein in the media contained inorganic fluoride.72 
Fluoroacetate (1) was not isolated but was identified by l 9F NMR analysis of the culture 
broth. The authors suggested that fluoroacetate (1) might be an intermediate, that could 
be metabolised to fluoroacetaldehyde (40). 4-Fluorothreonine (2) could then be formed 
by the condensation of fluoroacetaldehyde (40) and glycine (86). No discussion on C-F 
bond formation was presented. 
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Fig. 1.28: Proposed biosynthesis of fluoroacetate (1) and 4-fluorothreonine (2), Sanada 
etal.12 
Resting cells of Streptomyces cattleya were already known to produce thienamycin (52), 
so Sanada et al. used this system to study fluorometabolite production under a variety of 
fluorine sources. Resting cells are prepared when an organism is in its idiophase and the 
cells are harvested and suspended in a buffer. This allows the biosynthesis to be studied 
by supplementing the cells with putative precursors as the sole carbon source. Both of 
the fluorometabolites were produced by resting cells of S. cattleya in the presence of 4-
fluoroglutamate, sodium fluoroacetate and potassium fluoride. They also noted that 4-
fluorothreonine (2) when supplemented to resting cells, could support fluoroacetate (1) 
biosynthesis. 
Reid et al." in the first publication from a collaboration between The Queen's 
University of Belfast and The University of Durham, published a detailed account of 
fluorometabolite production in both growing and resting cells. The concentrations of 
the fluorometabolites were determined by l9F-NMR analysis, by comparing integral 
heights with an internal standard (fluoroacetone (39)) for which a calibration curve had 
been obtained. It was noted that fluorometabolite production commenced just after 
maximum growth of the organism, in a classical manner. The onset of fluorometabolite 
production was characterised by the concurrent production of fluoroacetate (1) and 
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4-fluorothreonine (2), although the rate of fluoroacetate (1) production was greater. The 
culture medium when supplemented with 2 mM inorganic fluoride generated 
fluoroacetate (1) at 1.2 mM and 4-fluorothreonine (2) at 0.5 mM. In time, essentially all 
of the fluoride was utilised for fluorometabolite production and both of the 
fluorometabolites were excreted extracellularly. 
Resting cells of Streptomyces cattleya were optimised for fluorometabolite production. 
It was noted that resting cells prepared from cells 6 - 1 0 days old were capable of 
fluorometabolites production. The pH optima in terms of fluoride uptake into the cells 
was pH 6.0, however there was a discrepancy between amount of fluoride taken into the 
cells and fluorometabolites excreted from the cells. Even though the rate of fluoride 
uptake was low at pH 6.5 (compared to pH 6.0) the fluorometabolites produced equated 
with the amount of fluoride removed from the buffer. Therefore these conditions 
revealed that the rate-limiting step is fluoride uptake by the cells. 
Using these optimised resting cells (6 day old cultures, pH 6.5) various H C labelled 
putative intermediates were administered to the bacterium and specific incorporations 
into fluoroacetate (1) measured.99100 The best carbon source under these conditions was 
[U-MC]-glycolate (incorporation between 1.7 % and 4.1 %). D-[U-14C]-Glucose and [U-
l4C]-glycerol gave lower incorporations (1.6 % and 1.1 % respectively). However, it 
was suggested that these are such good carbon sources that they were also being utilised 
in primary metabolic processes. The relatively high incorporation of [U-14C]-glycolate 
could be consistent with fluoroacetate (1) being biosynthesised by the nucleophilic 
displacement of the alcohol group (most likely in an activated form) by inorganic 
fluoride (section 1.5.2) 
In 1995 Soda et al.m published an account of the biosynthesis of fluoroacetate (1) and 
4-fluorothreonine (2) in Streptomyces cattleya. They monitored the production of both 
fluoroacetate (1) and 4-fluorothreonine (2) by l9F-NMR and noticed that fluoroacetate 
(1) started to accumulate earlier than 4-fluorothreonine (2). From this they conjectured 
that fluoroacetate (1) is metabolised to 4-fluorothreonine (2). However, the 
accumulation of a metabolite does not imply its position in a biosynthetic pathway as 
many intermediates exist only in low steady-state concentrations. In fact if the rate of 
the hypothetical conversion of fluoroacetate (1) to 4-fluorothreonine (2) was high then 
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the latter might be expected to accumulate first despite the former preceding it 
biosynthetically. 
Soda et al. also reported feeding experiments with l 4C labelled primary metabolite 
intermediates, in both growing and resting cell preparations, supplemented with 10 mM 
KF. These feeding studies were conducted using a mutant organism (Streptomyces 
cattleya NTG29), generated by treating the wild type (S. cattleya NRRL 8057) with JV-
methyl-A '^-nitro-A^-nitrosoguanidine. They surmised that fluoroacetate (1) was 
biosynthesised from glycerol (87) via P-hydroxypyruvate (88), a conclusion supported 
by relatively high incorporations of label from [U-14C]-glucose, [U-l4C]-glycerol, [U-
l4C]-serine and [U-l4C]-(i-hydroxypyruvate compared with lower incorporations from 
[U-14C]-aspartate, [2,3-l4C]-succinate and [3-14C]-pyruvate. A key experiment involved 
the feeding of [2-l3C]-glycerol (89). The resultant fluoroacetate was isolated and 
purified by preparative HPLC and was analysed by NMR ('H, , 3C and 19F) and GCMS 
of the methyl ester. [2-l3C]-Glycerol (89) labelled only C-l of fluoroacetate (la) at a 
high incorporation of 40 %. 
Fig. 1.29: [2-l3C]-glycerol (89) incorporation into fluoroacetate (la), Soda et al. 
The authors proposed that glycerol (87) is converted to p-hydroxypyruvate (88) which is 
processed through to fluoroacetate (1) by fluorination and decarboxylation. 
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Fig. 1.30: Putative conversion of p-hydroxypyruvate (88) to fluoroacetate (1), 
Soda et al. 
As there are two possible pathways there are two possible intermediates: p-
fluoropyruvate (65) and glycolate (50). Feeding experiments with [2-14C]-glycolate and 
[l,2-nC2]-glycolate resulted in low incorporations into fluoroacetate (1) (c.f. Reid et al.) 
and it was concluded that glycolate (50) is unlikely to be a direct intermediate. No 
experiments with commercially available p-fluoropyruvate (65) were reported, but this 
compound defluorinates rapidly in vivo by the action of pyruvate decarboxylase. 
The authors suggested that as fluorination could not be catalysed by a haloperoxidase, 
the displacement of a leaving group by the fluoride anion was clearly a more 
satisfactory possibility. 
1.6.4 The biosynthetic relationship between fluoroacetate (1) and 4-fluorothreonine 
(2) 
Both Sanada et al. and Soda et al. suggested that 4-fluorothreonine (2) was derived by 
fluoroacetate (1) metabolism. However, evidence now argues against this. Reid et al. 
incubated resting cells of S. cattleya with various organofluorine compounds including 
fluoroacetate (1) and 4-fluorothreonine (2). In both cases the rate of interconversion 
was estimated to be at least an order of magnitude too low to account for the levels of 
the fluorometabolites generated when the bacterium is grown in the presence of fluoride. 
The rate of interconversion from fluoroacetate to 4-fluorothreonine (2) was 20-fold too 
slow and when [2-2H2]-fluoroacetate (lb) was administered to the bacterium the isotope 
was not incorporated into 4-fluorothreonine (2). 
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Fig. 1.31: [2-2H2]-Fluoroacetate (lb) does not label 4-fluorothreonine (2), Reid et al. 
This suggests that interconversion per se does not happen, but the 4-fiuorothreonine (2) 
production can be rationalised by defluorination. I f Streptomyces cattleya has the 
ability to defluorinate fluoroacetate (1) the liberated fluoride will be utilised in de novo 
biosynthesis of both fluoroacetate (1) and 4-fluorothreonine (2). Evidence for this was 
provided by incubating S. cattleya with [3-2H]-4-fluorothreonine (2a), which indeed 
generated unlabelled fluoroacetate (1) and 4-fluorothreonine (2) from fluoride, as well 
as retaining some labelled [3-2H]-4-fluorothreonine (2a). 
1.6.5 Incorporation of stable isotope enriched glycolate (50), glycine (86) and 
pyruvate (10) 
Reid et al. demonstrated that glycolate (50) could act as an effective carbon source for 
fluorometabolite production. The development in Belfast and Durham of GC-MS and 
l 9F NMR analysis of the fluorometabolites has allowed for a more detailed study of their 
biosynthesis.102103 I 9F NMR analysis of fluoroacetate (1) and 4-fluorothreonine (2) was 
refined so that proton decoupled l 9F{'H}-NMR spectra could give positional 
information on the incorporation into fluoroacetate (1) and positions 3 and 4 of 4-
fluorothreonine (2). GC-MS analysis of derivatives of fluoroacetate (1) and 4-
fluorothreonine (2) (para-phenylphenacyl and T^-memyl-A^-trimethylsilyltrifluoro-
acetamide (MSTFA) derivatives respectively) enabled the determination of absolute 
levels of stable isotope incorporation. For a more detailed discussion of these 
techniques see sections 2.2.2 & 2.2.3. 
Initial feeding experiments have traced l3C-labelled glycolate (50) and, the 
metabolically related, glycine (86), through to fluoroacetate (1) and 4-fluorothreonine 
(2). [1-13C]-, [2- l3C]- & [l,2,-13C2]-Glycine (90), (91) & (92) were each fed to resting 
cells of Streptomyces cattleya. This series of experiments revealed that both C-l and C-
2 of fluoroacetate (1) and both C-3 and C-4 of 4-fluorothreonine (2) are derived from 
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[2-13C]-glycine (91). [l-l3C]-Glycine (90) did not label the fluorometabolites, and [1,2-
l3C2]-glycine (92) gave a labelling pattern similar to that of [2-l3C]-glycine (91) alone. 
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Fig. 1.32: Recombination of label from [2-13C]-glycine (91) into both fluoroacetate (lc) 
and 4-fluorothreonine (2b). 
[2-l3C]-Glycine (91) was incorporated at a level of 32 %, whereas [2-13C]-glycolate gave 
a similar labelling pattern, but at a level of 9 %. This apparently contradicts the results 
obtained by Reid et al. who noted that glycolate (50) was a better precursor than glycine 
(86). However, further studies in the light of this anomaly have shown that the level of 
incorporation into the fluorometabolites was particularly sensitive to both substrate 
concentration and cell density in these resting cells experiments. This also explains why 
Sanada et al. found that glycolate (50) was a poor precursor in their experiments. 
The incorporation of double label from [2-13C]-glycine (91) can be explained in terms of 
serine (54) metabolism. Serine hydroxymethyltransferase catalyses the combination of 
two molecules of glycine (86) to generate serine (54). The conversion utilises N5^10-
methylenetetrahydrofolate (THF), and can account for the observed labelling pattern 
from glycolate (50) and glycine (86). 
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Fig. 1.33: Glycine (86) recombination via serine (54). 
Clearly following this hypothesis serine and related metabolites should become readily 
incorporated into both fluoroacetate (1) and 4-fluorothreonine (2). This is indeed the 
case with 13C labelled serine (54) and pyruvate (10) labelling the fluorometabolites in a 
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manner consistent with this hypothesis. Pyruvate (10) is metabolically related to serine 
by way of serine dehydratase. [2- l3C]- & [3-13C]-Pyruvate (93) & (94) labelled C-l and 
C-2 of fluoroacetate (1) and C-3 and C-4 of 4-fluorothreonine (2) respectively, by 
analogy and [l-l3C]-pyruvate did not result in any significant labelling. 
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Fig. 1.34: Incorporation of [2-13C]- & [3-13C]-pyruvate (93) & (94) into fluoroacetate 
(la & Id) and 4-fluorothreonine (2c & 2d). 
The similarity of the labelling patterns into each metabolite in given examples, both in 
terms of magnitude and regiochemistry in fluoroacetate (1) and positions 3 and 4 of 4-
fluorothreonine (2) was observed to be a reproducible feature of these whole cell 
feeding experiments. Since they contain the same labelling pattern the biosynthesis of 
fluoroacetate (1) and 4-fluorothreonine (2) must follow, at least in part, a common 
pathway. This common pathway must include the fluorination step and as it is already 
known that the level of interconversion between the fluorometabolites is low. The 
current working hypothesis predicts at least one common fluorinated intermediate. 
1.6.6 The stereochemical processing of glycerol (87) 
Sanada et al. fed [2-l3C]-glycerol (89) and demonstrated that it effectively labelled 
position 1 of fluoroacetate (1). Glycerol (87) is prochiral, and can be rendered chiral 
when labelled with stable isotope. Nieschalk et al.m synthesised both (2^)-[l , l- 2 H 2 ]-
glycerol (95) and (2S)-[l,l-2H2]-glycerol (96), and fed these chiral glycerols to resting 
cells of Streptomyces cattleya. Analysis of the fluorometabolites demonstrated that 
label was incorporated only via the metabolism of (2i?)-[l,l-2H2]-glycerol (95), which 
delivered both deuterium atoms into the fluoromethyl group. 
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Fig. 1.35: The feeding of chiral glycerols (95) & (96) to S. cattleya, Nieschalk et al. 
This key experiment highlighted the involvement of the glycolytic pathway in the 
biosynthesis of the fluorometabolites. The glycolytic pathway catabolises carbohydrates 
to yield pyruvate (10), which is then involved in further catabolism via the TCA cycle. 
Glycerol (87) can enter the glycolytic pathway as glycerol-3-phosphate (97) which is 
oxidised to form dihydroxyacetone phosphate (98), a key intermediate in the pathway. 
When glycerol (87) is used as a carbon source by a microorganism, the first step in its 
activation is phosphorylation by glycerol kinase. This phosphorylation is stereospecific 
operating on the pro-R hydroxymethyl group of glycerol (87). 
In the event label was retained from the chiral glycerol (95) where the deuterium atoms 
were present on the pro-R arm. This indicated that the fluoromethyl group in the 
fluorometabolites is ultimately derived from C-l of 1-phosphoglycerol (97), the carbon 
that is phosphorylated. 
There is a low amount of single label (5 % compared with 28 % double label) which can 
be accounted for by wash out, possibly via enolisation on the glycolytic pathway. 
However retention of both deuteriums suggests that this carbon does not become 
oxidised between phosphorylation and fluorination and a plausible explanation could be 
that fluorination is effected by the displacement of a phosphate leaving group (section 
1.5.2). 
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1.6.7 Overview 
Previous studies have shown the assimilation of many different metabolites into 
fluoroacetate (1) and 4-fluorothreonine (2). The metabolic relationship between the 
primary metabolites that incorporate label into the fluorometabolites and the pattern in 
which they do so is consistent with the substrate for fluorination being delivered from 
the glycolytic pathway and is outlined below in Fig. 1.36. 
glycerol 
glycolytic pathway ». fluorometabolites 
pyruvate oxaloacetate 
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Fig. 1.36: The metabolic relationship between primary metabolites that contribute to 
fluorometabolite biosynthesis. 
From the outset this project has focused on identifying the substrate for fluorination. 
Initially the role of the glycolytic pathway was investigated and this developed towards 
further biotransformation studies with putative initial products of fluorination. 
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Chapter 2 V 
Fluorometabolite biosynthesis and primary metabolism 
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2.1 Maintenance and growth 0/Streptomyces cattleya 
At the outset of this study it was necessary to reassess the production parameters of 
fluoroacetate (1) and 4-fluorothreonine (2) in Streptomyces cattleya. To this point, our 
collaborators at the Queen's University of Belfast had carried out the majority of the 
resting cell feeding experiments. It was important that resting cell experiments in 
Durham were conducted in an identical fashion in both laboratories so that results 
generated from the two groups could be directly compared. 
Reid et a/.98 had conducted a detailed study of fiuorometabolite production in batch 
cells. The onset of fluoroacetate (1) and 4-fluorothreonine (2) production was shown to 
be concurrent, starting just after day 4 of batch cell growth. Day 4 was also a maximum 
in terms of cell density in the culture and so fiuorometabolite production could be 
considered to initiate with the onset of the idiophase. 
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Fig. 2.1: Growth of S. cattleya and fluorometabolite production. • growth, a fluoride, 
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Fig. 2.2: • Fluoroacetate (1) and o 4-fluorothreonine (2) production in S. cattleya. 
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However, these results were obtained over 4 years ago and in a different laboratory. It 
was therefore important to assess the onset of fluorometabolite production in the 
Durham laboratory. 
2.1.1 Preparation of a starter culture o/Streptomyces cattleya 
Streptomyces cattleya NRRL 8057, obtained from the Belfast laboratory, was 
maintained on agar slopes on a complex media. The media contained soybean flour (2 
% w/v), mannitol (2 % w/v), agar (1.5 % w/v) and tap water, and the culture was grown 
for 14 days at 28 °C. It was usual to observe growth within 2-3 days as small white 
colonies. By day 10 the thick vegetative mycelium that had formed began to colour, so 
that by day 14 the culture was pink / purple. These slants were then sealed and stored at 
4 °C, and in general they remained viable for one year. 
For biosynthetic studies on the fluorometabolites the bacterium was grown in a 
chemically defined (minimal) liquid media. The media was prepared as follows: 
Previously prepared solutions (ion solution 150 ml, carbon source solution 75 ml, 
phosphate buffer solution 75 ml, fluoride solution 3 ml) were added to 450 ml of water 
in a 1 1 Erlenmeyer flask. For the exact composition of these solutions see section 
5.2.2. After mixing, an aliquot (90 ml) was decanted into a sterilised 500 ml 
Erlenmeyer flask and was inoculated with a loop of mature mycelium from the agar 
slopes. This starter culture was then incubated for 4 days at 28 °C on an orbital shaker 
(175 rpm). It was necessary to subculture the bacterium once it had past the lag phase 
(4 days), when there was considerable cell mass, and the culture was starting to colour 
slightly (pink / purple). 
2.1.2 Preparation of batch cultures of Streptomyces cattleya 
The sterile defined media, prepared for the starter culture, was stored at 4 °C for 4 days. 
It was then transferred to 7 x 500 ml Erlenmeyer flasks (90 ml each), and inoculated 
from the starter culture (0.3 ml). The cultures were then incubated for 8 days at 28 °C. 
During this time the following observations were made. By day 4 the cell mass had 
coloured (pink-purple) and the cultures began to smell of the volatile, geosmin (79). By 
day 6-7 the cultures lost their pink-purple colour and become golden-brown. 
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2.1.3 Time course study on fluorometabolite biosynthesis 
In order to monitor the ability of these batch cultures of Streptomyces cattleya to 
produce fluorometabolites a time course study was planned at the outset. In this 
experiment, batch cultures, prepared as described above had an aliquot removed every 
12 hours for 14 days. For each aliquot the pH was measured and the fluoride 
concentration determined. The cells were removed from this aliquot (1 ml) by 
microcentrifugation (5000 rpm, 10 minutes) and the supernatant stored at -4 °C pending 
analysis. 
2.1.3.1 Results: pH analysis 
The pH of all of the samples was recorded using a pH microelectrode. The mean 
average of 4 samples for each time point was determined and is plotted against time as 
shown below (Fig. 2.3). 
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Fig. 2.3: The variation of pH with time in batch cells of S. cattleya. 
The pH of the defined media is buffered to pH 7.0. Therefore the observed 
perturbations are effects greater than the buffering capacity of the phosphate buffer. On 
day 3 there is a clear drop in the pH value to 5.7 after which the pH rises again and 
remains relatively constant at pH = 6.5 for the remainder of the experiment. 
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2.1.3.2 Results: fluoride analysis 
Fluoride concentrations were determined using a fluoride selective electrode. Each 
sample (0.5 ml) was mixed with 1.0 M H 2 S0 4 (0.5 ml) and 0.5 M K N 0 3 & 0.5 M 
trisodium citrate (4.0 ml). The potential difference of the sample was recorded and 
compared with a standard curve generated in the same way, with NaF solutions of 10.0 
mM, 5.0 mM, 2.0 mM, 1.5 mM, 1.0 mM, 0.5 mM and 0.1 mM. 
[NaF] / mM 10.0 5.0 2.0 1.5 1.0 0.5 0.1 0.0 
P D / m V -470 -453 -430 -420 -413 -392 -367 -309 
Table 2.1: Calibration data for the fluoride selective electrode. 
-350 . 
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-lg [NaF] 
Fig. 2.4: Calibration curve for fluoride selective electrode. 
The calibration curve was generated by plotting the -lg [F ] against the potential 
difference (PD). Using this calibration curve the fluoride concentration for any given 
sample could be measured. To that end the supernatant (0.5 ml) from each aliquot of 
batch cells was treated in a standard manner and the potential differences measured to 
deduce the fluoride concentration. Fig. 2.5 shows the mean average of 4 samples at 
each time point plotted against time of incubation 
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Fig. 2.5: Fluoride uptake by batch cells of S. cattleya. 
Clearly, the fluoride concentration in the supernatant began to drop after day 3 and 
continued to do so until day 8. It then remained constant until the termination of the 
experiment. 
2.1.3.3 Discussion 
The drop in pH and the beginning of fluoride ion uptake into the cells are concurrent, on 
day 3. This also correlates; visually with the maximum in cell growth, and therefore the 
end of the trophophase. Reid1 0 5 showed that fluorometabolite biosynthesis begins when 
fluoride is taken up into the cells and therefore, the fluorometabplites are produced in a 
classical manner for microbial' secondary metabolites. However it was noticed that not 
all of the fluoride (approximately 1 mM) was utilised by the bacterium in 
fluorometabolite biosynthesis, whereas Reid 1 0 5 found that essentially all of the free 
fluoride was utilised by the cells. 
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2.2 Studying fluorometabolite biosynthesis 
2.2.1 Preparation of resting cells of Streptomyces cattleya 
Resting cells have been used extensively in the study of fluorometabolite production in 
Streptomyces cattleya. ">i.tc»2.io3.io5,io6,io7,io8 S T E R I L I S E D M E S b u f f e r ( 5 0 mM) was used 
throughout this and the previous studies and the pH was adjusted to 6.5 using 1.0 M 
NaOH (aq.). The viability of the cells was assessed, prior to harvesting, by removing an 
aliquot from each flask. The cells were removed by centrifugation and the pH of the 
supernatant measured to assess i f the pH was 6.5 ± 0.2. In cases of any doubt the 
fluoride uptake was also measured as discussed in section 2.1.4. Only 'healthy' cells 
were used in resting cell experiments. Cells were then prepared by harvesting mature 
cells of the bacterium (on day 8 of batch cell growth) by centrifugation. As the 
fluorometabolites are excreted extracellularly, the cells were washed three times in MES 
buffer, to remove any endogenous fluorometabolites and any other potential carbon 
sources excreted from the cells. Typically, batch cells were prepared by the method 
described in section 2.1.2, yielding between 10 and 12 g in wet weight. The bacterial 
pellet was then resuspended in buffer at a final concentration of 0.176 g.ml"1 wet wt. 
Resting cell experiments were carried out by taking this cell suspension (5 ml) and 
adding putative precursors at a known concentration. I f the precursor contained no 
organically bound fluorine then the cells were supplemented with NaF (final 
concentration 2 mM) and the total volume of the experiment taken to 23 ml with MES 
buffer. To maintain the aseptic conditions in the resting cell flask, putative precursors 
were added via filter sterilisation, through a presterilised 20 |j.m nylon membrane. 
Resting cell experiments were then incubated for 48 hours at 28 °C on an orbital shaker 
(180 rpm). The experiments were arrested by spinning down the cells by centrifugation 
(20,000 rpm, 20 minutes) and the supernatants were frozen pending analysis. Individual 
experiments were then analysed by 1 9F {'H} NMR (section 2.2.2) and / or GCMS 
(section 2.2.3). 
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2.2.1.1 Resting cell experiments: controls 
Resting cell experiments were conducted in duplicate (whenever possible) and the 
following controls were employed. Fluorometabolite production was assessed in the 
absence of any putative precursors, that is utilising only carbon sources present in the 
cells, by incubating cells (5 ml) with 40 mM NaF (1 ml, final concentration 2 mM) in 
MES buffer (17 ml). This was designed to demonstrate any anomalies from usual 
patterns of fluorometabolite production and allowed the natural isotopic abundance of 
the fluorometabolites to be calculated for referencing in GCMS analysis (see section 
2.2.3). 
The ability of a specific set of resting cell experiments to incorporate isotopically 
enriched precursors was evaluated by adding [2-13C]-glycine (91) to the medium as a 
control. Cells (5 ml) were incubated with 40 mM NaF (1 ml, final concentration 2 
mM), and 200 mM [2- l3C]-glycine (91) (1 ml, final concentration 10 mM) in MES 
buffer (16 ml). The labelling pattern resulting from this experiment is well established 
and the levels of isotope incorporation are used as a reference. The observations from 
feeding this precursor are described in greater depth in the subsequent sections. 
2.2.2 Studying fluoroacetate and 4-fluorothreonine with 19FNMR 
As discussed previously l 9F NMR has been used by both Soda et al.101 and Reid et al" 
to monitor and quantify fluorometabolite production. However, this technique is 
particularly powerful for determining incorporation of isotopes into both of the 
fluorometabolites. Using proton decoupled l 9F {'H} NMR regiochemical information 
on stable isotope incorporation (both 2 H and 1 3C) into the fluorometabolites can be 
readily obtained. For example, in the case of 4-fluorothreonine (2), deuterium atoms 
can potentially label C-3 and C-4 once (in 2 combinations), twice (2 combinations) or 
three times (see Fig. 2.6). 
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OH OH OH HO D 
T Y 
D H D CO CO CO CO D D D 
NH NH NH NH 
[4,4-2 [3,4,4-2H3]-(2) [4-'H]-(2) H,H2) 2 
HO D HO D 
H CO CO D 2 
NH NH 
[3,4-2 H,]-(2) [3-2H]-(2) 
Fig. 2.6: Potential patterns of deuterium labelling in 4-FT (2). 
The fluorine signal in the l 9 F{ 'H} NMR spectrum in all of the labelled species 
illustrated in Fig. 2.6 is different, because the chemical shift is perturbed by the 
deuterium isotope, to a different extent in each case. This induced isotope shift is 
cumulative and decreases with the increased distance between the isotope and the 
fluorine atom. The effect is also observed with 1 3C isotope incorporation, although the 
magnitude of the upfield shift is not so great, because the ratio of the mass 1 3C / l 2C is 
much less than 2 H / 'H. The magnitude of the induced upfield shifts in 1 9F NMR are 
tabulated below (Table 2.2). 
Stable Isotope Shifts to the lower frequency / ppm 
a-shift P-shift y-shift 
2 H 0.55 0.30 
13 C 0.07 0.02 
Table 2.2: Upfield shifts observed in l 9F {'H} NMR due to 2 H and l 3 C in both 
fluoroacetate (1) and 4-fluorothreonine (2). 
Proton decoupling greatly enhances the signal to noise ratio as the signals collapse into 
singlets as coupling to protons in removed. 
The following two examples from previous studies demonstrate the use of these upfield 
shifts in determining the regiochemical location of isotope incorporation. When resting 
52 
cells of Streptomyces cattleya were supplemented with [2,2,3,3-2H<t]-succinate (99),103 
both fluoroacetate (1) and 4-fluorothreonine (2) were labelled with a single deuterium 
atom in the fluoromethyl group (le & 2f). Fig. 2.7 shows that both fluorometabolites 
have a large unlabelled peak and associated with each is the signal arising from the 
population of molecules carrying a deuterium atom. 
J 
FAc (1) 
[2-2H]-FAc (le) 
4-FT (2) 
[4-2H]-4-FT (2f) 
• I I I ' 
-216 -218 -220 -222 -224 -226 -228 
Fig. 2.7: l 9 F{ 'H}NMR of FAc (1 & le) and 4-FT (2 & 2f) labelled via [2,2,3,3-2H4]-
succinate (99) metabolism. 
As , 3 C has I = Vi there is coupling between carbon-13 and the fluorine atom (I = I/2), 
generating a doublet. [3-13C]-Pyruvate (100) is metabolised to deliver isotope into the 
fluoromethyl groups of each fluorometabolite and accordingly Fig. 2.8 shows that the 
unlabelled signal for each fluorometabolite has an associated doublet (centred on an 
upfield shift of + 0.07 ppm and 'J F C = 165 Hz), arising from this coupling. 
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FAc (1) 4-FT (2) 
r i 
U I 
u 
t V 
s 
9.30 -229.50 ppm 15.05 ppm -229.10 14.85 214.65 
-216 -218 -220 -222 -224 -226 -228 ppm 
Fig. 2.8: 1 9 F{ 'H}NMR of FAc (1 & Id) and 4-FT (2 & 2d) labelled Wo [3- 1 3C]-
pyruvate (100) metabolism. 
1 9 F{ 'H}NMR analysis cannot, however, yield any information on labelling in positions 
1 & 2 of 4-fluorothreonine (2) as isotopes at these locations are too distant from the 
fluorine atom to perturb the chemical shift. For that information GC-MS analysis is 
used. 
2.2.2.1 Feeding2H20 
In order to demonstrate the effectiveness of the upfield shift originating from deuterium 
incorporation into the fluorometabolites an experiment was carried out in 20 % 2 H 2 0 . 
Deuterium from the medium was expected to label the fluorometabolites in a rather 
indiscriminate manner. Accordingly, deuterium oxide (5 ml) was added to the cell 
suspension (5 ml) with 50 mM MES buffer (13 ml). After incubation for 48 hours, the 
resultant supernatant was analysed by 1 9F {'H} NMR (Fig. 2.9). 
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Fig. 2.9: 1 9F { l H} NMR analysis of resting cells of Streptomyces cattleya incubated in 
the presence of 2 H 2 0 . 
The fluoroacetate (1) resonance (8F = -2\SA1 ppm) in the resultant l 9F {'H} NMR 
spectrum has two associated upfield peaks (5F = -216.05 ppm and 5F = -216.63 ppm), 
which corresponds to populations of to FDHC- and FD2C- fluoroacetate (1). The 
deuterium nuclei also couples with the fluorine nuclei, although the resolution of the 
spectrum is not sufficient to obtain accurate information on those coupling constants. 
The 4-fluorothreonine (2) resonance (8 F = -229.89 ppm) also has related upfield peaks, 
due to unlabelled populations of 4-fluorothreonine (2). These display quite elegantly 
the additive nature of the upfield shift. The first peak (8F = -230.13 ppm) results from a 
y-shift (+ 0.24 ppm) due to a 2 H at C-3 and the second peak (5F = -230.47 ppm) is also 
due to a single isotope incorporation, in this case a (3-shift (+0.58 ppm), from a 
deuterium atom on the fluoromethyl group. Following this are two additional resolved 
peaks corresponding to double label incorporations. Label in both the C-3 and C-4 
results in a (3 + y-shift. combination (8F = -230.71 ppm, +0.82 ppm). The peak to the 
highest field is due to a 2p-shift (8F = -231.05 ppm, +1.16 ppm). 
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There are also other resonances in the fluoromethyl region shown in Fig. 2.9. These 
relate to as yet unidentified fluorinated metabolites of Streptomyces cattleya, the 
production of these metabolites is relatively rare but they do appear from time to time in 
low concentration and clearly could have some significance as biosynthetic 
intermediates or are metabolites of fluoroacetate (1) and 4-fluorothreonine (2). 
2.2.2.2 Incorporation of [2-'3C/-glycine (91) into the fluorometabolites: 19F NMR 
analysis 
As stated previously (section 2.2.1.1) [2-'3C]-glycine (91) is used as a control in feeding 
experiments on resting cells of Streptomyces cattleya. The label at C-2 of this amino 
acid has been shown to recombine (section 1.6.5) via serine hydroxymethyl transferase 
to contribute both C-l and C-2 of fluoroacetate (1). Likewise [2- l3C]-glycine (91) 
enriches C-3 and C-4 of 4-fluorothreonine (2) with carbon-13. This incorporation is 
readily observed by l 9 F{ 'H}NMR (Fig. 2.10), where each fluorometabolite signal has an 
associated doublet of doublets (centred on an upfield shift of + 0.09 ppm 'J F C = 165 Hz 
and 2 J F C = 18 Hz) due to coupling of fluorine with both isotopes. 
- 2 1 6 a - 2 1 6 . 6 - 2 1 6 . 8 ppm 
Ml" 
- 2 3 0 . 7 - 2 3 0 . 9 ppm 
Fig. 2.10: l 9F {'H} NMR analysis of resting cells of Streptomyces cattleya incubated 
with [2- l3C]-glycine (91). 
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2.2.3 GCMS analysis of fluoroacetate (1) and 4-fluorothreonine (2) 
Gas chromatography - mass spectroscopy (GC-MS) is a powerful tool in biosynthetic 
studies. In this study it provides a limited amount of positional information, but more 
importantly accurate data on the levels of isotope incorporation, with a lower detection 
level than l 9F {'H} NMR. GC-MS is also used for accurate quantification of 
fluoroacetate (1) levels in different experiments. This analysis was carried out by our 
collaborators at The Queen's University, Belfast and all of the GCMS data presented in 
this thesis was obtained from the Belfast laboratory. 
2.2.3.1 GCMS analysis of fluoroacetate ( l ) m 
A method was developed whereby fluoroacetate (1) was analysed as its phenylphenacyl 
derivative (102), prepared in situ from the supernatant resulting from a resting cell 
experiment. The culture supernatant was lyophilised and the derivative was prepared by 
dissolving it in toluene / acetonitrile (1:1), with 2-bromo-4'-phenacetophenone (101), 
18-crown-6, and heating the resultant solution at 75 °C for 12 hours. 
O 
O O 
O O 
4 o Br toluene / acetonitrue ^5 
18-crown-6 
101 102 
Fig. 2.11: Derivatisation of fluoroacetate (1) with 2-bromo-4'-phenacetophenone (101). 
Prior to derivatisation the culture supernatant was mixed with a known quantity of 
sodium propionate, for accurate quantification by GCMS. The phenylphenacyl 
derivatives of fluoroacetate (102) and propionate (103) were then analysed by GCMS in 
selected ion monitoring (SIM) mode. 
To detect levels of incorporation of stable isotope the ion current at m/z = 272 
(molecular ion) and the masses immediately above that (m/z = 273, m/z = 274) are 
observed. After correcting for natural isotope abundances the incorporation of label into 
both C-l and C-2 of fluoroacetate is evaluated. Details on incorporation into C-2 of 
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fluoroacetate (1) were determined by monitoring the ion current m/z = 33 and those 
immediately above that. This ion arises due to cleavage of the fluoromethyl group. The 
incorporation into C-l is then deduced by subtracting the level of single label 
incorporation in both positions from that at C-2 only. 
Quantification of fluoroacetate (1) levels was measured by monitoring the ion current 
m/z =181 of both the fluoroacetate (102) and the propionate (103) derivatives, relative 
to a standard response curve. This fragment arises due to cleavage of the 
phenylphenacyl derivative to yield C 6H 5C 6H 4CO +. Fluoroacetate (1) can be detected at 
concentrations down to 0.01 mM using this method. 
2.2.3.2 GCMS analysis of 4-fluorothreonine (2)m 
GCMS can be used to detect isotope incorporation into 4-fluorothreonine (2). However 
attempts to quantify absolute levels of 4-fluorothreonine (2) by this method have proven 
unreliable.106 4-Fluorothreonine (2) was conveniently analysed as its per-
trimethylsilylated derivative (104) prepared directly from a resting cell experiment. The 
culture supernatant was lyophilised and the derivative prepared by heating with Af-
methyl-A^-(trimethylsilyl)-trifluoroacetamide (MSTFA) at 100 °C for 1 hour. The 
derivative (104) was then analysed by GCMS in selected ion monitoring (SIM) mode. 
No mass ion is observed under the ionisation conditions for the per-trimethylsilylated 
derivative of 4-fluorothreonine (104) as it fragments a to the amino group on either 
side. However this gives rise to two signature ions (m/z = 218 and m/z = 272, see Fig. 
2.12). 
I ion 218 
ion 236 
TMS 
O O 
OTMS 104 
HN 
TMS 
Fig. 2.12: Cleavage of per-trimethylsilylated derivative of 4-fluorotltreonine (104). 
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Fragmentation allows the incorporation of isotope into these two fragments to be 
evaluated separately. Ion currents rn/z = 218, 219 and 220 show none, single and 
double label, respectively, into positions C-l and C-2 of 4-fluorothreonine (2). 
Whereas, ion currents m/z = 236, 237, 238 and 239 show none, single, double and triple 
label, respectively, into positions C-2, C-3 and C-4 of 4-fluorothreonine (2). In both 
eases the natural isotope: abundances require to be corrected for. 
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2.3 Resting cell incorporation studies 
2.3.1 [6,6-2HJ-Glucose (105) 
2.3.1.1 Background 
Previous experiments have highlighted the involvement of the glycolytic pathway in 
fluorometabolite biosynthesis. Murphy 1 0 7 had shown that glycerol (87) is an efficient 
precursor to the fluorometabolites after feeding [2- l3C]-glycerol (89) to resting cells of 
S. cattleya. This confirmed the findings of Soda et al.,m with both groups reporting a 
level of incorporation of ~ 40 %. Furthermore, Nieschalk et al.m have shown that when 
(2R)-[\-2H2]- and (25)-[l-2H2]-glycerol (95) & (96) were fed only label from the pro-R 
hydroxymethyl group of glycerol (87) became incorporated into the fluorometabolites. 
These findings are consistent with the assimilation of glycerol (87) into the 
fluorometabolites via the glycolytic pathway (section 1.6.6). Hamilton et al.m showed 
a high level of incorporation from 1 3C labelled pyruvates. Fig. 2.13 illustrates the 
glycolytic pathway, and demonstrates the metabolic relationship between glycerol (87) 
and pyruvate (10). The labelling in Fig. 2.13 does not refer to specific feeding 
experiments, but serves to highlight the equivalence of positions 1 and 2 of glycerol (87) 
with positions 2 and 3 of pyruvate (10). It is these positions that have been shown to 
account for C-l and C-2 of fluoroacetate (1) and C-3 and C-4 of 4-fluorothreonine (2). 
The glycolytic pathway converts glucose (9) to pyruvate (10), via the fission of fructose-
1,6-bisphosphate (108) to deliver the triose phosphates, dihydroxyacetone phosphate 
(DHAP) (98) and glyceraldehyde-3-phosphate (G-3-P) (11). These trioses are 
interconvertable and G-3-P (11) is further metabolised to pyruvate (10), where it may 
enter the TCA cycle. Notably the conversion of phosphoenolpyruvate (12) to pyruvate 
(10), mediated by pyruvate kinase, is irreversible. For pyruvate (10) to enter the 
glycolytic pathway it is converted to oxaloacetate (42) and then phosphoenolpyruvate 
(12) by intercepting gluconeogenesis. 
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Fig. 2.13: The glycolytic pathway, P = phosphate. 
As incorporation into the fluorometabolites had been demonstrated from glycerol (87) 
and pyruvate (10) it appeared appropriate to study the incorporation of labelled glucose, 
to provide further information on fluorometabolite biosynthesis via the glycolytic 
pathway. 
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2.3.1.2 Results and discussion 
[6,6-2H2]-Glucose (105) was fed at a final concentration of 5 mM to resting cells of 
Streptomyces cattleya, with the medium supplemented with 2 mM fluoride. Glucose (9) 
is a good carbon source for microorganisms and i f fed at a sufficiently high level then 
secondary metabolism may be suppressed as primary metabolism is reactivated, thus the 
relatively low concentration of 5 mM was judged to be an appropriate concentration. 
[2-'3C]-Glycine (91) was also fed as a control. 
j F A c ( l ) 
j 
i 
H 
i 
n X I 
19 Fig. 2.14: l 9F {'H} NMR of fluoroacetate (1) and 4-fluorothreonine (2), following 
incubation of resting cells of S. cattleya with 5 mM [6,6-2H2]-glucose (105). 
Incorporation into positions 2, 3 and 4 of 
4-fluorothreonine (2) (%) 
precursor none single double triple 
10 mM [2-13C]-glycine (91) 53.6 14.7 25.5 6.3 
5 mM [6,6-2H2]-glucose (105) 74.6 2.9 22.6 0.0 
Table 2.3: GCMS analysis of 4-fluorothreonine (2), following incubation of resting 
cells of S. cattleya with 5 mM [6,6-2H2]-glucose (105). 
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Incorporation into fluoroacetate (1) (%) 
Precursor None Single 
(C-l) 
Single 
(C-2) 
Double 
10mM[2- 1 3C]-glycine (91) 55.6 6.3 4.7 33.4 
5 mM [6,6-2H2]-glucose (105) 74.0 <0.5 3.0 23.0 
Table 2.4: GCMS analysis of fluoroacetate (1), following incubation of resting cells of 
5". cattleya with 5 mM [6,6-2H2]-glucose (105). 
Both 1 9F NMR and GCMS analyses indicated that [6,6-2H2]-glucose (105) has labelled 
the fluoromethyl position of both fluorometabolites, with a substantial population of the 
molecules retaining both deuterium atoms. 
H O — 
D-
OH 
I—OH 
OH 
OH 
S. cattleya 
D 
[2,2^HJ-(1) 
OH 
D ^ ,co: 
D 
F +NH, 
105 22% 
Fig. 2.15: Labelling pattern in the fluorometabolites from [6,6-2H2]-glucose (105). 
This result highlights two important issues. Firstly it confirms the role of the glycolytic 
pathway in fluorometabolite biosynthesis, as the three most efficient precursors are now 
demonstrated to be glycerol (87), glucose (9) and pyruvate (10). Secondly, both 
deuterium atoms are retained, in a similar result to the (2i?)-[l-2H2]-glycerol (95) 
experiment.104 This confirms that the process of fluorination does not alter the oxidation 
state of the carbon atom that becomes the fluoromethyl group, from the glycolytic 
intermediates to the fluorometabolites. 
These observations together support the proposed minimal mechanism (section 1.6.6) 
for fluorination that envisages displacement of a phosphate group by nucleophilic attack 
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by fluoride. Many of the glycolytic intermediates are phosphorylated in the position 
that would map through to the fluorination site, these include 3-phosphoglycerol (97), 
DHAP (98), G-3-P (11) and 3-phosphoglycerate (17), and all emerge as candidate 
substrates for the fluorination. 
Concurrent with this experiment was a study by Murphy 1 0 7 who fed [1- I 3C]-, [2- 1 3C]-
and [6-l3C]-glucose, (112), (113) & (114) all at 5 mM. These results support those 
generated above and highlight some further issues. Of particular interest was the 
difference in levels of incorporation from the three isotopomers. To briefly review 
Murphy's results, [6-13C]-glucose (114) labelled the fluoromethyl position by 30 %, 
whereas [l-13C]-glucose (112) labelled the same position by only 15 %. The glycolytic 
pathway renders these positions equivalent through the fission of fructose-1,6-
bisphosphate (108) to the triose phosphates. Murphy 1 0 7 rationalised this observation by 
partitioning of glucose metabolism through glycolysis, and also the pentose phosphate 
pathway. 
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Fig. 2.16: The pentose phosphate pathway, P = phosphate. Compounds in bold are 
glycolytic pathway intermediates and the label refers to that derived from 
[6-,3C]-glucose (114). 
Glucose (9) enters the pentose phosphate pathway as glucose-6-phosphate (106) and is 
converted to ribulose-6-phosphate (117), with the concomitant loss of C0 2 . This C0 2 
originates from C-l of glucose (9), which explains the relatively low level of 
incorporation from [l- l3C]-glucose (112). Isotope from C-6 of [6-I3C]-glucose (114) 
however, is wholly converted to [3-l3C]-G-3-P (11) by the pentose phosphate pathway, 
both directly and via fructose-6-phosphate (107), where it may re-enter the glycolytic 
pathway. The labelling pattern resulting from the [2-l3C]-glucose (113) experiment (C-
1 of fluoroacetate (la), 16 %; C-2 of fluoroacetate (Id), 8 %; likewise in 4-
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fluorothreonine (2c & 2d)) is more complex, though can be rationalised also by the 
same arguments of glycolytic / pentose phosphate pathway partitioning.107 
2.3.2 Isotopically labelled acetates 
2.3.2.1 Background 
Acetate (6) is central to primary metabolism. It becomes involved in the TCA cycle by 
condensation with oxaloacetate (42) to generate citrate (43). It appeared appropriate to 
feed isotopically labelled acetates to map their label through to the fluorometabolites. 
[1- I 3C]-, [1,2-1 3C]- & [2,2,2-2H3]-Acetate (20), (21) & (122) were each fed at a final 
concentration of 10 mM to resting cells of Streptomyces cattleya which were also 
supplemented with 2 mM fluoride. Again [2-13C]-glycine (91) was fed at 10 m M in a 
control experiment. 
2.3.2.2 Results and discussion 
The resting cell experiments were analysed by 1 9F {'H} NMR (see Fig. 2.17, Fig. 2.18 
and Fig. 2.19) and GCMS was used to analyse of the resultant fluoroacetate (Table 2.5). 
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Fig. 2.17: 1 9F {'H} NMR analysis of resting cells of S. cattleya fed with 
[l-13C]-acetate(20). 
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Fig. 2.18: l 9F {'H} NMR analysis of resting cells of S. cattleya fed with 
[l,2- l3C2]-acetate(21). 
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Fig. 2.19: 1 9F {'H} NMR analysis of resting cells of S. cattleya fed with 
[2,2,2-2H3]-acetate (122). 
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Incorporation into fluoroacetate (1) (%) 
Precursor None Single (CI) Single (C2) Double 
10mM[2- l 3C]-glycine(91) 64.7 8.0 2.4 24.9 
10mM[l- l 3C]-acetate(20) 94.0 3.4 2.6 0.1 
10 mM [l,2- l3C2]-acetate (21) 73.4 8.1 3.5 15.0 
10 mM [2-2H3]-acetate (122) 97.4 <0.1 2.6 0.1 
Table 2.5: GCMS analysis of fluoroacetate (1), following incubation of resting cells of 
S. cattleya with isotopically enriched acetates. 
It is clear from this series of experiments that acetate (6) is not incorporated into the 
fluorometabolites as an intact unit. There is a high level of double label resulting from 
[l,2- l3C2]-acetate (21), but notably [l-13C]-acetate (20) does not label the 
fluorometabolites significantly. Therefore the incorporation from [l,2- l3C2]-acetate (21) 
originates wholly from C-2 of acetate (6). It is interesting to note that deuterium is only 
incorporated poorly from C-2 of acetate (6). There was less than a 3 % incorporation of 
single deuterium into the fluoromethyl groups. This pattern of labelling from acetate (6) 
can be rationalised by considering acetate (6) metabolism around the TCA cycle and 
into the glycolytic pathway. 
Acetate (6) enters the TCA cycle, as acetyl-SCoA (13), by condensation with 
oxaloacetate (42) to form citrate (43). Oxaloacetate (42) is also the intermediate at 
which gluconeogenesis branches from the TCA cycle to enter the glycolytic pathway. 
Fig. 2.20 shows the TCA cycle and traces the fate of C-2 of acetate (6) through one 
revolution of the cycle. Positions C-2 and C-3 of oxaloacetate (42) label positions C-l 
and C-2 of fluoroacetate (1) respectively (and likewise in 4-fluorothreonine (2)). 
Therefore the single label from [l,2-l3C2]-acetate (21) can be explained in terms of 
biosynthesis of labelled oxaloacetate (42) which enters the glycolytic pathway and 
eventually contributes to fluorometabolite biosynthesis. Single label is observed in both 
C-l and C-2 of fluoroacetate (1), and this most probably arises as succinate (124) and 
fumarate (125) are symmetrical molecules, and thus the label is scrambled to synthesise 
[2-13C]-oxaloacetate ([2-13C]-42) and [2-13C]-oxaloacetate ([2- , 3C]-42). The lower level 
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of label at C-2 of fluoroacetate (1) must be attributed to incomplete scrambling, or 
perhaps some other i l l defined pathway. 
The incomplete scrambling of label in fumarate (125) explains the low level of 
deuterium incorporation from [2,2,2-2H3]-acetate (122). The assimilation of label from 
this metabolite can only occur via C-3 of oxaloacetate (42) and thus must arise after 
scrambling at succinate (124) or fumarate (125). Half of this label is necessary lost 
through oxidation of C-2 of oxaloacetate (42) (see Fig. 2.20). The level of incorporation 
of deuterium from [2,2,2-2H3]-acetate (122) is only slightly lower than that of single 
label incorporation into C-2 of fluoroacetate (1) from [l,2- l3C2]-acetate (21) (2.6 % vs 
3.5 % ) . It is usual for deuterium to label at a lower level than the equivalent 1 3C 
experiment (e.g. [6,6-2H2]-glucose (105), 22 %, c.f. [6-l3C]-glucose (114), 30 %) and 
this can be rationalised as label being lost through process exchange with the media. In 
this case the deuterium atom passes through a highly enolisable position in [3- 2H]-
oxaloacetate ([3-2H]-42). 
The high level of double label in the fluorometabolites after feeding [l,2- l3C2]-acetate 
(21) is rationalised by considering multiple revolutions of the TCA cycle. A single 
revolution produces [2-13C]-oxaloacetate ([2- l 3C]-42), which may go on to 
fluorometabolite biosynthesis to label C-l of fluoroacetate (1) and C-3 of 4-
fluorothreonine (2). Alternately, it may condense with a second molecule of [1,2- I 3C 2]-
acetate (21) and continue around the TCA cycle. This will eventually produce [2,3-
13C2]-oxaloacetate ([2,3-13C2]-42) and thus deliver label into both C-l & C-2 of 
fluoroacetate (1) and likewise in C-3 & C-4 of 4-fluorothreonine (2). 
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Fig. 2.20: The TCA cycle, demonstrating both the fate of [2-l3C]-acetate (127) and 
[2H3]-acetate (122), including the scrambling of label through fumarate (125). 
Fig. 2.20 also demonstrates why only one deuterium atom is retained in the 
fluorometabolites from [2-2H3]-acetate (122). The oxidation from succinate (124) to 
fumarate (125) removes one deuterium atom, thus only one is retained. 
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2.3.3 [2-2H]-Glycerol (128) and [2-2H]-glycerate (129) 
HO D HO D 
H O ^ X ^ O H O ^ y ^ O H 
128 0 129 
2.3.3.1 Background 
In order to understand where fluorometabolite biosynthesis branches from the glycolytic 
pathway it appeared appropriate to study deuterium incorporation into position 3 of 4-
fluorothreonine (2). Previously, labelling studies have shown incorporation of l 3C and 
2 H into all positions of fluoroacetate (1) and 4-fluorothreonine (2) except for C-3. 
In the context of delineating the branch point to fluorometabolite biosynthesis from the 
glycolytic pathway the origin of the C-3 hydrogen is clearly important. DHAP (98) is a 
significant metabolite is this respect, as metabolism passing through this intermediate 
wil l lose the proton that may account for C-3 in 4-fluorothreonine (2) (Fig. 2.21). 
HO H p 
H O ^ N ^ ^ O P - H O ^ ^ i k ^ O P 
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H OH 
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Fig. 2.21: Oxidation state at C-2 of the glycolytic intermediates on either side of DHAP 
(98), P = phosphate. 
Feeding a glycolytic intermediate labelled with a deuterium atom at C-2 could delineate 
which side of DHAP (98) fluorometabolite biosynthesis leaves the glycolytic pathway. 
Accordingly, [2-2H]-glycerol (128) and [2-2H]-glycerate (129) were prepared by a co-
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worker (Dr D. Bouvet) at the University of Durham, by sodium borodeuteride reduction 
of dihydroxyacetone and P-hydroxypyruvate respectively. 
2.3.3.2 Results and discussion 
[2-2H]-Glycerol (128) was fed at a final concentration of 5 mM to resting cells of S. 
cattleya supplemented with 2 mM NaF and incubated for 48 hours. 1 9F {'H} NMR 
analysis did not reveal any incorporation into C-3 of 4-fluorothreonine (2). Previous 
studies with isotope enriched glycerols demonstrated high levels of incorporation into 
the fluorometabolites, and glycerol (87) is a good carbon source for the 
fluorometabolites. This experiment perhaps suggests that fiuorometabolite biosynthesis 
does not derive from a glycolytic pathway metabolite upstream of DHAP (98). 
[2-2H]-Glycerate (129) was then fed to resting cells of S. cattleya supplemented with 2 
mM NaF and incubated for 48 hours. As glycerate (130) had not previously been fed to 
S. cattleya, nothing is known on its efficiency as a carbon source to the 
fluorometabolites and so 129 was fed separately at two concentrations, 2.5 mM and 10 
mM. I 9F {'H} NMR analysis did not reveal any incorporation into C-3 of 4-
fluorothreonine (2). This was also confirmed by GCMS analysis of the resultant 4-
fluorothreonine (2). 
Incorporation into 4-fluorothreonine (2) (%) 
Ion 218 (positions 1 and 2) Ion 236 (positions 2, 3 and 4) 
Precursor M M + 1 M + 2 M M + 1 M + 2 
lOmM [2-2H]-glycerate 
(129) 
96.1 1.3 2.6 97.9 1.4 0.7 
2.5 mM [2-2H]-glycerate 
(129) 
100.8 1.4 -2.3 98.2 0.9 0.8 
Table 2.6: GCMS analysis of 4-fluorothreonine (2), following incubation of resting 
cells of S. cattleya with [2-2H]-glycerate (129). 
The data (Table 2.6) does not indicate any significant incorporation into positions 2, 3 
and 4 of 4-fluorothreonine (2). 
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The absence of incorporation from [2-2H]-glycerate (129) may be due to a number of 
reasons. Perhaps deuterium is lost in the glycolytic pathway or during fluorometabolite 
biosynthesis itself. However, glycerate (130) itself is not a bone fide glycolytic 
intermediate, although phosphorylated analogues of it are. In feeding other non-
phosphorylated glycolytic intermediates (viz. glycerol (87) and glucose (9)) phosphate 
kinases have acted and allowed these to enter the glycolytic pathway. It may be that 
there is no phosphate kinase in Streptomyces cattleya capable of utilising glycerate 
(130) as a substrate. A further possibility is that glycerate (130) is phosphorylated but is 
not involved in fluorometabolite biosynthesis. The glycolytic pathway may be active in 
the direction from glucose (9) to pyruvate (10), which may channel the glycerate (130) 
downstream and thus remove it from possible involvement in fluorometabolite 
biosynthesis. 
Three additional experiments were designed to probe the incorporation of label from 
[2-2H]-glycerate (129) further. 
Experiment 1: [2-2H]-Glycerate (129) was fed at 10 mM to resting cells of S. cattleya 
one hour after they were supplemented with 2 mM NaF. The rational for this 
experiment was that after this time fluorometabolite biosynthesis will proceed 
efficiently and [2-2H]-glycerate (129) can then be channelled into that biosynthesis. 
Experiment 2: [2-2H]-Glycerate (129) at a final concentration of 10 mM and NaF at 2 
mM were fed to resting cells of S. cattleya one hour after they had been supplemented 
with 10 mM glycolate (50). Glycolate (50) is known to be an efficient carbon source, 
and may serve to channel the glycerate (130) into fluorometabolite biosynthesis. 
Experiment 3: [2-2H]-Glycerate (129) at a final concentration of 10 mM and 2 mM 
NaF were fed to resting cells of S. cattleya one hour after they had been supplemented 
with 10 mM glycerol (87). This may remove the possibility that label is lost through 
enolisation between G-3-P (11) and DHAP (98). Triose phosphate isomerase mediates 
this conversion and under normal conditions the equilibrium is in favour of production 
of DHAP (98).109 This equilibrium would clearly result in loss of deuterium label from 
G-3-P (11) to produce unlabelled G-3-P (11). 
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Fig. 2.22: The removal of deuterium from glyceraldehyde via triose phosphate 
isomerase. 
In all three of these experiments l 9F {'H} NMR analysis did not indicate any 
incorporation of deuterium into C-3 of 4-fluorothreonine (2), and this was also 
confirmed by GCMS analysis. 
Incorporation into 4-fluorothreonine (2) (%) 
Ion 218 (positions 1 and 2) Ion 236 (positions 2, 3 and 4) 
M M + 1 M + 2 M M + 1 M + 2 
Experiment 1 96.0 1.3 2.7 97.9 1.4 0.7 
Experiment 2 95.7 1.4 3.0 98.5 0.7 0.8 
Experiment 3 96.0 1.4 2.7 97.8 1.3 0.9 
Table 2.7: GCMS analysis of 4-fluorothreonine (2), following incubation of resting 
cells of S. cattleya with [2-2H]-glycerate (129). 
It appears that the deuterium from C-2 of the glycolytic intermediates, both upstream 
and downstream of dihydroxyacetone phosphate (98), was not carried through to label 
C-3 of 4-fluorothreonine (2). This result may be interpreted in one of two ways. Either 
DHAP (98) is the substrate for the first committed step of fluorometabolite biosynthesis, 
or the deuterium atom is lost during at a later stage in fluorometabolite biosynthesis 
itself. 
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2.4 Synthesis and feeding of 3-fluoro-l-hydroxypropanone 
2.4.1 Background 
Two events must occur between the glycolytic pathway and fluorometabolite 
biosynthesis; the fluorination event and a C-C bond cleavage. The bond cleavage is 
necessary as glycolytic intermediates are C 3 entities and the final stages of 
fluorometabolite biosynthesis must involve a C 2 moiety. Further, the labelling patterns 
from isotope feeding experiments have shown that a common fluorinated intermediate 
must be involved, as the labelling patterns in C-l and C-2 of fluoroacetate (1) are 
identical to that in C-3 and C-4 of 4-fluorothreonine (2) (section 1.6.5). 
The direct fluorination of a glycolytic intermediate, by nucleophilic substitution of a 
phosphate group would yield a C 3 fluorinated intermediate. This could then lie at a 
branch point to both of the fluorometabolites or it could be cleaved to a fluorinated C2 
intermediate, as shown schematically in Fig. 2.23. 
C 3 Metabolism > C 2 Metabolism 
glycolytic intermediate j 
i * i i 
fluorination I 
fluoro-C-intermediateX c l e a v a 8 e m fluoro-G-intermediate 
/ \ cleavage 
fluoroacetate 4-fluorothreonine fluoroacetate 4-fluorothreonine 
Fig. 2.24: Working hypothesis for fluorometabolite biosynthesis via a fluorinated C 3 
unit. 
Putative initial products of fluorination were fed to resting cells of the bacterium to 
assess their bio-conversion to the fluorometabolites. In previous studies1 0 7 1 0 8 
P-fluoropyruvate (65), 3-fluorolactate (131) and 3-fluoropropan-l,2-diol (132) have 
been synthesised in this respect and were administered to Streptomyces cattleya. 
Deuterium was substituted into these putative intermediates such that their fluoromethyl 
groups were labelled (c.f. 'bond labelling' in double labelled feeding experiments, 
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section 1.2.2.4). For these compounds to be implicated as bona fide intermediates in 
fluorometabolite biosynthesis, the fluoromethyl group must become incorporated intact 
into the fluorometabolites. 
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Fig. 2.25: Putative post fluorination products synthesised and fed by Amin 1 0 8 and 
Murphy, 1 0 7 respectively. 
In the event none of these intermediates proved to be directly involved in 
fluorometabolite biosynthesis. The experiments with P-fluoropyruvate (65) and 3-
fluorolactate (131) did lead to the production of fluoroacetate (1), although this was 
attributed to non-enzymatic oxidative cleavage. Also small amounts of unlabelled 
fluorometabolites were observed due to defluorination, of p-fluoropyruvate (65) and 3-
fluorolactate (131), followed by assimilation of that fluoride into fluorometabolite 
biosynthesis.108 3-Fluoropropan-l,2-diol (132) was stable to both oxidative cleavage 
and defluorination in resting cells of S. cattleya and proved resistant to metabolism.107 
These observations appear to rule out the direct fluorination 3-phosphoglycerate (17), 
1,3-bisphosphoglycerate (109) and 1-phosphoglycerol (97). However, stable isotope 
feeding experiments have highlighted the importance of the triose phosphates in 
fluorometabolite biosynthesis and so it appeared appropriate to extend this study further 
and to prepare and feed the fluorinated analogue of DHAP (98). 
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Fig. 2.26: 3-Fluoro-l-hydroxypropanone (133) and DHAP (98). 
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As in previous studies it is advantageous to have deuterium atoms geminal to the 
fluorine atom in the prepared precursor and a strategy towards such labelling was 
pursued. 
2.4.2 3-Fluoro-l-hydroxypropanone (133) 
3-Fluoro-l-hydroxypropan-2-one (133) was prepared in 1982 by Kozarich.1 1 0 In this 
study on halohydroxyacetones and halomethylglyoxals, p-fluoropyruvate (65) was 
converted to 3-fluoro-l-hydroxypropan-2-one (133) by protecting the ketone and 
reducing the carboxyl group to a primary alcohol (see Fig. 2.27). 
O O MeO OMe MeO OMe 
o OH OH O li in 
F O F O F F 
65 134 135 133 
Fig. 2.27: Synthesis of 3-fluoro-l-hydroxypropan-2-one (133) by Kozarich.1 1 0 
i) (MeO)3CH, MeOH, H 2S0 4 , 59 %; ii) L iAlH 4 , Et 20, 89 %; iii) H 3 0 + . 
In the event this literature method was not followed because the route did not facilitate 
the introduction of deuterium atoms geminal to the fluorine. Deuterium can be 
introduced into the required position via enolisation in a deuterium enriched solvent, 
and so synthetic schemes amenable to solvent exchange were investigated. 
Van Hij f te 1 " has described the synthesis of a-(monofluoromethyl) amino acids via 3-
fluoro-l-hydroxypropanone benzyl ether (136). It was envisaged that this compound 
could undergo enolisation to introduce deuterium geminal to the fluorine atom, and then 
removal of the protecting group would yield the target compound (133). 
O O O 
D D OH OBn OBn D D 
F 136 F 137 F 133 
Fig. 2.28: Putative synthesis of [3-2H2]-3-fluoro-l-hydroxypropanone ([3,3-2H2]-133) 
from 3-fluoro-l-hydroxypropanone benzyl ether (136). 
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Accordingly 3-fluoro-l-hydroxypropanone benzyl ether (136) was prepared by the 
method of Van Hijf te" 1 . 
2.4.3 Synthesis of 3-fluoro-l-hydroxypropanone (133) 
O 
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Fig. 2.29: Synthesis of 3-fluoro-l-hydroxypropan-2-one benzyl ether (140); i) NaH, 
THF, 0 °C then BnBr, 16 hours, 20 °C, 22 %; ii) KHF 2 , diethylene glycol, 
170 °C, 4 hours, 40 %; iii) (COCl)2, DMSO, DCM, -60 °C, then Et 3N, 93 
%. 
The first step in the route involved the protection of glycidol (138) as its benzyl ether 
(139). The Van Hijf te 1 " publication is a communication and so experimental details are 
scant. More detailed experimental description of the synthesis of glycidol benzyl ether 
(139) was given by L i u " 2 in the total synthesis of [(methylenecyclopropyl)acetyl]-SCoA 
and their method was followed here. Therefore glycidol benzyl ether (139) was 
prepared from racemic glycidol (138) in THF treated with freshly distilled benzyl 
bromide and using sodium hydride as the base. The resultant oil was purified by high 
vacuum distillation. The yield was significantly lower than that published (22 % vs 84 
% ) , although this can be rationalised because of impurities in the starting material. The 
commercial sample of glycidol (138) was discovered to be only 70 % pure by 'H NMR 
and the remainder appeared to be glycerol (87). However, sufficient material was 
purified for the synthesis to proceed. 
The epoxide (139) was then ring-opened to form the corresponding fluorohydrin (140). 
This reaction was mediated by heating 139 in the presence of potassium hydrogen 
fluoride. The epoxide (139) can open both ways to form either the benzyl ether of 3-
fluoro-2-hydroxypropan-l-ol (140) or 2-fluoro-3-hydroxypropan-l-ol (141) (see Fig. 
2.30), although literature precedents suggest predominant ring opening to the desired 
regioisomer (140)." 3 1 1 4 1 , 5 
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Fig. 2.30: Ring opening of glycidol benzyl ether (139) with KHF 2 . 
In the event both regiomers were produced although the reaction conditions strongly 
favoured the production of the desired fluorohydrin (140). The reaction was carried out 
in a high boiling solvent (diethylene glycol) at 170 °C. After 4 hours TLC analysis 
demonstrated complete consumption of the starting material (139), and the production 
of two products. 1 9F NMR analysis showed that the desired fluorohydrin (140) and its 
regioisomer (141) had formed (5F = -232 and -196 ppm respectively, in a ratio of 20:1, 
by l 9F NMR). The regioisomers were easily separated by dry flash chromatography as 
140 was less polar and overall the reaction proceeded in a modest yield of 40 %. 
Oxidation of the fluorohydrin (140) to yield the ct-fluoroketone (136) was performed 
using Swern methodology,116 and proceeded in good yield, 93 %. The synthesis so far is 
summarised in Fig. 2.29. 
Deuterium exchange into the a-fiuoromethyl group was followed be 1 9F NMR. At the 
outset it was envisaged that acid catalysed enolisation would be the most suitable 
method, however studies using D 2 S0 4 showed that the a-fluoroketone (140) was 
unstable under these conditions, even at relatively low acid concentrations. Therefore 
base catalysed exchange of deuterium was then investigated. Small amounts of Na 
metal were dissolved in CH3OD and the subsequent exchange monitored by l 9F NMR, 
observing the isotope induced shift associated with the fluorine signal. There was a 
limited level of exchange producing both the monodeutero- (~ 20 %) and dideutero-
labelled (~ 5 %) a-fluoroketones (140). 
The hydrogenation of the oc-fiuoroketone (140) to deliver the target compound (133) 
was studied in the first instance on unlabelled material. Firstly a transfer hydrogenation 
was explored by stirring the a-fluoroketone (140), with cyclohexene in MeOH using 
palladium supported on carbon as the catalyst. The reaction was monitored by tic and 
79 
1 9F NMR, but failed to proceed and the starting material (140) was reisolated. In a 
second attempt, the reaction was carried out under a positive pressure of hydrogen using 
the same catalyst. This time the reaction was successful and all of the starting material 
was consumed within 16 hours as monitored by tic. 
To isolate the deprotected a-fluoroketone (133) the catalyst was removed by filtration 
through a Celite plug. Care had to be taken in removing the methanol, as the boiling 
point of 3-fluoro-l-hydroxypropanone (133) was not envisaged to be very high. The 
boiling point of a fluorinated compound is generally only a few degrees Celsius above 
that for the non-fluorinated species. The boiling point of acetol is 145-146 °C, so that of 
3-fluoro-l-hydroxypropanone (133) will clearly be similar. Therefore the solvent was 
removed under reduced pressure ensuring that the temperature did not exceed 40 °C. 1 9F 
NMR analysis of the resultant oil demonstrated the presence of a number of 
fluoromethyl groups . 
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Fig. 2.31: 1 9F NMR of 3-fluoro-l-hydroxypropanone (133). 
Attempts to derivatise this product further for characterisation were not successful. 
DNP-derivatisation resulted in a precipitate that was dried and analysed by 1 9F NMR, 
however there were no resonances in the fluoromethyl region. Further analysis showed 
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that in forming the DNP derivative of 3-fluoro-l-hydroxypropanone (133) the 
compound was efficiently defluorinated. A putative mechanism for this facile 
defluorination is given in Fig. 2.32. 
HO 
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Fig. 2.32: Putative mechanism for 3-fluoro-l-hydroxypropanone DNP defluorination. 
In the published synthesis of 3-fluoro-l-hydroxypropanone (133) by Kozarich1 1 0 the 
final step involved an aqueous acetal hydrolysis. The product of this reaction was not 
isolated but observed only by NMR analysis. In our case l 9F and 'H NMR analyses of 
the debenzylation product was consistent with the reported data. Also the authors 
described how 3-fluoro-l-hydroxypropanone (133) exists as both the ketone and the 
hydrate. The equilibrium between these species was observed by l 9F NMR. As such it 
is not unreasonable to suggest the presence of the acetal, hemiacetal, hydrate and ketone 
after the debenzylation. In the feeding experiment the compound was administered as a 
dilute aqueous solution and as such the acetal and hemiacetal should convert back to 
either the ketone or the hydrate. 
In summary, 3-fluoro-l-hydroxypropanone (133) had been synthesised, in equilibrium 
with a complex mixture of other species. This material was then used in a feeding 
experiment. 
2.4.4 Biotransformation of 3-fluoro-l-hydroxypropanone (133) 
Accordingly 3-fluoro-l-hydroxypropanone (133) was administered to resting cells of 
Streptomyces cattleya and incubated for 48 hours. As the synthesised material was 
known not to be pure the final concentration could not be accurately determined, 
although it is estimated to be approximately 1 mM (experiment 1). In a separate 
experiment 3-fluoro-l-hydroxypropanone (133) was also fed at half of that 
concentration (experiment 2). No free fluoride was present in these samples at the 
beginning of the feeding experiments. 
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After 18 hours an aliquot was removed from each experiment and analysed by 1 9F NMR 
and then the fluoride concentration was measured. Fluoride analysis showed that 
inorganic fluoride had been liberated to the level of 0.25 mM in the medium in 
experiment 1. 
" I P ft 
n i I i r i i i i -216 -218 -220 —222 —224 —226 -228 —230 —232 —234 -236 -238 
Fig. 2.33: l 9F NMR spectrum of the resultant supernatant from incubating resting cells 
of S. cattleya for 18 hours with 3-fluoro-l-hydroxypropanone (133) 
(experiment 1). 
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Fig. 2.34: 1 9F NMR spectrum of the resultant supernatant from incubating resting cells 
of S. cattleya for 18 hours with 3-fluoro-l-hydroxypropanone (133) 
(experiment 2). 
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After 48 hours the experiments were terminated in the usual way and the supernatants 
analysed by 1 9F NMR. 
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Fig. 2.35: F NMR spectrum of the resultant supernatant from incubating resting cells 
of S. cattleya for 48 hours with 3-fluoro-l-hydroxypropanone (133) 
(experiment 1). 
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Fig. 2.36: 1 9F NMR spectrum of the resultant supernatant from incubating resting cells 
of S. cattleya for 48 hours with 3-fluoro-l-hydroxypropanone (133) 
(experiment 2). 
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I f 3-fluoro-l-hydroxypropanone (133) is the initial product of fluorination, then it was 
anticipated that upon addition to resting cells that the fluorometabolites would readily 
accumulate. In the event fluoroacetate (1) and 4-fluorothreonine (2) were only produced 
in low concentration. The presence, at all, of the fluorometabolites in these experiments 
can be rationalised in terms of defluorination of 3-fluoro-l-hydroxypropanone (133), or 
a metabolite of it, followed by a de novo biosynthesis of the fluorometabolites from the 
liberated fluoride. 
An interesting feature of the l 9F NMR analysis of these feeding experiments is the 
appearance of a new fluoromethyl resonance that was not in the administered sample. 
Fig 2.31 shows the 1 9F NMR spectrum of the solution that was fed to the bacterium. 
This is compared to the l 9F NMR spectrum resulting after experiment 1, both at 18 and 
48 hours (Fig. 2.33 and Fig. 2.35 respectively). In each case the spectra simplify and a 
new resonance appears at 5F = -232 ppm. This resonance is also visible in the spectrum 
relating to experiment 2. The resonance is not, as all the others are, a simple triplet 
resulting from a fluoromethylacyl moiety. In this case a doublet of triplets is observed 
( 2 J r a = 47.0 Hz, 3 J m = 22.3 Hz), clearly resulting from a fluoromethyl group with a 
proton on the vicinal carbon. This resonance is similar in pattern (but not chemical 
shift) to 4-fluorothreonine (2) and there are a number of explanations for this 
observation. 
Clearly, 3-fluoro-l-hydroxypropanone (133) may be reduced by an alcohol 
dehydrogenase to 3-fluoropropan-l,2-diol (132) a compound which has previously been 
shown not to be involved in fluorometabolite biosynthesis. However, the resonance that 
corresponds to [3,3-2H2]-3-fluoropropan-l,2-diol (132) in l 9F NMR is at -236.0 ppm, 1 0 7 
therefore the unlabelled resonance would be approximately -234.8 ppm. The signal 
resultant from feeding 3-fluoropropan-2-one (133) appears at -232 ppm, so this 
hypothesis cannot account for the appearance of this new resonance. 
Alternatively, 3-fluoro-l-hydroxypropanone (133) was metabolised by triose phosphate 
isomerase to yield the fluorinated analogue of G-3-P, 3-fluoroglyceraldehyde (142). 
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Fig. 2.37: Putative conversion of 3-fluoro-l-hydroxypropanone (133) to 3-
fluoroglyceraldehyde (142). 
3-Fluoroglyceraldehyde (142) has been synthesised by Wong," 7 " 8 " 9 to study its role in 
asymmetric aldol condensations. This compound is obviously difficult to handle and so 
spectroscopic data is only reported on the diethoxyacetal of 3-fluoroglyceraldehyde. 
Effenberger120 published a chemoenzymatic synthesis of 3-fluoroglyceraldehyde (142). 
Neither group published 1 9F NMR data of 3-fluoroglyceraldehyde (142), however 
Effenberger120 did publish a complete 'H NMR analysis. Using the coupling constants 
quoted from this analysis the l 9F NMR resonance of 3-fluoroglyceraldehyde (142) 
should be a triplet of doublets, with the coupling constants given in Fig. 2.38. 
Fig. 2.38: Coupling constants in 3-fluoroglyceraldehyde (142), taken from 
Effenberger.'20 
These values are in agreement with the observed resonance in the feeding experiment 
with 3-fluoro-l-hydroxypropanone (133). 
Clearly 3-fluoro-l-hydroxypropanone (133) is not directly involved in fluorometabolite 
biosynthesis. Instead, it appears that 3-fluoro-l-hydroxypropanone (133) was converted 
to, another species which may be 3-fluoroglyceraldehyde (142). Fluoride was then 
liberated from one of the fluorinated species present, which generated the 
fluorometabolites via a de novo biosynthesis. 
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O 
23.8 Hz 47.2 Hz 
H 
142 
85 
It was decided not to repeat the experiment with deuterium labelled 3-fluoro-l-
hydroxypropanone (133), as the absence of rapid conversion to either fluorometabolites 
rules out the direct involvement of this a-fluoroketone (133). 
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2.5 Conclusions 
The involvement of the glycolytic pathway in fluorometabolite biosynthesis in S. 
cattleya has been unambiguously confirmed by feeding isotopically enriched glucose 
and acetates. Glucose (9) enters fluorometabolite biosynthesis via both the glycolytic 
and pentose phosphate pathways. Acetate (6) was shown to become incorporated into 
the fluorometabolites via the glycolytic pathway after first being metabolised by the 
TCA cycle. This evidence and data collected by Murphy 1 0 7 demonstrate that the 
glycolytic pathway is the metabolic pathway that delivers substrates for 
fluorometabolite biosynthesis. 
Feeding experiments with [2-2H]-glycerol (128) and [2-2H]-glycerate (129) attempted to 
trace this deuterium atom through from the glycolytic pathway to position 3 of 4-
fluorothreonine (2). However, in none of these feeding experiments did this position 
become labelled. This implies that either dihydroxyacetone phosphate (98) is the 
substrate for the first committed step towards fluorometabolite biosynthesis from the 
glycolytic pathway, or that this deuterium is lost in subsequent steps in fluorometabolite 
biosynthesis. 
3-Fluoro-l-hydroxypropanone (133) was successfully synthesised and the difficulties in 
handling this compound were addressed. Feeding experiments appear to have ruled out 
its involvement as an intermediate in fluorometabolite biosynthesis. 1 9F NMR analysis 
suggested that 3-fluoro-l-hydroxypropanone (133) was converted to either 3-
fluoropropan-l,2-diol (132) or 3-fluoroglyceraldehyde (142). 
Fluorinated analogues of all of the glycolytic intermediates have now been administered 
to resting cells of Streptomyces cattleya. None of these substrates are converted to 
either fluoroacetate (1) or 4-fluorothreonine (2) and together these experiments appear 
to rule out a fluorination event on a bona fide glycolytic intermediate. 
87 
Chapter 3 
A role for fluoroacetaldehyde 
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3.1 Fluoroacetaldehyde 
None of the glycolytic intermediates appear to be a substrate for the fluorination 
process. As discussed previously (section 2.4.1), the final stages of fluorometabolite 
biosynthesis may involve C 2 units. Fluoroacetaldehyde (40) meets this criterion, as 
oxidation will directly generate fluoroacetate (1). Also condensation of 
fluoroacetaldehyde with a pseudo-C2 unit (section 3.5) in an aldol type process could 
generate 4-fluorothreonine (2). In order to assess the role of fluoroacetaldehyde a 
synthesis, amenable to isotopic labelling was required. 
3.1.1 Synthesis offluoroacetaldehyde (40) 
Fluoroacetaldehyde (40) was first synthesised by Saunders et a/121 in a series of papers 
studying the toxicity of fluoroacetate (1) derivatives on behalf of the Ministry of Supply 
during World War I I . In that case 2-fluoroethanol (71) was oxidised with manganese 
dioxide and produced a 6 % solution of fluoroacetaldehyde (40) in water. The L D 5 0 of 
fluoroacetaldehyde (40) was measured and it was found to be identical to that of 
fluoroacetate (1), so it was surmised that fluoroacetaldehyde (40) is efficiently 
converted to fluoroacetate (1) in vivo. Recently fluoroacetaldehyde has been implicated 
as a toxic impurity in the chemotherapy drug 5-fluorouracil (143).1 2 2 1 9F NMR studies 
have shown its presence in the drug formulation and the presence of fluoroacetate (1) in 
the urine of patients that have been exposed to the drug suggests that fluoroacetaldehyde 
(40) is indeed oxidised in vivo. Therefore during this project great care was taken in the 
handling and manipulation of fluoroacetaldehyde (40), which is hazardous both due to 
its toxicity and volatile nature. 
Studies into the synthesis of fluoroacetaldehyde (40) were initiated in Durham by a 
former member of the group, Dr J. Fuchser. The oxidation of 2-fluoroethanol (71) was 
investigated by enzymatic methods and with a variety of chemical oxidants. It emerged 
that the most efficient oxidant was pyridinium dichromate and this was adopted for 
these subsequent studies. 
Fluoroacetaldehyde (40) was synthesised by oxidation of 2-fluoroethanol (71) with 
pyridinium dichromate (PDC). PDC was suspended in dichloromethane, 2-
fluoroethanol (71) was added and the solution was heated to reflux for 16 hours. After 
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this time the solution was allowed to cool and the reflux condenser replaced with a 
vigreux distillation apparatus. The solution was then distilled to dryness, leaving PDC 
as a solid residue. Efforts to separate fluoroacetaldehyde (40) from 2-fluoroethanol (71) 
and DCM by distillation proved to be unsuccessful. Due to its toxic and volatile nature, 
the DCM solution containing both fluoroacetaldehyde (40) and 2-fluoroethanol (71) was 
extracted into water to form the less volatile hydrate. This generated an aqueous 
solution of 2-fluoroethanol (71) and the hydrate of fluoroacetaldehyde (40). PDC 
oxidation did not prove efficient under these conditions stopping at about a 20 % 
conversion. Efforts were made to optimise this by increasing the amount of oxidant and 
the reaction time, however the conversion remained at 20 %. Confirmation that 
fluoroacetaldehyde (40) was indeed prepared by this method was provided by analysis 
of its 2,4-dinitrophenylhydrazine (DNP) derivative (144). 
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Fig. 3.1: 1 9F NMR spectrum of fluoroacetaldehyde (40) and 2-fluoroethanol (71). 
Aqueous solutions of fluoroacetaldehyde hydrate (40) were routinely prepared, at a final 
concentration of 40 mM. These samples also contained 2-fluoroethanol (71) (160 mM) 
as a by-product of the synthesis as discussed above. The concentrations were deduced 
by l 9F NMR analysis, based on complete recovery of all fluorinated species. This 
appeared reasonable as the PDC and aqueous layer were routinely checked by l 9F NMR 
and contained no fluorine resonances. 
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2-Fluoroethanol (71) was confirmed as the contaminant by spiking the solution with 
commercial 2-fluoroethanol (71) and subsequent 1 9F NMR analysis. Likewise the 
concentration of fiuoroacetaldehyde (40) and 2-fluoroethanol (71) was confirmed by 
adding a known quantity of fluoroacetone (39) to the sample and comparing the 
integrals of the resonances in the 1 9F NMR spectrum. Gravimetric analysis of the DNP 
derivative of fluoroacetaldehyde (144) did not prove to be a reliable method for 
determining fluoroacetaldehyde (40) concentration 
Studies by Reid 1 0 5 have already shown that 2-fluoroethanol (71) is not involved in 
fluorometabolite biosynthesis, either directly or through defluorination. Therefore, this 
solution of fluoroacetaldehyde (40) and 2-fluoroethanol (71) was used in the following 
whole cell and cell free experiments. 
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3.2 Whole cell feeding studies with fluoroacetaldehyde 
3.2.1 Preliminary studies 
3.2.1.1 Introduction 
To assess whether fluoroacetaldehyde (40) has a role in fluorometabolite biosynthesis, 
the fluoroacetaldehyde solution was administered to resting cells of Streptomyces 
cattleya. Immediately prior to this study, fluoroacetaldehyde (40) (as an aqueous 
solution, section 3.1.1) was fed to the bacterium by co-workers in Belfast.107 Those 
resting cell experiments suggested that there was a rapid metabolism of 
fluoroacetaldehyde (40) to fluoroacetate (1). Importantly, those studies also 
demonstrated that 2-fluoroethanol (71) is not involved in fluorometabolite biosynthesis, 
either directly or through defluorination and de novo biosynthesis from fluoride. 
It was decided to develop these experiments in Durham and follow any metabolism of 
fluoroacetaldehyde (40) by 1 9F NMR in real time. 
3.2.1.2 Results and discussion 
Fluoroacetaldehyde (40) (2.0 mM) was administered to resting cells of Streptomyces 
cattleya. As this study utilised the fluoroacetaldehyde (40) solution prepared in section 
3.1.1 it contained 2-fluoroethanol (71), and under these conditions the final 
concentration of 71 was 10 mM. 
An aliquot was removed every 10 minutes and the cells were removed by 
microcentrifugation. The sample was then immediately analysed by l 9F NMR. Samples 
were stored at 4 °C prior to a high field l 9F NMR analysis that was compared with the 
original spectra, to ensure that there had been no subsequent metabolism. 
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Fig. 3.3: 1 9F NMR, fluoroacetaldehyde (40) (2.0 mM) fed to Streptomyces cattleya, 
Time = 10 minutes 
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Fig. 3.4: l 9F NMR, fluoroacetaldehyde (40) (2.0 mM) fed to Streptomyces cattleya, 
Time = 30 minutes 
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Fig. 3.5: l 9F NMR, fluoroacetaldehyde (40) (2.0 mM) fed to Streptomyces cattleya, 
Time = 40 minutes 
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It appears that resting cells of the bacterium are capable of rapidly metabolising 
fluoroacetaldehyde (40) to fluoroacetate (1), as monitored by 1 9F NMR (see Fig 3.2 to 
Fig. 3.5). At the first time point (T = 0 minutes), there is a significant level of 
conversion (25 % ) . It is worth noting that there is no fluoroacetate (1) in the 
fluoroacetaldehyde (40) solution added to the bacterium at the outset, and there is no 
conversion when the fluoroacetaldehyde (40) solution was added to MES buffer without 
cells in a control experiment. Therefore this metabolism is mediated by the bacterium. 
The conversion continues quite rapidly and utilises all of the 2 mM fluoroacetaldehyde 
(40) within 40 minutes under these conditions. 
Fluoroacetaldehyde (40) is the first organofluorine compound that has been shown to be 
converted to either of the fluorometabolites by Streptomyces cattleya. 
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Fig. 3.6: Conversion of fluoroacetaldehyde (40) to fluoroacetate (1), by resting cells of 
S. cattleya. 
3.2.2 Oxygen requirements of fluoroacetaldehyde (40) metabolism 
The conversion of fluoroacetaldehyde (40) to fluoroacetate (1) is formally an oxidation 
process. Enzymatically this could be mediated by either an aldehyde dehydrogenase, 
aldehyde oxidase or aldehyde mono-oxygenase.123 It appeared appropriate to study the 
dependence of this biotransformation on molecular oxygen, as this can be suggestive of 
the process that is occurring. To do this the conversion was studied both under a 
nitrogen atmosphere and in an 1 8 0 2 enriched atmosphere (section 3.2.2.1 & 3.2.2.2) 
3.2.2.1 Fluoroacetaldehyde (40) metabolism under nitrogen 
Flavin mediated oxidase and mono-oxygenase and also P 4 5 0 oxidative processes require 
molecular oxygen, whereas dehydrogenase mediated reactions do not as in the latter 
case molecular oxygen is not required for co-factor regeneration. 
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Fluoroacetaldehyde (40) was incubated in resting cells of the bacterium under a nitrogen 
atmosphere. This was done by taking the cell suspension and purging it with a stream 
of N 2 gas before it was stoppered with a rubber septum. Prior to this the MES buffer 
used in the experiment was degassed by three subsequent freeze-thaw cycles under a 
high vacuum. Fluoroacetaldehyde (40), again at a final concentration of 2 mM (i.e. with 
10 mM 2-fluoroethanol (71) present), was added and aliquots were removed every 10 
minutes as before. 
Fig. 3.7: Fluoroacetaldehyde (40) under a N 2 atmosphere, in resting cells of S. cattleya. 
Subsequent l 9F NMR analysis demonstrated that there was absolutely no conversion of 
fluoroacetaldehyde (40) to fluoroacetate (1) when oxygen was excluded. Simultaneous 
control experiments demonstrated that these cells did convert fluoroacetaldehyde (40) to 
fluoroacetate (1) when exposed to the air. 
3.2.2.2 Fluoroacetaldehyde (40) metabolism under 1802 
When an oxidative biotransformation is conducted under an atmosphere of l 8 0 2 then the 
assimilation of label into the substrate can be studied. Both mono-oxygenase and 
oxidase flavin catalysed processes would be expected to introduce label from l 8 0 2 into 
the species that is being oxidised.123 
To incubate the bacterium in an 1 8 0 2 atmosphere a specialist apparatus had to be 
designed and assembled. Essentially the glassware set up was the same as that for an 
atmospheric pressure hydrogenation. This involved a measuring cylinder, closed at both 
ends, which drains below to a reservoir of water and which has three taps at the top, for 
vacuum, gas inlet and gas outlet. The resting cell experiment itself was conducted in a 
100 ml Erlenmeyer flask with a tapped side arm. Before the bacterium was incubated 
under the 1 8 0 2 atmosphere, a trial run was conducted in which l 6 0 2 was used. The cell 
suspension, in previously degassed buffer, was subjected to a light vacuum and the 
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headspace above the cells filled with N 2 / 1 6 0 2 (1:1) gas, from the measuring cylinder 
described above. Fluoroacetaldehyde (40) solution (1 ml, 2 mM final concentration) 
was added by injection through the septum that seals the Erlenmeyer flask. The tap on 
the side arm was closed and the flask placed on the orbital shaker. After one hour the 
experiment was terminated and l 9F NMR analysis of the resultant supernatant 
demonstrated that all of the fluoroacetaldehyde (40) had been converted to fluoroacetate 
(1). 
The experiment was then repeated, this time using l 8 0 2 gas again mixed with N 2 in a 1:1 
ratio, and incubated for one hour. I 9F NMR analysis confirmed that conversion had 
occurred and the resultant fluoroacetate (1) was analysed by GCMS. That analysis 
showed that there was no incorporation at all of oxygen-18 into fluoroacetate (1). 
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Fig. 3.8: Incubation of fluoroacetaldehyde (40) in an l 8 0 2 atmosphere, with resting cells 
ofS. cattleya. 
3.2.2.3 Conclusions 
The inability of Streptomyces cattleya to convert fluoroacetaldehyde (40) in the absence 
of molecular oxygen suggests that oxygen is required for the biotransformation. This 
would appear to rule out a process mediated by an aldehyde dehydrogenase. Flavin 
mediated enzymatic processes require molecular oxygen, however l 8 0 2 labelling studies 
show that label is not assimilated into the carboxylate group of fluoroacetate (1) and this 
appears to rule out the involvement of a flavin mediated oxidase or mono-oxygenase 
process. Superficially these results are contradictory. Further experimentation was 
required to delineate the reaction type and this was done in cell free experiments, which 
are discussed in detail later in this chapter. 
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3.3 Fluoroacetaldehyde in fluorometabolite biosynthesis 
It has been demonstrated that fluoroacetaldehyde (40) is biotransformed to fluoroacetate 
(1) by Streptomyces cattleya, although whether this biotransformation has a role in the 
biosynthesis of fluoroacetate (1) is unclear. Therefore the biotransformation of 
fluoroacetaldehyde (40) to fluoroacetate (1) has been studied in other Streptomyces spp. 
3.3.1 Fluoroacetaldehyde (40) metabolism by other Streptomyces spp. 
The oxidation of fluoroacetaldehyde (40) to fluoroacetate (1) observed in S. cattleya 
may not be an integral part of fluorometabolite biosynthesis, but merely a peripheral 
activity mediated by an indiscriminate enzyme on an unusual substrate. It was therefore 
decided to incubate fluoroacetaldehyde (40) with different Streptomyces spp. to observe 
any conversion to fluoroacetate (1). The strain that produces the ionophoric antibiotic 
monensin (145),124 Streptomyces cinnamonensis, was available in the laboratory and so 
it was decided to study fluoroacetaldehyde (40) metabolism in that organism. 
3.3.1.1 Growth of Streptomyces cinnamonensis 
Streptomyces cinnamonensis was grown from spores that had been stored at -15 °C, 
suspended in a glycerol matrix. Once thawed, these spores were used to inoculate petri 
dishes containing a complex media (yeast and malt extract based, section 5.2.3), and 
were grown at 29.5 °C for 10 days. The resultant vegetative mycelium was then used to 
inoculate liquid complex media and the cultures were incubated for 14 days at 32 °C on 
an orbital shaker. The liquid complex media used was the same as that used for the 
biosynthetic studies carried out to evaluate monensin (145) biosynthesis.124 1 2 5 This 
medium contains both a high level of iron (FeS04.7H20, 5.5 g.l"1) and soybean flour 
(15.0 g.l"1). The latter did not dissolve completely, even after autoclaving, but was 
finely dispersed in the media. However, the bacterium grew as described in the 
previous publications125 and these cells were satisfactory for assessing the 
biotransformation. 
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3.3.1.2 Administering fluoroacetaldehyde (40) to resting cells of Streptomyces 
cinnamonensis 
The cells were harvested, then washed with MES buffer as for Streptomyces cattleya, 
and they were suspended in buffer to the same cell density (0.176 g wet wt. / ml). Two 
experiments were carried out, one at a high density and the other at a low density of 
cells. The high-density cell experiment was set up by adding an aqueous solution of 
fluoroacetaldehyde (40) (1 ml, final concentration 2 mM) to the cell suspension (22 ml) 
and the resting cells were incubated on an orbital shaker. The low-density experiment 
was conducted at the same cell density as in the whole cell studies with S. cattleya. 
MES buffer (17 ml) and fluoroacetaldehyde (40) (1 ml) were added to the cell 
suspension of S. cinnamonensis (5 ml). An aliquot (1 ml) was removed every 20 
minutes over one hour and the cells were then removed by microcentrifugation and the 
supernatants were analysed by l 9F NMR. 
Time / minutes 20 40 60 
low density cells 0 0 0 
high density cells 0 0 12 
Table 3.1: Percentage conversion of fluoroacetaldehyde (40) to fluoroacetate (1) by 
resting cells of Streptomyces cinnamonensis. 
The results of the conversion, as measured by l 9F NMR are tabulated above (Table 3.1). 
Fluoroacetaldehyde is not metabolised by Streptomyces cinnamonensis as efficiently as 
that observed in Streptomyces cattleya. In the aliquots removed after 20 minutes and 40 
minutes there was no conversion at all to fluoroacetate (1) in either experiment. In the 
aliquots removed after 60 minutes there is a low level of conversion (12 %) to 
fluoroacetate (1) in the high-density experiment but no conversion in the low-density 
experiment. 
Although only one additional strain had been studied, this experiment suggests that it is 
unlikely that the enzyme responsible for fluoroacetaldehyde (40) oxidation is ubiquitous 
in the Streptomycetes. Although there was a small level of conversion to fluoroacetate 
(1) at high cell density, this represents a very low level of activity compared with that 
observed in S. cattleya. 
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3.3.2 Fluoroacetaldehyde (40): incubation with alanine (146) and serine (54) 
The purpose of this experiment was to probe the role of fluoroacetaldehyde (40) in 4-
fluorothreonine (2) biosynthesis. It was anticipated that fluoroacetaldehyde (40) may 
undergo a condensation reaction with an as yet unidentified species, to produce 4-
fluorothreonine (2). This obviously mirrors the suggestion of Sanada et al.12 that 4-
fluorothreonine (2) could originate from a condensation between fluoroacetaldehyde 
(40) and glycine (86). However, it has been shown in previous studies that positions C-
1 and C-2 of 4-fluorothreonine (2) are readily labelled by C 3 primary metabolites, such 
as serine (54), alanine (146) and pyruvate (10), but not directly from glycine (86). 1 0 7 , 1 0 6 
The oxidation of fluoroacetaldehyde (40) to fluoroacetate (1) is rapid in whole cells of S. 
cattleya. Clearly, i f the concentration of the substrate for the condensation to 4-
fluorothreonine (2) is low, then only fluoroacetate (1) will be apparent. 
As it appears that fluoroacetaldehyde (40) is not oxidised in the absence of molecular 
oxygen, it appeared appropriate to repeat those experiments, in degassed buffer 
supplemented with alanine (146) and serine (54), as these are known carbon sources for 
C-l and C-2 of 4-fluorothreonine (2). This was anticipated to suppress oxidation and 
promote the putative condensation reaction. 
3.3.2.1 Experimental considerations 
For each amino acid two experiments were conducted. In the first experiment, cell 
suspension (5 ml), buffer and amino acid (final concentration 10 mM) were purged with 
N 2 (5 minutes) and sealed before the addition of fluoroacetaldehyde (40) (2 mM). 
Aliquots were removed for analysis at 1 hour, 3 hours and 48 hours. The cells were 
removed at each time point by microcentrifugation. In the second experiment the amino 
acid (10 mM) was incubated in the cell suspension (5 ml) and buffer for 2 hours,, whilst 
exposed to air. This was anticipated to allow metabolism for the synthesis the putative 
condensation adduct. After 2 hours the cell suspensions were purged in a stream of N 2 
(5 minutes), and the flasks were sealed and fluoroacetaldehyde (40) (2 mM) added. 
Aliquots were collected 1 hour, 3 hours and 48 hours after this time point and the cells 
were removed by microcentrifugation. The resultant supernatants were then analysed 
by l 9F NMR as discussed below. 
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3.3.2.2 Results and discussion 
In none of the 4 experiments (alanine (146) and serine (54), with and without pre-
incubation of the amino acid) was any 4-fluorothreonine (2) observed by l 9F NMR. In 
the samples that had been incubated for 48 hours there was an observable level of 
conversion of fluoroacetaldehyde (40) to fluoroacetate (1), although this is most likely a 
consequence of molecular oxygen leaking through the septum, perhaps when aliquots 
were removed from these experiments. The fact that 4-fluorothreonine (2) production 
was not observed in this set of experiments may be because fluoroacetaldehyde (40) 
does not have a role in 4-fluorothreonine (2) biosynthesis. Alternatively incubating 
resting cells of the bacterium under N 2 may adversely affect peripheral metabolism to 
such an extent that the adduct for condensation is not produced. 
3.3.3 The synthesis andfeeding of [l-2H]-fluoroacetaldehyde (147) 
Studies in Durham had concentrated on following fluoroacetaldehyde (40) metabolism 
by 1 9F NMR and as such the whole cell conversion of fluoroacetaldehyde (40) to 
fluoroacetate (1) has been studied in detail (section 3.2). The biosynthesis of 4-
fluorothreonine (2) from fluoroacetaldehyde (40) had not however been demonstrated 
by 1 9F NMR. As well as conducting feeding experiments in Durham, aqueous solutions 
of fluoroacetaldehyde (40) were sent to our collaborators in Belfast. Murphy 1 0 7 studied 
the metabolism of fluoroacetaldehyde (40) and quantified production of fluoroacetate 
(1) and 4-fluorothreonine (2) by GCMS and HPLC respectively. In a key experiment 
the production of 4-fluorothreonine (2) by resting cells of the bacterium incubated with 
fluoroacetaldehyde (40) was demonstrated, as summarised in Table 3.2. 
Treatment Incubation time 4-fluorothreonine fluoroacetate 
Resting cells + /hours ( 2 ) / m M ( l ) / m M 
0 <0.01 < 0.01 
NaF (2 mM) 1 0.02 0.01 
3 0.03 0.05 
0 <0.01 < 0.01 
Resting cells alone 1 <0.01 < 0.01 
3 0.02 0.01 
0 <0.01 0.16 
Fluoroacetaldehyde 
1 0.01 1.74 
(40)(1.9mM)' 
3 0.03 1.88 
0 <0.02 0.27 
Fluoroacetaldehyde 
1 0.02 1.46 
(40) (3.8 mM) 2 
3 0.04 3.71 
Table 3.2: Fluorometabolite production resultant from feeding fluoroacetaldehyde (40) 
to resting cells of Streptomyces cattleya, Murphy. 1 0 7 
The level of 4-fluorothreonine (2) production in this system is low. However, control 
experiments and monitoring the production of 4-fluorothreonine (2) by HPLC 
demonstrated that the amino acid production is increased on addition of 
fluoroacetaldehyde (40). Previous studies have demonstrated that the bacterium can 
defluorinate both fluorometabolites and the resultant fluoride is then involved in de 
novo fluorometabolite biosynthesis. However, the levels of 4-fluorothreonine (2) after 1 
hour (Table 3.2) were above such background levels and suggest that this is not due to 
defluorination of fluoroacetate (1) to liberate fluoride, but is a direct response to 
fluoroacetaldehyde additions. 
It was necessary to demonstrate unambiguously whether fluoroacetaldehyde (40) is 
involved in 4-fluorothreonine (2) biosynthesis. To study that [1-2H]-fluoroacetaldehyde 
1 contains 18 mM 2-fluoroethanol 2 contains 36 mM 2-fluoroethanol 
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(147) was synthesised and incubated with resting cells of Streptomyces cattleya. 
Clearly i f [1-2H]-fluoroacetaldehyde (147) is involved directly in 4-fluorothreonine (2) 
biosynthesis then [3-2H]-4-fluorothreonine (2) will be generated by the experiment. 
3.3.3.1 Synthesis of [l-H]-fluoroacetaldehyde (147) 
[l,l-2H2]-2-Fluoroethanol (148) can be envisaged as the product of reduction of an ester 
of fluoroacetate (149) using a deuterium labelled reducing agent (see Fig. 3.9). [1- 2H]-
Fluoroacetaldehyde (147) could then be prepared by oxidation of the resultant [1,1- 2H 2]-
2-fluoroethanol (148). 
O OH O 
D > 
F 
Fig. 3.9: Retrosynthetic analysis of [1-2H]-fluoroacetaldehyde (147). 
A potential problem in the synthesis of [l,l-2H2]-2-fluoroethanol (148) is the isolation 
of 2-fluoroethanol (71), which is a polar species of low molecular mass. A previous 
study in the group had approached the synthesis of [1- I 3C, l,l- 2H 2]-ethanol (151) by the 
reduction of the phenylphenacyl derivative of [l-13C]-acetate (150) using L i A l D 4 , 1 2 6 
following a method from Cane et al.127 Therefore it was decided to adapt this 
methodology in our approach to [l,l-2H2]-2-fluoroethanol (148). 
I I i )L iAlD 4 , diglyme HCL S 
° yC ii) 2-phenoxyethanol D D 
\ ^ 150 151 
Fig. 3.10: Synthesis of [1-1 3C, l,l- 2H 2]-ethanol (151), Rogers.126 
The key feature of this method is that the resultant ethanol (151) is the lowest boiling 
component of the solvent and product mixture. The reaction was carried out in a high 
boiling solvent (in this case diglyme) and the reaction was quenched with 2-
phenoxyethanol (152). This enables 151 to be collected by heating the solution to 
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50 °C, and collecting the vapour. In that case the labelled [l- l 3C,l,l- 2H 2]-ethanol (151) 
was not isolated but its tosylate was generated immediately in situ, and the yield over 
these two steps was 27 %. 
/?ara-Phenylphenacyl fluoroacetate (102) is the derivative already used for the GCMS 
analysis of fluoroacetate (1), and in previous l 4C labelling studies." Therefore a method 
of synthesis was already optimised. The adduct was formed by dissolving para-
phenylphenacyl bromide (101) in a 1:1 mixture of acetonitrile and benzene and then 
suspending sodium fluoroacetate (1) in the resultant solution. A catalytic amount of 18-
crown-6 was added and the solution was heated at reflux for 16 hours. The resultant 
solution was washed with water and the solvent removed to yield the product (102) in 
89 % as a yellow solid. 
O O 
Br O sodium fluoroacetate 
89% O 
102 101 
Fig. 3.11: Synthesis of para-phenylphenacyl fluoroacetate (102); in acetonitrile / 
benzene, 1:1, 18-crown-6, reflux, 16 hours. 
Studies then concentrated on the reduction of this adduct (102) using L iAlH 4 . Initially 
the method of Rogers126 was adapted, whereby /?ara-phenylphenacyl fluoroacetate (102) 
was suspended in diglyme and was added slowly to a suspension of L i A l H 4 in diglyme 
that had been cooled to -10 °C. The solution was then stirred at room temperature and 
then cooled in an ice bath such that the reaction could be quenched using 2-
phenoxyethanol (152). Attempts then to distil the 2-fluoroethanol (71) out of the 
resultant solution proved to be difficult. As 2-fluoroethanol (71) boils at 103 °C, an 
attempt was made to distil this product from the reaction solution through a vigreux 
column. A small quantity (90 mg) was collected that proved to be a mixture of 2-
fluoroethanol (71) and diglyme. 'H NMR analysis indicated that the sample was 62 % 
2-fluoroethanol (71), which in this reaction gave a yield of 9.8 %. The sample 
contained diglyme and so the next step was conducted to establish i f the PDC oxidation 
from 2-fluoroethanol (71) to fluoroacetaldehyde (40) could proceed in the presence of 
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this contaminant. The reaction proceeded smoothly and the diglyme did not inhibit the 
transformation. Fluoroacetaldehyde (40) was recovered in 12.5 % yield (as judged by 
1 9F NMR). 
O F 
H 
OH O 
11 
O H H 
F F 
40 102 71 
Fig. 3.12: Synthesis of fluoroacetaldehyde (40) from phenylphenacyl fluoroacetate 
(102); i) L iAlH 4 , diglyme, 4 hours then phenoxyethanol (152), 9.8 %; ii) 
PDC, DCM, 16 hours, 12.5 % 
This initial investigation was promising, however the yields required optimisation. As 
the L iAlH 4 reduction did not proceed in good yield it was decided to try to improve this 
step and investigate alternate methods for the preparation of [l,l- 2H 2]-2-fluoroethanol 
(148). Different methods of collecting the 2-fluoroethanol (71) were explored. 
Rogers126 synthesis of labelled ethanol (151) was adapted, whereby the quenched 
reaction was heated to below the boiling point of fluoroethanol (71) and a stream of N 2 
passed the vapours through into a cold trap. However this method failed to improve the 
recovery of 2-fluoroethanol (71), even when heated to 80 °C for 22 hours. The reaction 
solvent was also changed from diglyme to tetraglyme (boiling points: 162 °C vs. 276 
°C) as this boils at a higher temperature and should ensure that less solvent was distilled 
over with the 2-fluoroethanol (71). However, in the event the resultant 2-fluoroethanol 
(71) was still contaminated with the tetraglyme. 
Samples of [1-2H]-fluoroacetaldehyde (147) were prepared for feeding experiments as 
follows. /jara-Phenylphenacyl fluoroacetate (102) was reduced by LiAlD 4 in tetraglyme 
and the reaction was quenched with 2-phenoxyethanol (152). The resultant [ l , l - 2 H 2 ] - 2 -
fluoroethanol (148) was distilled out of the reaction mixture. The reaction mixture was 
cooled and DCM (5 ml) added to the residual. The resultant solution was distilled and 
l 9F NMR demonstrated that more [l,l-2H2]-2-fluoroethanol (148) was carried over. This 
procedure was repeated a further two times, until no more fluorine signals were 
observed in l 9F NMR of the distillate. This method maximised the 
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[l,l-2H2]-2-fluoroethanol (148) recovery, although an accurate yield could not be 
calculated as the final mass was now unknown. 
O F 
o OH O 
11 
D O D D 
148 147 102 
Fig. 3.13: Synthesis of [l-2H]-fluoroacetaldehyde (147) from ^ara-phenylphenacyl 
fluoroacetate (102); i) LiAlD 4 , tetraglyme, then 2-phenoxyethanol (152); ii) 
PDC, DCM, 20 %. 
PDC was added to the DCM that had been distilled from the reaction solution, to 
oxidise [1,1-2H2]-2-fluoroethanol (148) to [1-2H]-fluoroacetaldehyde (147). After 
heating under reflux for 16 hours the reaction mixture was distilled over a vigreux 
column and dropped into water (2 ml). The reaction mixture was also extracted with a 
further volume (2 ml) of water. The synthesis of [l-2H]-fluoroacetaldehyde (147) was 
confirmed by l 9F NMR. This method provided samples suitable for a feeding 
experiment with resting cells of Streptomyces cattleya. 
Fig. 3.14: 1 9F NMR of [l-2H]-fluoroacetaldehyde (147) and [l,l- 2H 2]-2-fluoroethanol 
(148). 
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[l,l- 2H 2]-2-fluoroethanol (148) recovery, although an accurate yield could not be 
calculated as the final mass was now unknown. 
O F 
V o OH O 
D O D D 
148 102 147 
Fig. 3.13: Synthesis of [l-2H]-fluoroacetaldehyde (147) from para-phenylphenacyl 
fluoroacetate (102); i) LiAlD 4 , tetraglyme, then 2-phenoxyethanol (152); ii) 
PDC, DCM, 20 %. 
PDC was added to the DCM that had been distilled from the reaction solution, to 
oxidise [l,l-2H2]-2-fluoroethanol (148) to [l-2H]-fluoroacetaldehyde (147).' After 
heating under reflux for 16 hours the reaction mixture was distilled over a vigreux 
column and dropped into water (2 ml). The reaction mixture was also extracted with a 
further volume (2 ml) of water. The synthesis of [l-2H]-fluoroacetaldehyde (147) was 
confirmed by 1 9F NMR. This method provided samples suitable for a feeding 
experiment with resting cells of Streptomyces cattleya. 
C 
If 
i i 1 1 1 1 1 1—i 1 1 1 1 1 1 1 1 [ 1 r — i 1 rl—i 1 1 1 1—\ r — i 1 1 1 1 1 r 1 1 1 1 1 1 1 1 1 1 1 1 1— • - i — i — i — i — i — i — i — i — i — i — i — i — i — i — i — * — i — i — • — i — i — j i — • — i — i — i — i — ^ —
r ~ ~ ' — • — i — ' — ' — • — ' — i — • — ' — > — 1 — i — • — < — • — • — i — ' — • — r ~ , _ 
- 2 2 6 -227 - 2 2 8 -229 -230 -231 - 2 3 2 - 2 3 3 - 2 3 4 - 2 3 5 ppm 
Fig. 3.14: 1 9F NMR of [l-2H]-fluoroacetaldehyde (147) and [l,l- 2H 2]-2-fluoroethanol 
(148). 
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The method described above exploits the fact that 2-fluoroethanol (71) is the lowest 
boiling component of the product mixture after the LiAlD 4 reaction is quenched. In an 
attempt to explore an alternative method a set of conditions was designed with 2-
fluoroethanol (71) as the highest boiling component of the product mixture. This could 
be achieved by reducing ethyl fluoroacetate (153) in diethyl ether and quenching the 
reaction with ethanol (154). 
OH 
LiAlFJ, EtjO 
+ ' OH 
then EtOH 
F 71 154 
Fig. 3.15: Putative reduction of ethyl fluoroacetate (153) with L iAlH 4 
As the boiling point of 2-fluoroethanol (71) is 25 °C above that of ethanol (154) (103 °C 
vs. 78 °C), an attempt was made to separate the two alcohols by distillation. Ethyl 
fluoroacetate (153) was added slowly to a cooled suspension of L i A l H 4 in ether. It was 
allowed to warm and stir for 4 hours before the reaction was quenched by the addition 
of ethanol (154). The solid L iAlH 4 residues were removed by filtration and the solvent 
removed by distillation at atmospheric pressure. 1 9F NMR of the product mixture 
indicated that there were no fiuoromethyl resonances. Treatment of L i A l H 4 residues 
with water liberated 2-fluoroethanol (71) and fluoride (ratio 35:65). This indicated that 
during the reduction 2-fluoroethanol (71) is bound to the L iAlH 4 residue, probably as an 
aluminium oxide. Further studies on this system allowed for an optimal release of 2-
fluoroethanol (71) from the reduction. However, this route was not developed further as 
it proved difficult to separate ethanol (154) from 2-fluoroethanol (71). Oxidation of 
ethanol (154) generates acetaldehyde (155), which is known to be toxic to bacterial 
cells. Therefore it was judged that the sample would be unsuitable for feeding 
experiments as it is significantly contaminated with acetaldehyde (155). 
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3.3.3.2 Feeding [l-H]-fluoroacetaldehyde (147) 
[l-2H]-Fluoroacetaldehyde (147) (4 ml) was fed to resting cells of Streptomyces cattleya 
(5 ml) in MES buffer (14 ml). Aliquots were removed 0, 1, 2, 3, 4, 7.5 and 18.5 hours 
into the experiment. 1 9F NMR analysis demonstrated that [l-2H]-fluoroacetaldehyde 
(147) was converted to fluoroacetate (1) as previously observed. The 4-fluorothreonine 
(2) content of each sample was then assessed by GCMS, to assess the presence of [3-
2H]-4-fluorothreonine (2) and the data is presented below (Table 3.3). 
Incorporation into positions 2, 3 & 4 of 4-fluorothreonine (2) (%) 
time / hours none (M) single (M+l) double (M+2) 
0 nd nd nd 
1 nd nd nd 
2 74.8 39.7 -14.5 
3 63.5 52.7 -16.4 
5 51.6 51.8 -3.2 
7.5 41.8 59.5 -1.3 
21 86.6 13.8 -0.3 
48 87.7 12.6 -0.3 
Table 3.3: % Incorporation into positions 2, 3 & 4 of 4-fluorothreonine (2), resulting 
from feeding [l-2H]-fluoroacetaldehyde (147), to resting cells of S. cattleya. 
Table 3.3 shows that the 4-fluorothreonine (2) resulting from feeding [1- 2H]-
fluoroacetaldehyde (147) does indeed incorporate deuterium at C-3. However the levels 
of 4-fluorothreonine (2) are very low. At 0 and 1 hours they were below the level that 
could be detected by GCMS. At 2 and 3 hours the level of 4-fluorothreonine (2) reaches 
the detectable threshold, and approximately half of the 4-fluorothreonine (2) contains 
isotopic label. After 7.5 hours the level of single label in 4-fluorothreonine (2) 
decreases. This is readily explained by dilution with unlabelled 4-fluorothreonine (2) 
arising from de novo biosynthesis. Early in the experiment, before all the [1- 2H]-
fluoroacetaldehyde (147) was consumed, [3-2H]-4-fluorothreonine (2) production 
accounted for the origin of a significant amount of the 4-fluorothreonine (2). 
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Fluoroacetate (2) is biosynthesised concurrently and in time becomes defluorinated 
liberating fluoride ions. The fluorometabolites are then biosynthesised de novo from 
fluoride and the unlabelled 4-fluorothreonine (2) dilutes the pool of labelled 4-
fluorothreonine (2). 
This experiment clearly supports a role for fluoroacetaldehyde (40) as an intermediate in 
4-fluorothreonine (2) biosynthesis. However there is an important caveat, as the 
generation of low concentrations of labelled 4-fluorothreonine (2) could perhaps arise 
by the presence of an indiscriminate aldolase, acting to condense fluoroacetaldehyde 
(40) with e.g. glycine (86). In view of this a feeding experiment with [1- 2H]-
fluoroacetaldehyde (147) and [2- l3C]-glycine (91) was conducted, in an attempt to 
explore the issue. 
+ r 
D OH 
CO' 4-fluorothreonine ^CO'n 
biosynthesis 
91 [3-2H]-2 
+NH 3 F +NH 3 
+ r 
D OH 
CO; aldolase mediated ^ \ ~ ^ C 0 2 
condensation | \ 
+ N H 3 F +NH 3 
91 [2- 1 3C,3- 2H]-2 
Fig. 3.16: Potential labelling patterns in 4-fluorothreonine (2) from feeding both 
[l-2H]-fluoroacetaldehyde (147) and [2- l3C]-glycine (91), to resting cells of 
S. cattleya. 
Fig. 3.16 shows the two possible outcomes that could result from feeding both [1- 2H]-
fluoroacetaldehyde (147) and [2-13C]-glycine (91) together. Therefore in feeding the 
labelled compounds together a high level of double label in 4-fluorothreonine (2) would 
indicate that fluoroacetaldehyde (40) condensed directly with glycine (86), whereas a 
low level of double label wil l lead to the opposite conclusion. 
Accordingly [l-2H]-fluoroacetaldehyde (147) was fed to resting cells of Streptomyces 
cattleya in two separate experiments, one supplemented with 10 mM [2-13C]-glycine 
(91) and the other with 1.0 mM [2- l3C]-glycine (91). 
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Experiment 1: Resting cells of S. cattleya (2.5 ml) were supplemented with [1- 2H]-
fluoroacetaldehyde (147) (2 ml) and 10 mM [2- l3C]-glycine (91), total volume (11.5 
ml). 
Experiment 2: Resting cells of S. cattleya (2.5 ml) were supplemented with [1- 2H]-
fluoroacetaldehyde (147) (2 ml) and 1.0 mM [2-13C]-glycine (91), total volume (11.5 
ml). 
Experiment 3: Resting cells of S. cattleya (5 ml) were supplemented with 2 mM 
fluoride and 10 mM [2-13C]-glycine (91), total volume (23 ml). 
Aliquots were removed at the times indicated in Table 3.4 and the cells were removed 
by microcentrifugation. The 4-fluorothreonine (2) content of the samples was then 
analysed by GCMS (4-fluorothreonine (2) production between 0 and 3 hours was too 
low to be determined by GCMS). 
time / 
hours 
Incorporation into positions 2, 3 & 4 of 4-
fluorothreonine (2) / % 
Treatment none single double triple 
Experiment 1 6 46.8 29.4 22.5 1.3 
Experiment 2 6 57.2 39.0 3.4 0.3 
Experiment 1 9 63.5 18.4 17.3 0.8 
Experiment 2 9 72.0 24.9 2.5 0.6 
Experiment 1 24 58.7 15.9 24.6 0.8 
Experiment 2 24 87.2 11.1 1.4 0.3 
Experiment 3 24 69.3 9.3 21.3 0.3 
Table 3.4: Incorporation of 13C & 2 H into positions 2, 3 & 4 of 4-fluorothreonine (2), 
resulting from incubating [l-2H]-fluoroacetaldehyde (147) and [2- l 3C]-
glycine (91) with resting cells of S. cattleya. 
In analysing these results it is helpful to reduce the problem down to the individual 
reactions that can take place. There is the condensation of [l-2H]-fluoroacetaldehyde 
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(147) with either [2-13C]-glycine (91) or a dedicated biosynthetic intermediate (see Fig. 
3.16). It is assumed that whichever of these is happening, the process has ceased 6 
hours into the experiment, as all of the [l-2H]-fluoroacetaldehyde (147) will have been 
consumed. Therefore all changes in labelling patterns from that point onwards are due 
to [2- l3C]-glycine (91) and its assimilation into the fluorometabolites via a de novo 
biosynthesis involving fluoride. This biosynthesis from [2- l3C]-glycine (91) and 
fluoride wil l deliver a high level of double, and some triple label, as [2- l3C]-glycine (91) 
is known to recombine in positions C-4 and C-3 of 4-fluorothreonine (2) and assimilates 
separately into position C-2. Within 6 hours the label from [2-13C]-glycine (91) will 
have incorporated into the biosynthetic intermediate responsible for positions C-l and 
C-2 of 4-fluorothreonine (2) and this makes it difficult to delineate between direct 
condensation with [2-13C]-glycine (91) and the direct biosynthetic intermediate. 
Experiment 1: The most significant observation of this experiment is the dilution of 
labelled 4-fluorothreonine (2) at 9 hours. Fig. 3.17 shows the variation of the 
populations of labelled 4-fluorothreonine (2) with time. At 9 hours 63.5 % of the 4-
fiuorothreonine (2) is unlabelled, compared to 46.8 % at 6 hours and 58.7 % at 24 hours. 
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Fig. 3.17: Comparison of populations of none (M), single (M+1), double (M+2) and 
triple (M+3) label in positions 2, 3 & 4 of fluorothreonine (2) resultant from 
incubating [l-2H]-fluoroacetaldehyde (147) and 10 mM [2- l3C]-glycine (91) 
with resting cells of S. cattleya, Experiment 1. 
I l l 
Between 6 & 9 hours the amount of both single and double label decreases. Between 9 
and 24 hours the amount of single label decreases, but the amount of double label 
increases. This represents labelling from the de novo biosynthesis of 4-fluorothreonine 
(2) from [2- l3C]-glycine that is additive on the labelled 4-fluorothreonine (2) already 
present. Considering the label in 4-fluorothreonine (2) at 6 hours, the single label 
originates either from 2 H in C-3 or l 3C in C-2. However, the majority of this single label 
must originate from [l-2H]-fluoroacetaldehyde (147) in the early stages of this 
experiment, before fluoride is liberated. This high level of single label suggests 
incorporation of [ 1-2H]-fluoroacetaldehyde (147) and from not glycine (86). [2- 1 3C]-
Glycine (91) was fed at 10 mM, which would clearly label the glycine (86) pool. 
Double label (22 %) at 6 hours can be accounted for by the coupling of [1- 2H]-
fluoroacetaldehyde (147) and a l 3C labelled species. I f that species were [2- l3C]-glycine 
(91), there should be a general increase in the M+2 in going from 6 to 9 hours and this is 
not observed. It is concluded therefore that [l-2H]-fluoroacetaldehyde (147) does not 
couple directly with glycine (86). In summary the single and double labelled 4-
fluorothreonine (2) present after 6 hours must originate directly from the biosynthesis of 
4-fluorothreonine (2) via fluoroacetaldehyde (40) and not an aldolase mediated 
biotransformation. 
Experiment 2: [2- l3C]-Glycine (91) was fed at the lower concentration of 1.0 mM. 
I f [1-2H]-fluoroacetaldehyde (147) is condensing directly with [2- l3C]-glycine (91) then 
again the proportion of double label after 6 hours would be expected to be higher 
compared to the single label. 
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Fig. 3.18: Comparison of populations of none (M), single (M+l) , double (M+2) and 
triple (M+3) label in positions 2, 3 & 4 of fluorothreonine (2) resultant from 
incubating [l-2H]-fluoroacetaldehyde (147) and 1.0 mM [2-13C]-glycine (91) 
with resting cells of S. cattleya, Experiment 2. 
The level of double label in 4-fluorothreonine (2) remains low even at 24 hours (c.f. 
Experiment 1) as the label in the [2-13C]-glycine (91) pool is diluted by endogenous 
glycine (86). Thus recombination of label is less in this experiment than the higher 
concentration fed in experiment 1. This experiment confirms that 
[l-2H]-fluoroacetaldehyde (147) is involved in the biosynthesis of 4-fluorothreonine (2). 
It is noteworthy that in both experiments the level of unlabelled (M) 4-fluorothreonine 
(2) is high. That is clearly because the labelled 4-fluorothreonine (2) is additional to 
that generated by the cells by de novo biosynthesis (Table 3.2). 
3.3.3.3 Conclusions 
These experiments demonstrate that 4-fluorothreonine (2) is biosynthesised when 
resting cells of Streptomyces cattleya are incubated with fluoroacetaldehyde (40). The 
4-fluorothreonine (2) is not accounted for by a direct condensation with glycine (86), 
but with some other intermediate. The results presented in this chapter suggest that 
fluoroacetaldehyde (40) has a pivotal role both in fluoroacetate (1) and 4-
fluorothreonine (2) biosynthesis. Fluoroacetaldehyde emerges as a common 
intermediate in the biosynthesis of the fluormetabolites. 
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3.4 Cell free studies on fluoroacetaldehyde (40) metabolism 
It was necessary to develop cell free methodologies for further study of fluorometabolite 
biosynthesis. Fluoroacetaldehyde (40) is readily converted to fluoroacetate (1) by whole 
cells of Streptomyces cattleya, and this activity provides a useful starting point to study 
cell free metabolism to the fluorometabolites. Methods for disrupting the cells and 
measuring the subsequent protein concentration were explored. 
3.4.1 Protein determination 
Throughout these cell free studies protein concentrations were determined using the 
Bradford assay.128 Coomassie Brilliant Blue G changes colour from red to blue when 
bound to protein, the blue form absorbs at X = 590 nm. Using this chromophore the 
concentration of protein in a given sample can be quantified. A reagent solution 
containing (0.01 % (w/v) Coomassie Blue G, 4.7 % (w/v) ethanol and 8.5 % (w/v) 
phosphoric acid) was prepared and mixed (1.0 ml) with a test sample (20 ul). The 
absorbance at X = 590 nm was measured between 5 and 15 minutes later. Standard 
curves were generated using bovine serum albumin (BSA) solutions and a typical 
standard curve is presented below (Fig. 3.19). The protein concentration in the test 
sample can then be determined directly from the standard curve. 
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Fig. 3.19: Standard curve for protein (BSA) determination using the Bradford assay. 
114 
3.4.2 Disruption of the cells by sonication 
Our collaborators at The Queen's University of Belfast had studied defluorination 
activity in S. cattleya. A partial purification of a defluorination activity was performed 
in this study after cell disruption by sonication.107 Disrupting cells with ultra sound has 
been used extensively in Streptomyces Spp., therefore it was decided to prepare cell free 
extracts by sonication and study the conversion of fluoroacetaldehyde (40) to 
fluoroacetate (1). 
3.4.2.1 Maximising the protein yield 
Preliminary studies focused on maximising the yield of protein from the cells using a 
sonic probe. Cells were harvested and suspended in ice cold MES buffer (50 mM) at 
1.0 g wet wt. / ml. The slurry was placed in a thick test tube supported in ice water and 
was exposed to repeated pulses from the sonic probe, ensuring that the internal 
temperature did not rise above 7 °C. It emerged that the yield of protein fell of f with 
prolonged exposure to sonication and the optimum conditions were 3 pulses, each of 10 
seconds on 60 % power (the maximum power for that probe), allowing the solution to 
cool between pulses. The cell debris was then removed by centrifugation (20,000 rpm, 
40 minutes, 4 °C) in a pre-chilled centrifuge. Typically this method yielded between 4 
mg /ml and 8 mg /ml of protein in the resultant cell free extract. 
3.4.2.2 Fluoroacetaldehyde metabolism 
The conversion of fluoroacetaldehyde (40) to fluoroacetate (1) was studied using cell 
free extracts obtained in this manner. The cell free extract (0.625 ml, 4 mg / ml protein) 
was incubated with fluoroacetaldehyde (40) (2 mM), at 29 °C in 50 mM MES buffer 
containing dithiothreitol (DTT) (2 mM) and a variety of co-factors; NAD + (2 mM), 
NADP + (1 mM), FAD (2 mM), FMN (2 mM), ATP (5 mM) and Co ASH (2 mM). The 
experiments were stopped after 0, 2 and 4 hours by placing the test tube in hot water (> 
85 °C) for 5 minutes and the resultant protein precipitate was removed by 
centrifugation. The supernatants were analysed by 1 9F NMR, however in none of the 
experiments was the presence of fluoroacetate (1) observed. 
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3.4.3 Disruption of the cells with a French Press 
In view of the lack of success with cell free extracts prepared by sonication an alternate 
method of cell disruption was explored by using a French press (Biological Sciences 
Department, University of Durham). This method involves pumping a cellular slurry 
through a small aperture (0.25 mm), onto a metal target and the resultant solution is 
drained into a collection vessel. The whole unit can be refrigerated, and was generally 
cooled to 4 °C. Harvested cells were suspended in ice cold 50 mM MES buffer that 
contained DTT (2 mM). A thin cell slurry (0.1 g wet wt. / ml) was passed through the 
French press, at an operating pressure of 26,000 psi (1700 bar) and collected into pre-
chilled glassware. The French press was then washed with ice cold 50 mM MES 
(containing 2 mM DTT) buffer, with a volume equal to half that of the cell slurry and 
the washings combined with the extract. The cellular debris was removed by 
centrifugation (20,000 rpm, 40 minutes, 4 °C) and the supernatant collected. The 
protein concentration of the resultant cell free extract was then determined using the 
method described in section 3.4.1. The protein concentration was routinely found to be 
between 1 and 2 mg / ml. Importantly this generated a far greater volume of crude cell 
free extract than the sonication method and consequently a far greater amount of protein 
could be used in each experiment. This method of disrupting the cells was used in all of 
the subsequent cell free experiments. 
3.4.3.1 Fluoroacetaldehyde metabolism 
The following experiment was used to study fluoroacetaldehyde (40) metabolism in cell 
free extracts (2.5 mg/ml protein) of S. cattleya. 
A B c D E F 
cell free extract 5 5 5 
50 mM MES + 2 mM DTT 5 5 5 
co-factor 'soup' 1 1 1 1 1 1 
40 mM fluoroacetaldehyde (40) 1 1 1 1 1 1 
incubation time / hours 0 0 7 7 24 24 
Table 3.5: The experimental protocol for studies into fluoroacetaldehyde metabolism 
by cell free extracts of S. cattleya. Numbers refer to volume (ml). 
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The co-factor 'soup' contained (final concentration upon adding 1 ml to cell free 
experiment): N A D + (2 mM), NADP + (1.33 mM), FAD (2 mM), FMN (2 mM), CoASH 
(0.5 mM) and ATP (5 mM). The experiments were terminated by immersing the test 
tube into hot water (>85 °C) for 5 minutes and the resultant protein precipitate removed 
by centrifugation (20,000 rpm, 10 minutes). 
3.4.3.2 Results and discussion 
l 9F NMR analysis of the resultant supernatants A —> F revealed that the was no 
conversion in the samples in the controls without cell free extract (B, D & F). 
Conversion of fluoroacetaldehyde (40) to fluoroacetate (1) was observed only in those 
samples (A, C & E ) containing the cell free extract (Table 3.6). 
A time = 0 hours 3.1 % conversion 
C time = 7 hours 10.6 % conversion 
E time = 24 hours 35.9 % conversion 
Table 3.6: Conversion of fluoroacetaldehyde (40) to fluoroacetate (1) by cell free 
extracts of S. cattleya. % Conversion determined from integrals of l 9F 
NMR analysis. 
These results demonstrates that cell free extracts of S. cattleya, with the co-factor 
'soup', are capable of converting fluoroacetaldehyde (40) to fluoroacetate (1). The 
concentration of fluoroacetaldehyde (40) that was administered to the resting cells was 
high (5.7 mM) compared with that for each co-factor (2 mM). In sample E (24 hours), a 
36 % conversion was observed which represents a final concentration of fluoroacetate 
(1) of approximately 2 mM. Therefore this may represent the complete consumption of 
one of the co-factors (2 mM). 
3.4.3.3 Conclusions 
The conversion of fluoroacetaldehyde (40) to fluoroacetate (1) has been demonstrated in 
cell free extracts of S. cattleya. The final concentration was approximately 2 mM, 
which equates with the amount of NAD + , FAD and FMN that was added to the buffer. 
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It may be that one or more of these co-factors has a direct role in the oxidation of 
fluoroacetaldehyde (40) to fluoroacetate (1). 
3.4.4 Co-factor dependence 
In order to establish the co-factor dependence for the oxidation of fluoroacetaldehyde 
(40) to fluoroacetate (1) a set of experiments were conducted where one co-factor was 
removed each time from the co-factor cocktail. 
3.4.4.1 Experimental protocol 
Cell free extracts were prepared as described previously and the protein concentration 
measured as 1.4 mg /ml. In this series of experiments fluoroacetaldehyde (40) was 
supplied at a final concentration of 2 mM. 
A B c D E F G H I 
cell free extract 5 5 5 5 5 5 5 5 
50 mM MES & 2 mM DTT 5 
fluoroacetaldehyde (40) (14 mM) 1 1 1 1 1 1 1 1 1 
co-factor 'soup' 1 1 1 
NAD + (70 mM) 0.2 0.2 0.2 0.2 0.2 
NADP + (35 mM) 0.2 0.2 0.2 0.2 0.2 
FAD (54 mM) 0.2 0.2 0.2 0.2 0.2 
FMN (70 mM) 0.2 0.2 0.2 0.2 0.2 
CoASH (17.5 mM) 0.2 0.2 0.2 0.2 0.2 
ATP (175 mM) 0.2 0.2 0.2 0.2 0.2 
time / hours 24 0 24 24 24 24 24 24 24 
Table 3.7: Experimental protocol for co-factor dependence studies. Numbers refer to 
volume (ml). 
The co-factor 'soup' contained (final concentration upon adding 1 ml to cell free 
experiment): N A D + (2 mM), NADP + (1.33 mM), FAD (2 mM), FMN (2 mM), CoASH 
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(0.5 mM) and ATP (5 mM). The experiments were terminated by immersing the test 
tube into hot water (> 85 °C) for 5 minutes and the resultant protein precipitate was 
removed by centrifugation. 
3.4.4.2 Results and discussion 
The results of the 1 9F NMR analysis are summarised below in Table 3.8. The numbers 
refer to the percentage conversion of fluoroacetaldehyde (40) to fluoroacetate (1) 
observed after 24 hours. 
ExptC 
(none) 
ExptD 
(NAD +) 
ExptE 
(NADP+) 
ExptF 
(FAD) 
ExptG 
(FMN) 
ExptH 
(CoASH) 
Expt I 
(ATP) 
100 0 100 100 100 100 100 
Table 3.8: Percentage conversion of fluoroacetaldehyde (40) to fluoroacetate (1) as 
determined from integrals of 1 9F NMR analysis. The bracketed 
abbreviations refer to the co-factor that was absent in that experiment. 
The data is very clear and reveals that the conversion of fluoroacetaldehyde (40) to 
fluoroacetate (1) proceeds only when NAD + is present. The transformation does not 
require any other co-factors. Interestingly it was noted that after 4 hours of incubation 
in all of the experiments, except D, a fine dark precipitate formed, suggesting that 
fluoroacetate (1) production may account for this colouring. 
The conversion of fluoroacetaldehyde (40) to fluoroacetate (1) requires N A D + and is 
therefore mediated by an aldehyde dehydrogenase. A minimal mechanism is presented 
in Fig. 3.20. 
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Fig. 3.20: Action of NAD + on the fiuoroacetaldehyde dehydrogenase. 
The concomitantly produced NADH contains a chromophore that absorbs in the ultra-
violet region. Therefore the reaction could be followed spectrophotometrically. An 
experiment was set up as outlined in Table 3.9 to assess the production of fluoroacetate 
(1) from fluoroacetaldehyde (40) with time in the cell free extract. 
A B c D E F G 
cell free extract 5 5 5 5 5 5 5 
50 mM MES & 2 mM DTT 1 
fluoroacetaldehyde (40) (14 mM) 1 1 1 1 1 1 
NAD + (14 mM) 1 1 1 1 1 1 1 
time / hours 0 0 2 4 8 16 24 
Table 3.9: Experimental protocol for spectrophotometric analysis of fluoroacetate (1) 
production in cell free extracts of S. cattleya incubated with 
fluoroacetaldehyde (40) and NAD + . Numbers refer to volume (ml). 
The protein concentration was determined as 2.1 mg /ml and the experiments were 
terminated by immersing the test tube into hot water (> 85 °C) for 5 minutes and the 
resultant protein precipitate removed by centrifugation. The results of the 1 9F NMR and 
spectrophotometric analysis are tabulated below. UV measurements were taken by 
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comparing samples with a reference (sample A). Absorbance was measured at 340 nm, 
in a quartz curvette. 
Time / hours 0(B) 2(C) 4(D) 8 (E) 16(F) 24(G) 
% Conversion ( 1 9 F NMR) 29.0 70.0 83.2 98.5 100 100 
% Absorbance (k = 340 nm) 0.079 0.165 0.993 0.302 -0.107 -0.235 
Table 3.10: % conversion and % absorbance of experiments to determine fluoroacetate 
(1) and NADH production in cell free extracts of S. cattleya. 
Fluoroacetate (1) production was concomitantly monitored by l 9F NMR analysis and is 
shown below (Fig. 3.21) with the variation in the spectrophotometric analysis. 
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Fig. 3.21: Graphical representation of conversion of fluoroacetaldehyde (40) to 
fluoroacetate (1) and the variation of absorbance, measured at A, = 310 nm. 
The change in absorbance increases initially as a result of reduction of N A D + to NADH, 
however it reaches a maximum before the complete consumption of fluoroacetaldehyde 
(40) and then falls off to a value below that in the reference cell. This may be due to the 
NADH produced by the oxidation of fluoroacetaldehyde (40) being used in another 
enzymatic reaction, for which there is sufficient substrate in the cell free extract. It is 
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noticeable that the rates of NAD + reduction by the cell free extract when incubated with 
fluoroacetaldehyde diminished significantly with the age of the cell free extract. This is 
shown in Fig. 3.22, where the gradient of the initial slope decreases with time. 
Tirol hr 
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Fig. 3.22: Decrease in rate of NADH production with time. All samples are cell free 
extract, 2 mM fluoroacetaldehyde (40) and 2 raM NAD + 
This data demonstrates that the crude cell free extract is not stable, either due to the 
inherent instability of the aldehyde dehydrogenase, or perhaps that proteases gradually 
diminish the activity. 
3.4.5 Substrate specificity 
In order to test the substrate specificity of fluoroacetaldehyde dehydrogenase a variety 
of commercially available aldehydes were incubated with the cell free extract and the 
rate of oxidation measured spectrophotometrically. It was particularly interesting at the 
outset to assess the efficiency of acetaldehyde as a substrate, as acetaldehyde (155) is 
the substrate for mammalian and yeast acetaldehyde dehydrogenase. As this was a 
crude cell free extract only the relative rates of NADH production could be assessed for 
the different aldehydes, with respect to that of fluoroacetaldehyde (40). 
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3.4.5.1 Experimental protocol 
The assay was conducted simultaneously on two spectrophotometers kept in a room at 
constant temperature (26 °C). Crude cell free extracts were prepared as previously 
described and each experiment was conducted as follows: 
Sample A: cell free extract (5 ml) and 14 mM fluoroacetaldehyde (1 ml) 
Sample B: cell free extract (5 ml) and 14 mM aldehyde (1 ml) 
Sample C: cell free extract (5 ml) and 50 mM MES with 2 mM DTT (1 ml) 
All three samples were incubated for 5 minutes at 28 °C before 14 mM NAD + (1 ml) 
was added and mixed by vortex. The final concentration of both aldehyde and NAD + 
was 2 mM. The absorbance of samples A and B were measured at X = 340 nm with 
respect to time in separate spectrophotometers using sample C as an in situ reference. 
Data was collected for a sufficient time to compare the initial rate of NADH production 
in both A and B. 
Acetaldehyde (155), benzaldehyde (156), chloroacetaldehyde (157), propionaldehyde 
(158), trifluoroacetaldehyde (159) and glycolaldehyde dimer (160) were all assessed as 
substrates for the aldehyde dehydrogenase. 
3.4.5.2 Results and discussion 
The relative rate of oxidation of the various aldehydes was calculated relative to 
fluoroacetaldehyde (40) (i.e. by comparing the initial rate in sample B with that in 
sample A). This is expressed as a percentage and tabulated (Table 3.11) with the 
structures below. 
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Aldehyde Relative rate of 
NAPH production 
Aldehyde Relative rate of 
NAPH production 
0 
F 40 
100 % 
0 A 
155 
40% 
0 
\ ^ 156 
31 % 
0 
CI 157 
24% 
0 
H 158 
2 % 
0 x 
F X ' ^ H 
159 
0% 
O ^ ^ O H 
HO 0 160 
140 % 
Table 3.11: Relative rate of aldehyde oxidation by the crude cell free extract of S. 
cattleya and NAD+. 
All of the aldehydes, except trifluoroacetaldehyde (159) emerged as substrates for the 
aldehyde dehydrogenase. The rates were all slower than that of fluoroacetaldehyde (40) 
which appears to be the optimal substrate for the aldehyde dehydrogenase. 
Acetaldehyde (155), which is the substrate for a yeast and mammalian acetaldehyde 
dehydrogenase, is the most efficient substrate after fluoroacetaldehyde, but is oxidised 
at only 40 % of the rate of fluoroacetaldehyde. 
Benzaldehyde (156) and chloroacetaldehyde (157) both had similar activities as 
substrates (31 % & 24 %), whereas that of propionaldehyde (158) was far lower (2 %). 
This suggests that electronic considerations are more significant than steric factors in 
determining the efficiency of a substrate for this enzyme. 
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It would appear that the enzyme prefers a hydrate to an aldehyde as a substrate. This 
was demonstrated by the effective metabolism of glycolaldehyde dimer (160). When 
crude cell free extract and NAD+ were incubated with glycolaldehyde dimer (160) 
oxidation occurred more rapidly (140 %) than in the case of fluoroacetaldehyde (40). 
As there are two centres on the glycolaldehyde dimer (160) that are potential sites for 
oxidation it was incubated at half the concentration of the other aldehydes (that is 1 mM 
instead of 2 mM). 
3.4.5.3 Conclusions 
The aldehyde dehydrogenase that is responsible for the oxidation of fluoroacetaldehyde 
(40) to fluoroacetate (1) is capable of oxidising a variety of different aldehydes to their 
respective carboxylic acids. It appears that the ability to generate a hydrate in solution 
is significant in determining whether an aldehyde will act as a substrate. 
3.4.6 Fluoroacetaldehyde dehydrogenase: membrane bound or soluble? 
An enzyme that is membrane bound is more difficult to purify than i f it is soluble. 
However, membrane bound enzymes tend to be more stable in cell free extracts as they 
can be supported in situ by fragments of membrane. It appeared appropriate to conduct 
a preliminary investigation into whether the putative fluoroacetaldehyde dehydrogenase 
is membrane bound or soluble. 
3.4.6.1 Experimental protocol 
Crude cell free extract was prepared as previously described and divided into two 
portions. The first was stored in ice until required and the second was subjected to 
ultracentrifugation (50,000 rpm, 4 °C, 1 hour, equivalent to 200,000 g). This provided a 
centrifugal force sufficient to remove all particulate matter from solution. The 
supernatant was then decanted and stored in ice. The pellet was resuspended in its 
original volume of 50 mM MES and 2 mM DTT. The three fractions were then 
examined for fluoroacetaldehyde dehydrogenase activity by the method that is outlined 
below (Table 3.11). 
125 
A B C 
crude cell free extract 5 
supernatant (solubles) 5 
resuspended pellet (particulate) 5 
14 mM fluoroacetaldehyde (40) 1 1 1 
14 mM NAD+ 1 1 1 
Table 3.12: Experimental protocol for membrane bound study. Number refer to 
volume (ml). 
Each experiment was incubated at 29 °C and aliquots were removed at 0, 1,3 and 24 
hours. The aliquots were immersed in hot water (> 85 °C) for 5 minutes and the 
resultant precipitate removed by microcentrifugation. 
3.4.6.2 Results and discussion 
The supernatants were analysed by l9F NMR and the results are tabulated below (Table 
3.13). 
Time / hours 1 3 24 
A crude cell free extract 40.5 % 91.7% 100% 
B supernatant (solubles) 21.8% 100% 100% 
C resuspended pellet (particulate) 0% 0% 0% 
Table 3.13: F NMR analysis of membrane bound study for fluoroacetaldehyde 
dehydrogenase in S. cattleya, the figures refer to % conversion of a 
2 mM fluoroacetaldehyde (40) solution. 
Table 3.13 clearly demonstrates that fluoroacetaldehyde dehydrogenase activity is 
located in the soluble fraction of the cell free extract and that the enzyme is not 
membrane bound 
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3.5 Cell free studies on 4-fluorothreonine (2) biosynthesis 
Whole cell studies on fluoroacetaldehyde (40) metabolism have demonstrated its 
involvement in fluorometabolite biosynthesis in Streptomyces cattleya. It has been 
demonstrated that fluoroacetaldehyde (40) is rapidly oxidised to fluoroacetate (1) and 
that it also undergoes a condensation to form 4-fluorothreonine (2). Initial studies on 
cell free extracts of Streptomyces cattleya have focused on the identification of a 
fluoroacetaldehyde dehydrogenase activity. It appeared appropriate to initiate studies 
into cell free biosynthesis of 4-fluorothreonine (2) from fluoroacetaldehyde (40). In an 
attempt to study 4-fluorothreonine (2) biosynthesis in a cell free system 
fluoroacetaldehyde (40) was incubated, in the absence of NAD+, with putative 
intermediates that may contribute C-l and C-2 of 4-fluorothreonine (2). 
Hamilton et al.m have already studied the incorporation of labelled pyruvate into 4-
fluorothreonine (2). It was noted that both [1- , 3C]- and [3-13C]-pyruvate (161), (100) 
label positions C-l and C-2 of 4-fluorothreonine (2) at approximately the same level 
(4.4 % vs. 4.6 % respectively). Also [2-l3C]-pyruvate (93) labelled those same positions 
at approximately twice that level (11.6 %). This would suggest that pyruvate (10) is 
metabolised through to C-l and C-2 of 4-fluorothreonine (2) via a symmetrical C3 
intermediate. A possible candidate for this role would be 2-aminomalonate (162). Such 
a compound could undergo a decarboxylative condensation with fluoroacetaldehyde 
(40) to produce 4-fluorothreonine (2) (Fig. 3.23), providing a rationale for all of the 
labelling studies carried out to date. 
O O O OH 5 
^ 
CO 
o o H 
F ^ + N H 3 F +NH3 
40 162 2 
Fig. 3.23: Putative biosynthesis of 4-fluorothreonine (2) from fluoroacetaldehyde (40) 
and 2-aminomalonate (162). 
With this hypothesis in mind, it was decided to prepare a sample of 2-aminomalonate 
(162), for incubation with cell free extracts of Streptomyces cattleya. 
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3.5.1 Synthesis of 2-aminomalonate (162) 
2-Aminomalonate (162) was prepared by the hydrolysis of diethyl 2-aminomalonate 
hydrochloride (163), which is commercially available.129 Ester hydrolysis in potassium 
hydroxide generated the zwitterionic potassium salt of 2-aminomalonate (162). 
o o 0 0 
J i X KOH(aq.) 11 11 
BO Y oa —-—- - o ' ^ x r ^ o - K + 
. 1 reflux, 4 hours, 70 % I +NH 3 CI" + N H 3 
163 162 
Fig. 3.24: Synthesis of potassium 2-aminomalonate (162). 
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3.5.2 Cell free studies with 2-aminomalonate (162) 
Pyridoxal phosphate (PLP) is a co-factor involved in amino acid decarboxylation 
Therefore it was decided to involve PLP in this study as this co-factor may have a role 
in a decarboxylative condensation type reaction. In order to delineate between 4-
fluorothreonine (2) biosynthesis and adventitious condensation with fluoroacetaldehyde 
(40), control experiments involving glycine (86) and boiled cell free extract were run 
simultaneously. 
Crude cell free extracts of Streptomyces cattleya were prepared as previously described 
using the French press and the protein concentration was determined to be 1.8 mg /ml. 
The experiment was then set up as outlined below (Table 3.14). 
After 2 hours a further 0.5 ml of 28 mM 2-aminomalonate (162) was added to 
experiments B and D. Likewise, a further 0.5 ml of 28 mM glycine (86) was added to C 
and E . All of the experiments (A —> E) were incubated at 29 °C for 16 hours, and were 
then terminated by immersing the test tube in hot water (> 85 °C) for 5 minutes and the 
resultant precipitate was removed by centrifugation. The supernatants were then 
analysed by 19F NMR and 4-fluorothreonine (2) assessed by HPLC. 
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A B C D E 
cell free extract 5 5 5 
14 mM fluoroacetaldehyde (40) 1 1 1 1 1 
28 mM NAD+ 0.5 
28 mM aminomalonate (162) 0.5 0.5 
28 mM glycine (86) 0.5 0.5 
28 mM PLP 0.5 0.5 0.5 0.5 
boiled cell free extract 5 5 
50 mM MES & 2 mM DTT 0.5 
Table 3.14: Experimental protocol for 2-aminomalonate (162) incubations in cell free 
extracts of S. cattleya. 
In the control (experiment A), complete conversion to fluoroacetate (1) was observed 
indicating active fluoroacetaldehyde dehydrogenase in the cell free extract. I 9F NMR 
analysis of experiments B —> E demonstrated only the presence of fluoroacetaldehyde 
(40) and the associated 2-fluoroethanol (71). In none of these experiments was 4-
fluorothreonine (2) production observed and this was confirmed by HPLC, which failed 
to identify any 4-fluorothreonine (2) in these samples. 
3.5.3 Conclusions 
The failure to identify any 4-fluorothreonine (2) does not rule out the involvement of 2-
aminomalonate (162) in 4-fluorothreonine (2) biosynthesis. It may be that a co-factor is 
required that was not included in this experiment or that the necessary condensing 
enzyme was deactivated during preparation of the cell free extract. However, in the 
absence of a positive result this experiment yields little information on the role of 2-
aminomalonate (162) in the biosynthesis of 4-fluorothreonine (2). 
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3.6 Conclusions 
The role of fluoroacetaldehyde (40) in fluorometabolite biosynthesis has been 
addressed. The rapid oxidation of fluoroacetaldehyde (40) to fluoroacetate (1) has been 
observed in both whole cell and cell free systems of Streptomyces cattleya. Co-factor 
studies have shown a dependence on NAD+ and therefore the conversion is mediated by 
an aldehyde dehydrogenase. This is in agreement with the l 8 0 2 study too, where 
oxygen-18 was not incorporated into the product. 
In the absence of molecular oxygen the oxidation of fluoroacetaldehyde (40) to 
fluoroacetate (1) is arrested in whole cells. The flavin, FAD can convert NADH to 
NAD + and the flavins, in turn, are recycled by molecular oxygen.123 It may be that in 
this case the conversion of fluoroacetaldehyde (40) to fluoroacetate (1) stops in the 
absence of 0 2 as this cycle is arrested. 
NAD FADR O H 
F 40 
O 
peroxide 
NADH FAD O radical 
F 1 
Fig. 3.25: Putative relationship between molecular oxygen and fluoroacetaldehyde (40) 
oxidation in S. cattleya. 
Murphy107 observed very low levels of 4-fluorothreonine (2) production from resting 
cells of Streptomyces cattleya incubated with fluoroacetaldehyde (40). To study the 
biosynthesis of 4-fluorothreonine (2) in more detail [l-2H]-fluoroacetaldehyde (141) 
was synthesised for incubation studies. The synthesis of this labelled species (141) 
proved to be problematic at the outset, although sufficient material was prepared in 
solution for feeding experiments. The label was converted through into 4-
fluorothreonine (2). To rule out an adventitious condensation between 
fluoroacetaldehyde (40) and glycine (86) a feeding study using both of these species in 
labelled form was conducted. The analysis of those experiments indicated that glycine 
(86) does not contribute directly to 4-fluorothreonine (2), an observation in agreement 
with previous labelling studies. The results imply that fluoroacetaldehyde (40) is 
directly involved in 4-fluorothreonine (2) biosynthesis. 
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It can now be stated with some confidence that fluoroacetaldehyde (40) is a common 
fluorinated intermediate to both of the fluorometabolites elaborated by Strepiomyces 
cattleya. 
F-
O 
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Fig. 3.26: The pivotal role of fluoroacetaldehyde in fluorometabolite biosynthesis in 
S. cattleya. 
When resting cells of S. cattleya are incubated with fluoride, fluoroacetate (1) and 4-
fluorothreonine (2) are biosynthesised in a 2:1 ratio." Conversely, when resting cells 
are incubated with fluoroacetaldehyde (40) the ratio is how approximately 100:1 (Table 
3.2). This change in ratio may hint at mechanistic aspects of 4-fluorothreonine (2) 
[biosynthesis. Fluoroacetaldehyde (40) could be biosynthesised, and reacts on to form 4-
fluorothreonine (2), whilst bound to ah enzyme or co-factor, potentially as an imine. 
Fluoroacetaldehyde (40) is potentially toxic to bacterial cells, so S. cattleya may have 
evolved an efficient fluoroacetaldehyde dehydrogenase so as to oxidise this toxin and 
expel it extracellularly. 
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Fig. 3- 27: Hypothetical role of channelled fluoroacetaldehyde in fluorometabolite 
biosynthesis, in S. cattleya. 
This would suggest that 4-fluorothreonine (2) is the secondary metabolite that 
Streptomyces cattleya is attempting to produce, whereas fluoroacetate (1) is a shunt 
metabolite liberated by a toxic intermediate from that biosynthesis. 
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Chapter 4 
Cell free investigation of the fluorination event 
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Chapter 4: Cell free investigation of the fluorination event 
Fluoroacetaldehyde (40) has been identified as a common fluorinated intermediate in 
the biosynthesis of fluoroacetate (1) and 4-fluorothreonine (2) in Streptomyces cattleya. 
The project now aimed to investigate the biosynthetic origin of fluoroacetaldehyde (40). 
Clearly, to produce fluoroacetaldehyde (40) from a C3-glycolytic intermediate two 
events must occur; fluorination and bond cleavage. 
C3-glycolytic non-fluorinated 
intermediate C2 intermediate 
C3-fluorinated 
glycolytic intermediate 
Fig. 4.1: Oxidative bond cleavage and fluorination are required to synthesis 
fluoroacetaldehyde (40) from a glycolytic intermediate. 
Fluorination of a glycolytic intermediate will generate a fluorinated C3 intermediate 
(Fig. 4.1), as explored in section 2.4 and in previous studies.100 There are however 
unanswered questions in the direct fluorination of glycolytic intermediates, such as the 
role for 3-fluoroglyceraldehyde (142), that have not been satisfactorily addressed. Also, 
if a glycolytic intermediate were to undergo bond cleavage prior to fluorination there 
would have to be a non-fluorinated C2 intermediate, acting as the substrate for 
fluorination. Clearly, this role could be fulfilled by glycolaldehyde phosphate (164). 
glycolytic b o n d c l e a v a S e i l ^ fluorination 
intermediate *" [ ^ 
O-P 
n 164 
Fig. 4.2: Putative role of glycolaldehyde phosphate (164) in fluoroacetaldehyde (40) 
biosynthesis. 
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Fluorination of glycolaldehyde phosphate (164), via substitution of the phosphate group, 
would provide a route to fluoroacetaldehyde (40). 
The cell free methodologies developed in studying the fluoroacetaldehyde 
dehydrogenase (section 3.4) were employed to explore the fluorination event. The 
general approach was to incubate cell free extracts of S. cattleya with fluoride and 
putative substrates for fluorination. In addition to studying glycolaldehyde phosphate 
(164) as a substrate, various glycolytic intermediates were explored as additional 
candidates. The putative initial product of fluorination for DL-a-glycerophosphate (97), 
di hydroxy acetone phosphate (98) and 3-phosphoglycerate (17) have all been synthesised 
and fed to resting cells of S. cattleya with no apparent fluorometabolite biosynthesis 
(section 2.4). However, it appeared appropriate to include them in this study as a matter 
of rigour. 
O OH O 
o o o HO O HO O O H 
O O O. / O O 
97 98 164 
O 
O 
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Fig. 4.3: Putative substrates for the fluorination event in S. cattleya. 
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4.1 Cell free studies with phosphorylated intermediates 
Several of the phosphorylated glycolytic intermediates are commercially available. 
However, glycolaldehyde phosphate (164) is not and therefore it was prepared following 
the method of Eschenmoser et al.m 
4.1.1 Synthesis of glycolaldehyde phosphate (164) 
Glycolaldehyde phosphate (164) has been implicated in the prebiotic synthesis of 
ribonucleic acids, in a variation of the formose reaction.131 Eschenmoser et al.m have 
developed a convenient synthesis of this phosphate (164) and explored its base catalysed 
aldol condensations to generate higher sugars. 
+NH O 
o \ OH O O 
166 72 
Ca2+ 
EtjNH 
164 167 
Fig. 4.4: Synthetic scheme to glycolaldehyde phosphate (164), Eschenmoser et al.m i) 
H3P04, Et3N, CC13CN, 75 °C, then cyclohexylamine, 76 %; ii) IR 120 (H+ 
form), Et3N; iii) 0 3 / MeOH, -78 °C Me2S, -20 °C, then IR 120 (H + form), 
then Ca(OAc)2, 74 % from 167. 
Glycolaldehyde phosphate (164) was thus synthesised following the method outlined in 
Fig. 4.4. The first step involved activating allyl alcohol (72) with trichloroacetonitrile 
before nucleophilic attack by phosphoric acid. The cyclohexylamine salt of allyl 
phosphate (166) was then isolated in good yield (74 %). The key step in the synthesis 
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of glycolaldehyde phosphate (164) is the ozonolysis of allylphosphate. The authors 
reported that the ozonolysis is more successful on the mono(triethylamine) (167) salt 
rather than the bis(cyclohexylamine) (166). Therefore allylphosphate 
mono(triethylamine) (167) was prepared using acidic ion exchange resin to generate 
allylphosphoric acid and addition of triethylamine resulted in a modest recovery of 
allylphosphate mono(triethylamine) (167) (44 %). The ozonolysis was carried out 
according to the literature preparation. Accordingly, allylphosphate 
mono(triethylamine) (167) was dissolved in methanol and cooled to -78 °C. A stream 
of 0 3 was passed through this solution until it turned light blue, indicating ozone 
saturation and complete formation of the ozonide. The ozonide was reduced by adding 
DMS and the reaction was stirred for 24 hours at -20 °C. Glycolaldehyde phosphoric 
acid was generated using acidic DOWEX ion exchange resin and the calcium salt (164) 
isolated by adding Ca(OAc)2. The salt precipitated out on treatment with acetone, to 
form a white amorphous solid (74 % from allylphosphate mono(triethylamine) (167)). 
4.1.2 Preliminary cell free experiments 
All of the candidate substrates were used in the cell free experiments. The glycolytic 
intermediates were all soluble in MES buffer, however glycolaldehyde phosphate (164) 
required a drop of 1 M HC1 (aq.) to help it dissolve. The cell free extract was incubated 
with the relevant substrate (2 mM for a single stereoisomer, 4 mM if racemic), fluoride 
(2 mM as NaF) and a mixture of co-factors (Co-factors administered were at the 
following final concentrations; thiamine pyrophosphate, 2 mM; ATP, 5 mM; 
MgS04.7H20, 2 mM; NAD+, 2 mM; NADP+, 1 mM; NADH, 2 mM; NADPH, 0.5 mM; 
CoASH, 0.5 mM; pyridoxal phosphate, 1 mM). The experimental protocol is outlined 
below in Table 4.1. 
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A B C D E F G H 
cell free extract 5 5 5 5 5 5 5 5 
50 mM MES and 2 raM DTT 1 
14 mM fluoroacetaldehyde (40) 1 
co-factor 'soup' and 14 mM F" 1 1 1 1 1 1 1 1 
28 mM DL-oc-glycerophosphate (97) 1 
14 mM dihydroxyacetone phosphate (98) i 
28 mM DL-glyceraIdehyde-3-phosphate (11) 1 
14 mM 3-phosphoglycerate (17) 1 
14 mM 2,3-diphosphoglycerate (165) 1 
14 mM glycolaldehyde phosphate (164) 1 
time / hours 24 24 24 24 24 24 24 24 
Table 4.1: Experimental protocol for preliminary fluorination event studies in cell free 
extracts of S. cattleya. Numbers refer to volume (ml). 
The experiment was then incubated for 24 hours at 29 °C and terminated by immersing 
in hot water (> 85 °C) for 5 minutes and the resultant precipitate removed by 
centrifugation. The supernatants were then analysed by l 9F NMR and subsequently by 
GCMS quantification of fluoroacetate (1). Control A contained no fluorometabolites, 
which demonstrated that there was no endogenous fluorometabolites in the cell free 
extract. Control B showed a 70 % conversion from fluoroacetaldehyde (40) to 
fluoroacetate (1), demonstrating that the cell free extract contained active 
fluoroacetaldehyde dehydrogenase. 
I 9F NMR demonstrated that samples C —> H contained no resonances equivalent to 
fluoromethyl groups, and fluoride remained in all of the samples. GCMS confirmed 
that there was no fluoroacetate (1) in samples C —> H. 
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The experiment was repeated with the same result. Therefore, it is concluded that the 
cell free extract of S. cattleya, with those co-factors and substrates was not capable of 
generating fluorinated organic intermediates. To explore this further the investigation 
was extended to an analysis of further co-factors. 
4.1.3 Cell free experiments with SAM (168), methionine (169), cysteine (55) and 
glutathione (170) 
Microorganisms that are symbionts on plants that biosynthesise fluoroacetate (1) have 
developed a defluorination strategy based on nucleophilic attack of a free thiol residue 
of the dehalogenase (section 1.4.5). Glutathione (170) has also been implicated as 
having a role in fluoroacetate defluorination. Therefore it was deemed appropriate to 
investigate the putative involvement of sulphur-containing bio-molecules. A thiol, for 
example, could displace phosphate to generate a thio ether (172), which in turn could be 
subject to nucleophilic attack, by fluoride (see Fig. 4.5). 
R S O H O 
171 LA„ O^X H 
172 
d'o -/-V 164 
Fig. 4.5: Putative mechanism for fluorination via nucleophilic displacement of 
phosphate by a thiol (171), followed by nucleophilic attack by fluoride. 
Glycolaldehyde phosphate (164) is used as the substrate by way of 
example. 
Cell free extracts were prepared as previously described using a French press and were 
incubated with fluoride (2 mM as NaF) and the co-factor 'soup'. The co-factor soup 
contained NAD + (2 mM), NADP + (2 mM), ATP (5 mM) and thiamine pyrophosphate (2 
mM), MgS0 4 .7H 20 (2 mM). Two sets of experiments were conducted. In the first the 
co-factor 'soup' was supplemented with both 2 mM S-adenosine methionine (SAM) 
(168) and 2 mM methionine (169) (experiment 1). In the second it was supplemented 
with both 2 mM cysteine (55) and 2 mM glutathione (170) (experiment 2). 
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Fig. 4.6: SAM (168), methionine (169), cysteine (55) and glutathione (170). 
A B C D E F G H 
cell free extract 5 5 5 5 5 5 5 5 
50 mM MES and 2 mM DTT 1 
14 mM fluoroacetaldehyde (40) 1 1 
co-factor 'soup' and 14 mM F" 1 1 1 1 1 1 1 
14 mM NAD + 1 
14 mM glycolaldehyde phosphate (164) 1 
14 mM dihydroxyacetone phosphate (98) 1 
28 mM DL-glyceraldehyde-3-phosphate (11) 1 
14 mM 3-phosphoglycerate (17) 1 
14 mM 2,3-diphosphoglycerate (165) 1 
time / hours 24 24 24 24 24 24 24 24 
Table 4.2: Experimental protocol for cell free study. Experiment 1: Co-factor soup 
was supplemented with 2 mM SAM (168) and 2 mM methionine (169). 
Experiment 2: Co-factor soup was supplemented with 2 mM cysteine 
(55) and 2 mM glutathione (170). Numbers refer to volume (ml). 
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The experiments (1 & 2) were set up as outlined in the protocol (Table 4.2), and were 
then incubated for 24 hours at 29 °C and the experiments were terminated by immersing 
in hot water (> 85 °C) for 5 minutes and the resultant precipitate removed by 
centrifugation. The supernatants were then analysed by l 9F NMR. In neither 
experiment were any fiuoromethyl resonances observed in samples incubated with 
substrate and fluoride (C -> G), demonstrating that the presence of SAM (168), 
methionine (169), cysteine (55) or glutathione (170) did not act to mediate the 
fluorination. No fluoroacetate was detected by GCMS analysis in any of the samples (C 
->G). 
In experiment 1 (SAM (168) and methionine (169)) the controls were as expected, with 
the cell free extract capable of converting fluoroacetaldehyde (40) to fluoroacetate (1) in 
the presence of both NAD + alone and with the co-factor 'soup' (which included NAD + , 
SAM (168) and methionine (169)). However, in experiment 2 (cysteine (55) and 
glutathione (170)), an anomalous result was revealed in the control. When incubated 
with NAD + alone fluoroacetaldehyde (40) was converted to fluoroacetate (1), but when 
it was incubated with the co-factor 'soup' (which included NAD + , cysteine (55) and 
glutathione (170)) no fluoromethyl resonances were observed and the fluoride signal 
was enhanced. This demonstrated that cysteine (55) or glutathione (170) could act to 
defluorinate either fluoroacetate (1) or fluoroacetaldehyde (40). 
It was decided to study this defluorination activity further particularly as it may emerge 
that either cysteine (55) or glutathione (170) are co-factors in fluorometabolite 
biosynthesis, and that they were also acting to defluorinate fluoroacetate (1) in a 
reversible manner. Accordingly, cell free extracts were prepared as previously 
described and an experiment was conducted, as outlined in the protocol below (Table 
4.3). 
141 
A B C D E F G H 
cell free extract 5 5 5 5 
denatured cell free extract 5 5 
50 mM MES & 2 mM DTT 0.5 0.5 0.5 0.5 5.5 5.5 
14 mM fluoroacetaldehyde (40) 1 1 1 1 1 1 1 1 
28 mM NAD + 0.5 0.5 
28 mM cysteine (55) 0.5 0.5 0.5 0.5 
28 mM glutathione (170) 0.5 0.5 0.5 0.5 
time / hours 16 16 16 16 19 19 19 19 
Table 4.3: Experimental protocol for defluorination studies with cysteine (55) and 
glutathione (170). 
The cell free extract was denatured for experiments E & F by immersion in hot water (> 
85 °C) for 5 minutes and the resultant precipitate removed by centrifugation. The 
experiment was incubated at 29 °C for the times indicated and terminated by immersion 
in hot water (> 85 °C) for 5 minutes and the precipitate removed by centrifugation. The 
supernatants were then analysed by l 9F NMR. 
Samples A & B contained predominantly fluoroacetate (1) and a small quantity of 
fluoride. This suggested that fluoroacetaldehyde (40) and not fluoroacetate (1) was 
defluorinated. It also demonstrated that both cysteine (55) and glutathione (170) are 
capable of defluorinating fluoroacetaldehyde (40). This was confirmed by studying 
samples C & D, which contained only fluoride and no fluoroacetaldehyde (40) at the 
end of the reaction. Samples E -> G contained fluoride only, demonstrating that the 
defluorination of fluoroacetaldehyde (40) by cysteine (55) or glutathione (170) is non-
enzymatic. In sample H approximately half of the fluoroacetaldehyde (40) had been 
defluorinated, suggesting that cysteine (55) is a better defluorinating agent than 
glutathione (170). 
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A plausible explanation for this non-enzymatic defluorination is nucleophilic attack of 
the free thiol at the cc-position of fluoroacetaldehyde (40), liberating fluoride and 
generating a thioether. Cysteine (55) may be more efficient than glutathione (170) as 
fluoroacetaldehyde (40) could form an imine (173) with cysteine (55) followed by an 
intramolecular displacement of fluoride to generate the thiapiperidine 174 (Fig. 4.7). 
O 
CO CO CO 
H + HS HS 
+NH 
40 55 H 173 H 174 
Fig. 4.7: Putative mechanism for fluoroacetaldehyde (40) defluorination by cysteine 
(55). 
Although the observation is clear, these mechanistic conclusions remain tentative. The 
focus of this study was on the enzymatic fluorination and isolation of reaction products 
was not pursued. 
4.1.4 Cell free studies with pyridoxamine (175) 
Pyridoxamine phosphate (PMP) (175) bonds, as an imine, with aldehydes and ketones 
to facilitate biotransformations such as transaminase reactions, thus it appeared 
appropriate to study the involvement for PMP (175) in the fluorination event. The role 
of PMP on a-phosphocarbonyl compounds was studied as they may be activated to 
nucleophilic attack (Fig. 4.8) by this cofactor. 
o 
o o \ 
R R 
+ 
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H 
Fig. 4.8: Putative mechanism involving pyridoxamine phosphate (PMP) (175). 
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Cell free extracts were prepared as previously described and the experiment was 
conducted as outlined below (Table 4.4). Dihydroxyacetone phosphate (98) and 
glycolaldehyde phosphate (164) were selected as potential substrates, with the putative 
site for fluorination a to the carbonyl. 
A B C 
cell free extract 5 5 5 
14 mM fluoroacetaldehyde (40) 1 
14 mM NAD + 1 
28 mM glycolaldehyde phosphate (164) 0.5 
28 mM dihydroxyacetone phosphate (98) 0.5 
co-factor 'soup', contains 28 mM PMP (175) 0.5 0.5 
14 mM NaF 1 1 
Table 4.4: Experimental protocol on pyridoxamine (175) co-factor study. Numbers 
refer to volume (ml). 
The co-factor 'soup' contained (as final concentrations); 2 mM PMP (175) and 2 mM 
NAD + . After the experiment had been incubated for 19 hours at 29 °C it was terminated 
by immersing the samples in hot water (> 85 °C) for 5 minutes and the resultant 
precipitate removed by centrifugation. The supernatants were analysed by l 9F NMR. 
Sample A was capable of catalysing the conversion from fluoroacetaldehyde (40) to 
fluoroacetate (1), demonstrating that the cell free extract contained an active 
fluoroacetaldehyde dehydrogenase. There were no fluoromethyl resonances in either 
sample B or C, and GCMS analysis did not reveal any evidence for fluoroacetate (1) in 
the samples. This indicates that the PMP (175) did not act to facilitate the fluorination 
of either glycolaldehyde phosphate (164) or dihydroxyacetone phosphate (98). 
4.1.5 Conclusions 
Incubating potential substrates with fluoride and a plethora of co-factors in the cell free 
extract of S. cattleya did not result in any demonstrable fluorination activity. In each 
experiment the cell free extract has been shown to be active by monitoring 
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iluoroacetaldehyde dehydrogenase activity, although it may be that the fluorination 
enzyme is more susceptible to degradation, resulting in ready loss of activity. 
Alternatively, the experiments may be deficient in one or more co-factors or in the 
correct substrate. As this series of experiments has explored potential co-factor 
requirement in some depth; but without success, an alternate strategy was pursued. It 
was considered more fruitful to study the degradation or further metabolism of the 
candidate substrates. Some of the issues surrounding the substrates are addressed in the 
next section. 
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4.2 Assessing phosphatase activity in the cell free extract 
Cell free studies were designed based on the putative mechanistic hypothesis, whereby 
phosphate is displaced in a nucleophilic attack by fluoride. The glycolytic intermediates 
and glycolaldehyde phosphate (164) have all been studied as potential substrates in cell 
free experiments (section 4.1), however these experiments did not demonstrate any 
fluorinating capability. 
In the crude cell free extract of S. cattleya there will clearly be other enzymes displaying 
activities other than fluorination and fluoroacetaldehyde dehydrogenase. It is possible 
that phosphatase activities are acting on the substrates to dephosphorylate them, and 
lead to deactivation. It appeared appropriate therefore to study phosphatase activity in 
cell free extracts of Streptomyces cattleya. 
4.2.1 Phosphate assay 
Traditionally malachite green assays are used to determine inorganic phosphate (Pj) 
concentration.132 However it was decided to use the method of Jenkins and Marshall,1 3 3 
because the method does not require deproteinisation of the sample and MES buffer is 
known not to interfere with the assay. 
To determine the phosphate concentration in a sample, an aliquot (1.0 ml) was mixed 
with 1.0 M perchloric acid (0.2 ml), which acts to denature the protein. To the resultant 
solution 0.25 M pH 5.0 imidazole (0.1 ml) and 1.5 % sodium molybdate were added and 
mixed by vortexing. Butyl acetate (2.0 ml) was added to the solution and then the 
reaction was mixed by vortexing for 10 seconds. Phase separation was achieved by 
centrifugation (5,000 rpm, 2 minutes) and 1.0 ml of the sample was removed from the 
organic layer. The absorbance of this sample was then measured at X = 310 nm and 
correlated to a standard curve (Fig. 4.9). 
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0 0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9 1 
[ inorganic phosphate] / mM 
Fig. 4.9: Standard curve for phosphate assay, absorbance @ X = 310 nm. 
The assay can detect levels of phosphate between 0.02 mM and 0.5 mM, at which 
concentration the response reaches a plateau. 
4.2.2 Preliminary dephosphorylation studies 
Cell free extracts were prepared as previously described and the experiment was set up 
following the protocol outlined below (Table 4.5). The co-factor soup contained (final 
concentration); N A D + (2 mM), NaF (2 mM), ATP (5 mM) and MgS0 4 .7H 20 (2 mM). 
Therefore, it is important to note that all the samples contain ATP, which i f acted on by 
an appropriate phosphatase, could result in phosphate release. 
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A B C D E F G H I 
cell free extract 5 5 5 5 5 5 4.6 5 
50 mM MES & 2 mM DTT 5 
10 mM NaH 2 P0 4 1.4 
14 mM fluoroacetaldehyde (40) 1 1 1 
14 mM NAD + 1 1 
14 mM DHAP (98) 1 
28 mM G-3-P (11) 1 
14 mM 3-phosphoglycerate (17) 1 
14 mM 2,3-diphosphoglycerate (165) 1 
14 mM glycolaldehyde phosphate (164) 1 
co-factor 'soup' 1 1 1 1 1 1 1 
Table 4.5: Experimental protocol for preliminary dephosphorylation studies. Numbers 
refer to volume (ml). 
The experiments were incubated at 29 °C and the phosphate concentration of each 
sample determined after 0 and 4 hours by the method previously described (section 
4.2.1). The results are tabulated below (Table 4.6). 1 9F NMR of the supernatant of 
sample I demonstrated complete conversion from fluoroacetaldehyde (40) to 
fluoroacetate (1). 
Time / hours A B C D E F G H 
0 0.02 <0.02 0.02 0.03 0.02 0.02 0.02 >0.5 
4 0.05 O.02 >0.5 >0.5 >0.5 >0.5 >0.5 >0.5 
Table 4.6: Phosphate release (mM) from glycolytic intermediates and glycolaldehyde 
phosphate (164) incubated with crude cell free extract of S. cattleya. 
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After 4 hours of incubation all of the samples contained greater than 0.5 mM phosphate. 
This clearly indicates that there was a release of phosphate from the substrate and/or 
ATP. There was also a moderate release (< 10 %) from the cell free extract in the 
absence of endogenous phosphate sources, sample A. 
It was deemed necessary to study this dephosphorylation further. To that end cell free 
extracts were prepared as previously described and a series of experiments set up as 
outlined in the protocol below (Table 4.7). It was decided to focus on phosphate release 
from glyceraldehyde-3-phosphate (11) and glycolaldehyde phosphate (164) only, as all 
of the substrates in the previous study demonstrated the same response. 
A B C D E F G H I 
cell free extract 5 5 5 5 5 5 
50 mM M E S & 2 m M DTT 1 6 1 6 1 6 1 2 
14 mM fluoroacetaldehyde (40) 1 
ATP 1 1 
14 mM glyceraldehyde-3-phosphate (11) 1 1 
14 mM glycolaldehyde phosphate (164) 1 1 
14 mM NaH 2 P0 4 1 
NAD + 1 
Table 4.7: Experimental protocol for dephosphorylation studies on glycolaldehyde 
phosphate (164) and glyceraldehyde-3-phosphate (11). Numbers refer to 
volume (ml). 
The experiments were incubated at 29 °C and aliquots removed at 0, 0.75, 1.5, 6.5 and 
18 hours. The aliquots were then treated as previously described to determine the 
phosphate concentration and the results are tabulated below (Table 4.8). 
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[PJ / m M in sample 
time / hours B C D E F G H I 
0 <0.02 0.05 0.07 >0.5 <0.02 0.02 >0.5 <0.02 
0.75 0.10 0.05 >0.5 >0.5 <0.02 0.02 >0.5 n.d. 
1.5 0.12 0.05 >0.5 >0.5 0.03 0.02 >0.5 0.02 
6.5 0.15 0.06 >0.5 >0.5 >0.5 0.04 >0.5 0.08 
18 >0.5 0.06 >0.5 >0.5 >0.5 0.03 >0.5 n.d. 
Table 4.8: Phosphate release (mM) from glyceraldehyde-3-phosphate (11) and 
glycolaldehyde phosphate (164). 
Samples B & C demonstrate the dephosphorylation of ATP when incubated in cell free 
extracts or MES buffer, respectively. This experiment demonstrated that ATP was 
slowly dephosphorylated in the cell free extract, or during the phosphate assay. The 
first step of the assay involved the addition of dilute perchloric acid to denature the 
protein. It may be that this process hydrolyses ATP. However, the release of phosphate 
from ATP was different in the control (buffer only, 0.06 mM after 18 hours) from that in 
cell free extract (>0.5 mM after 18 hours). The experiments revealed that phosphate 
release from ATP by the cell free extract does not become significant until after 6 hours 
of incubation. 
Samples F & G (glycolaldehyde phosphate (164) with and without CFE, respectively) 
demonstrate that glycolaldehyde phosphate (164) was dephosphorylated by the cell free 
extract of S. cattleya. Phosphate release from glycolaldehyde phosphate (164) was 
minimal in the presence of buffer only. However samples D & E (glyceraldehyde-3-
phosphate (11) with and without CFE, respectively) are ambiguous. In the presence of 
the cell free extract glyceraldehyde-3-phosphate (11) was dephosphorylated, but the 
control contained a high level of phosphate (>0.5 mM), even at time = 0 hours. This 
anomaly is difficult to rationalise as glyceraldehyde-3-phosphate (11) was added at the 
same concentration to the cell free extract (D) and to the buffer (E). It would be 
expected that the concentration of phosphate in the t = 0 samples should be identical. 
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It is concluded from these experiments that glycolaldehyde phosphate (164) can be 
dephosphorylated and that glyceraldehyde-3-phosphate (11) may be dephosphorylated 
by cell free extracts of S. cattleya. The cell free extract itself also releases a small 
amount of phosphate with time, as demonstrated by sample I. 
With this initial survey of dephosphorylation completed, it was decided to attempt a 
partial purification of the cell free extract to determine i f dephosphorylation and the 
putative fluorination activities could be separated. 
4.2.3 Partial purification of the cell free extract 
A partial purification of the cell free extract was facilitated by precipitation of protein 
from solution by adding ammonium sulphate. Ammonium sulphate is routinely used to 
salt out protein from solution, as the density of a saturated solution (4 M , 761 g.l"1) is 
less than that of most aggregate proteins (1.235 g.cm"3 vs. 1.33 g.cm'3). Therefore 
precipitated protein can be removed from the solution by centrifugation.134 
Cell free extracts were prepared as previously described and ammonium sulphate was 
slowly added to it, whilst stirred at 4 °C. The amount of ammonium sulphate required 
to achieve the desired saturation was calculated using published precipitation tables.135 
Once the correct amount of ammonium sulphate had dissolved in the extract it was left 
to stir for 10 minutes, before the protein precipitate was removed by centrifugation 
(20,000 rpm, 4 °C, 10 minutes). By this method protein in the cell free extract was 
separated into that which salted out between 0 - 40 %, 40 - 65 %, 65 - 100 % and 0 - 100 
% saturation (fractions a, b, c & d respectively). The protein was resuspended in 50 
mM MES with 2 mM DTT, to one fif th the original volume. The experiment was then 
set up as outlined in the protocol below (Table 4.9). 
151 
A B C D E F G H 
0 - 40 % saturation, fraction a 1 1 
40 - 65 % saturation, fraction b 1 1 
65 - 100 % saturation, fraction c 1 1 
0 - 100 % saturation, fraction d 1 1 
14 mM fluoroacetaldehyde (40) 1 1 1 1 
14 mM NAD + 1 1 1 1 
14 mM G -3 -P( l l ) 1 1 1 1 
50 mM MES & 2 mM DTT 4 4 4 4 5 5 5 5 
Table 4.9: Experimental protocol for assay of partially purified CFE. Numbers refer to 
volume (ml). 
The experiment was incubated at 29 °C and aliquots removed at various time points for 
l 9F NMR studies (A -> D) or phosphate (P,) concentration determination (E -> H). The 
phosphate release (Table 4.10) and fluoroacetaldehyde (40) to fluoroacetate (1) 
conversion results (Table 4.11) are tabulated below. 
Fraction of cell free extract, as % 
saturation with ammonium sulphate 
0 - 40 % 40 - 65 % 65 - 100% 0-100% 
time / hours E F G H 
0 <0.02 0.02 <0.02 0.03 
4 >0.5 >0.5 >0.5 >0.5 
Table 4.10: Phosphate release (mM) from glyceraldehyde-3-phosphate (11) when 
incubated with fractions a -> d of the CFE of S. cattleya. 
Clearly the data presented in Table 4.10 demonstrate that the phosphatase activity is 
spread across all three fractions of the cell free extract. Ammonium sulphate cuts will 
not therefore be an effective method for separating phosphatase activity from the 
putative fluorination activity. These results also imply that more than one phosphatase 
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is active in the cell free extract as the efficiency of the fractionation process is 
demonstrated by monitoring the conversion from fluoroacetaldehyde (40) to 
fluoroacetate (1) (Table 4.11). 
fraction of cell free extract, as % 
saturation with ammonium sulphate 
0 - 40 % 40 - 65 % 65 - 100% 0-100% 
time / hours A B C D 
0.5 0% 5.0 % 0% 0% 
2 0% 62.4 % 0% 65.7 % 
8 12.9 % 100% 0% 100% 
Table 4.11: Conversion from fluoroacetaldehyde (40) to fluoroacetate (1) by fractions a 
—> d of the CFE of S. cattleya. Estimated from integrals of l 9F NMR. 
The fluoroacetaldehyde dehydrogenase activity was partially purified after ammonium 
sulphate treatment. The activity is predominately in the fraction of protein that salted 
out between 40 and 65 % saturation. It appeared appropriate to treat the crude cell free 
extract further so as to establish where in this ammonium sulphate precipitate fraction 
the fluoroacetaldehyde dehydrogenase activity was located. 
4.2.4 Partial purification of fluoroacetaldehyde dehydrogenase 
Cell free extracts were prepared as previously described and treated with ammonium 
sulphate (as described in section 4.2.3). By this method protein was separated into that 
which salted out between 0 - 65 % saturation, 40 - 53 % saturation and 53 - 65 % 
saturation (fractions a, b & c respectively). The amount of ammonium sulphate required 
to achieve the desired saturation was again calculated using published precipitation 
tables.135 The protein was resuspended in 50 mM MES with 2 mM DTT to one fifth the 
original volume. The experiment was then set up as outlined in the protocol below 
(Table 4.12). 
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A B C D 
0 - 65 % saturation, fraction a 1 
40 - 52.5 % saturation, fraction b 1 
52.5 - 65 % saturation, fraction c 1 
crude cell free extract 5 
14 mM fluoroacetaldehyde (40) 1 1 1 1 
14 mM NAD+ 1 1 1 1 
50 mM MES & 2 mM DTT 4 4 4 
Table 4.12: Experimental protocol for partial purification of fluoroacetaldehyde 
dehydrogenase. Numbers refer to volume (ml). 
These experiments were incubated at 29 °C and aliquots were removed at 1, 2.75 and 
5.5 hours and terminated by immersing in hot water (> 85 °C) for 5 minutes and the 
protein removed by centrifugation. The supernatants were then analysed by 19F NMR to 
calculate the conversion from fluoroacetaldehyde (40) to fluoroacetate (1) (Table 4.13). 
fraction of CFE, as % saturation 
with ammonium sulphate 
0 - 65 % 40 - 53 % 53 - 65 % CFE 
time / hours A B C D 
1 54.6 % 49.8 % 0% 38.8 % 
2.75 100% 82.2 % 28.3 % 100 % 
5.5 100% 100% 40.8 % 100% 
Table 4.13: Conversion from fluoroacetaldehyde (40) to fluoroacetate (1) by fractions a 
-» c of the CFE of S. cattleya. Estimated from integrals of 19F NMR. 
Clearly the majority of the fluoroacetaldehyde dehydrogenase activity was salted out 
between 40 % and 53 % saturation of ammonium sulphate. A further experiment 
demonstrated that the actual level of purification of the cell free extract was poor. 
Crude cell free extracts were prepared as usual and the fraction equivalent to 40 -55 % 
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saturation with ammonium sulphate was precipitated out. The protein was resuspended 
in one fifth of the original volume with 50 mM MES and 2 mM DTT and desalted by 
passage through a sephadex slurry. The crude cell free extract and partially purified 
protein were then compared by SDS-PAGE electrophoresis. Both samples were 
denatured in SDS buffer heated to 95 °C for 5 minutes and loaded onto a stacking gel. 
A potential difference of 150 mV was applied across the gel, which was standing in 
SDS buffer, for 1 hour. The gel was washed and developed in Coomassie blue dye 
solution. 
Lane 
. . . . . . . 
97 kDa > 
66 kDa -> 
45 kl)a > 
31 kDa-> 
21 kDa > 
14 kDa -> 
Fig. 4.10: SDS-PAGE electrophoresis analysis of crude and partially purified cell free 
extract of S. cattleya. Lane 1, molecular weight markers; Lane 2, 10 ul 
crude CFE; Lane 3, 17 ul crude CFE; Lane 4, 10 ul partially purified CFE; 
Lane 5, 17 ul partially purified CFE. 
Clearly the difference between lanes 2 & 4 or 3 & 5 is not dramatic. In the partially 
purified cell free extract two bands with a molecular mass just over 31 kDa (present in 
crude CFE) have been removed. Other than that there is no significant increase in 
purification. 
155 
4.2.5 Conclusions 
The phosphate assay has demonstrated that phosphate is released from all of the 
glycolytic intermediates and glycolaldehyde phosphate (164) when they are incubated 
with cell free extracts of S. cattleya. Fluorination activity is yet to be demonstrated in 
cell free experiments and the rate of phosphate release could perhaps account for the 
degradation of the glycolytic phosphates at a faster rate than fluorination. 
Ammonium sulphate precipitate cuts of the cell free extract of S. cattleya facilitated a 
partial purification of the fluoroacetaldehyde dehydrogenase, albeit with little visual 
purification of the CFE (when studying the SDS-PAGE gel of the CFE and the partially 
purified fraction). Purification of the phosphatase activity could not be achieved in this 
way. 
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4.3 Synthesis and evaluation of isotope enriched glycolaldehydes 
Glycolaldehyde phosphate (164) has been implicated as a putative substrate for 
fluorination and significant attempts have been made to study this in a cell free system. 
In the absence of any observed fluorination activity in those experiments it was decided 
to synthesise and feed stable isotopically labelled glycolaldehyde (176) to resting cells 
of Streptomyces cattleya and evaluate incorporation into the fluorometabolites. This 
would provide an alternative strategy to investigate the direct fluorination of 
glycolaldehyde phosphate (164) to generate fluoroacetaldehyde (40). 
S. cattleya 
Fig. 4.11: Putative conversion of glycolaldehyde (176) to fluoroacetaldehyde (40) via 
glycolaldehyde phosphate (176). 
4.3.1 Synthesis of isotope enriched glycolaldehydes 
In this study it was envisaged that a double labelled feeding experiment would be 
required. This would ensure that glycolaldehyde (176) was incorporated as an intact 
unit, if isotope became incorporated into the fluorometabolites. Routes were explored 
that were amenable to the synthesis of this desired labelling pattern. 
Glycolaldehyde (176) is a C2 carbohydrate. Therefore it could be prepared by a Kiliani-
Fischer type synthesis involving attack of cyanide onto formaldehyde (177). 
OH i) reduction 
H - 7 ^ r M ii) hydrolysis 
H 
177 178 176 
Fig. 4.12: Kiliani-Fischer type synthesis to prepare glycolaldehyde (176). 
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This method has been used to prepare l 3C enriched carbohydrates, including [1-13C]-
glycolaldehyde (179),136 starting with [13C]-KCN. The method was modified by 
Thirkettle for the preparation of [1-13C, l,2,2-2H3]-glycolaldehyde (180) by using [ 2H 2]-
formaldehyde (181), [13C]-KCN and conducting the reduction in a D 2 atmosphere.137,138 
It was decided to attempt the synthesis of [1-13C, 2,2-2H2]-glycolaldehyde (182) using 
[2H2]-formaldehyde (181) and [13C]-KCN. The intact incorporation of both isotopes 
would secure its role in fluoroacetaldehyde biosynthesis. Additionally, it would be 
desirous to synthesise [l-2H]-glycolaldehyde (183) to establish if the isotope is retained 
at C-3 of 4-fluorothreonine (2), in a similar manner to that observed with [1-2H]-
fluoroacetaldehyde (147). 
[1-13C, 2,2-2H2]-Glycolaldehyde (182) was prepared by dissolving [13C]-KCN in D 20 
and adjusting the pD to 8.5 with [l-2H]-acetic acid. The pD of solution was measured 
using a pH probe calibrated to protic buffers and using the formula, pD = pH + 0.4. An 
equimolar quantity of [2H2]-formaldehyde (181), as an aqueous solution in D 20, was 
added dropwise and the resultant solution stirred at room temperature. The pD was 
maintained at 8.5 with aqueous solutions (in D 20) of [l-2H]-acetic acid and NaOD. 
Formation of [1-13C, 2,2-2H2]-glycolonitrile (184) was observed by tic (CH3CN : H 2 0 : 
AcOH, 40 : 10 : 0.5, Rf = 0.9, compared against commercial glycolonitrile (178)) and a 
negative result in a cyanide precipitation test. The reaction was quenched by lowering 
the pD to 4.2 with [l-2H]-acetic acid. Glycolonitrile (178) is known to be unstable to 
the elimination of cyanide and to polymerisation, therefore the solution was reacted 
directly without isolation of [1-13C, 2,2-2H2]-glycolonitrile (184). The pD was lowered 
to 1.7 (with D2S04) and was reduced at atmospheric pressure with hydrogen, using Pd-C 
as a catalyst (60 mg per mmol of nitrile). Complete conversion was confirmed by tic 
after 16 hours and the catalyst was removed by filtration through a hyflo plug. The 
solution was then treated to remove sulphate, by lowering the pD with DOWEX (H+) 
resin and adding BaC03 to precipitate BaS04. The precipitate was removed by 
centrifugation, as a sticky white solid. The solution was then treated with subsequent 
additions of DOWEX (AcO ) and DOWEX (H+) such that the final pD was 0.9. The 
solvent and acetic acid was partially removed in vacuo to yield [1-I3C, 2,2-2H2]-
glycolaldehyde (184). 13C NMR analysis revealed that [1-13C, 2,2-2H2]-aminoethan-2-ol 
(185) (resulting from the further reduction of the imine of glycolaldehyde under the 
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reaction conditions) was also present along with acetic acid. The solution contained 
approximately 65 % [1- ,3C, 2,2-2H2]-glycolaldehyde (184) compared with 5 % [1- ,3C, 
2,2-2H2]-aminoethan-2-ol, (185) the remainder comprising of acetic acid (unlabelled). 
The volume of this solution was not reduced further due to the relative instability of 
glycolaldehyde, and was used directly in feeding studies, after neutralisation to pH 7. 
O OH O D A 11 1 D H D D D D N OH 
181 184 182 
Fig. 4.13: Synthesis of [1-I3C, 2,2-2H2]-glycolaldehyde (182). i) K I 3CN, D 20, pD = 8.5 
; ii) H 2 , Pd-C, pD = 1.7 (D2S04). 
A sample of [l-13C]-glycolaldehyde (179) was also prepared by this synthetic method, 
but without a deuterium labelled solvent. In this case the sample was free of any [1-
l3C]-aminoethan-2-ol (186), but did contain acetic acid. 
4.3.2 Feeding isotope enriched glycolaldehydes 
The prepared solutions of [1-13C, 2,2-2H2]-glycolaldehyde (182) and [1- I 3C]-
glycolaldehyde (179) were fed to resting cells of Streptomyces cattleya and incubated 
with 2 mM fluoride. Resting cells were prepared as previously described and the 
experimental set-up was as detailed below in Table 4.14. 
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A B C D E 
cells 5 5 5 5 5 
50 mM MES 16 16 15 16 15 
40 mM fluoride 1 1 1 1 1 
200 mM [2-'3C]-glycine (91) 1 
[1-13C, 2,2-2H2]-glycolaldehyde (182) 1 2 
[l-13C]-glycolaldehyde (179) 1 2 
Table 4.14: Experimental protocol for feeding isotope enriched glycolaldehydes to 
resting cells of S. cattleya. Numbers refer to volume (ml). The 
concentration of both glycolaldehydes was estimated to be 200 mM, 
therefore their final concentration was approximately 10 mM and 20 mM 
(from 1 ml and 2 ml respectively). 
Each experiment was incubated at 28 °C for 48 hours on an orbital shaker and 
terminated by centrifugation to remove the cells. I 9F NMR analysis demonstrated that 
in sample A, fluorometabolite production followed a normal profile. Samples B -> E 
all showed the same result, that of low incorporation of l3C label into C-l of 
fluoroacetate (1) and C-3 of 4-fluorothreonine (2). There was, however, no detectable 
incorporation from the deuterium atoms in either metabolite (by 19F NMR and GCMS). 
Incorporation into positions 2,3 & 4 
of 4-fluorothreonine (2) (%) 
precursor none single double 
10 mM [1-13C, 2,2-IH2]-glycolaldehyde (182) 96.8 3.2 0.0 
20 mM [1- , 3C, 2,2-2H2]-gIycoIaIdehyde (182) 96.5 3.2 0.3 
10 mM [l-13C]-glycolaldehyde (179) 96.5 3.2 0.3 
20 mM [l-13C]-glycolaldehyde (179) 95.0 4.9 0.1 
Table 4.15: GCMS analysis of 4-fluorothreonine (2) (positions 2, 3 & 4) resulting from 
incubation of resting cells of S. cattleya with isotopically labelled 
glycolaldehydes. 
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W-7S-.i/,'.,v-
- 2 1 5 . 2 0 - 2 1 5 . 3 5 - 2 1 5 . 5 0 - 2 2 9 . 3 5 - 2 2 9 . 5 0 - 2 2 9 . 6 5 - 2 2 9 . 8 0 ppm 
- 2 1 6 - 2 1 8 - 2 2 0 - 2 2 2 -224 - 2 2 6 - 2 2 8 
Fig. 4.14: l 9F {'H} NMR of fluoroacetate (1) and 4-fluorothreonine (2), following 
incubation of resting cells of S. cattleya with 10 mM [1-13C, 2,2-2H2]-
glycolaldehyde (182). 
These results demonstrate that glycolaldehyde (176) was not incorporated as an intact 
unit into the fluorometabolites. Carbon-13 from C-l of glycolaldehyde (176) does label 
C-l of fluoroacetate (1) and C-3 of 4-fluorothreonine (2). For that label to be 
assimilated directly into the fluorometabolites then the deuterium atoms should also be 
retained at C-2 of fluoroacetate (1), however this was not the case. 
O O HO 
D 
Streptomyces cattleya 
H o-
HO 
co: 
182 [1-,3C]-1 [3-13C]-2 
4% 
Fig. 4.15: Labelling observed in fluoroacetate (1) and 4-fluorothreonine (2) resulting 
from incubation of resting cells of S. cattleya with [1-13C, 2,2-2H2]-
glycolaldehyde (182). 
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Glycolaldehyde (176) does not appear to be directly involved in fluorometabolite 
biosynthesis. Perhaps it is also possible that it is a precursor and the bacterium does not 
have the capacity to phosphorylate glycolaldehyde (176), however its role must be 
considered tentative after these experiments. 
Interestingly, glycolaldehyde (176) has not entered fluorometabolite biosynthesis via 
oxidation to glycolate (50) or by transamination to glycine (86), as the labelling patterns 
that result from these species are well established and would have resulted in double 
label in C-l and C-2 of fluoroacetate (1) and C-3 & C-4 of 4-fluorothreonine (2). An 
explanation for the observed labelling pattern resultant feeding [1-I3C, 2,2-2H2]-
glycolaldehyde (182) may involve the pentose phosphate pathway. This pathway was 
discussed in terms of rationalising the incorporation of 13C enriched glucoses in section 
2.3.1. The pathway is mediated by a series of transketolase reactions that transfer an 
activated glycolaldehyde (176) unit. The glycolaldehyde (176) unit is resonance 
stabilised, bound to thiamine pyrophosphate (190 & 191), as represented in Fig. 4.16. 
O R Me R' Me H R v \ 
< L / S + I 1 
H H 
N N 
R OH OH R 
OH R 
A OH 
Co i 
187 188 
OH 
O 189 H 
J H R T 
O Me R Me R' H H N N R R 
^ 1 HO HO 
OH OH 191 190 
Fig. 4.16: The biosynthesis of activated glycolaldehyde by thiamine pyrophosphate and 
transketolase. 
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Perhaps the glycolaldehyde (176) that was administered to the bacterium condensed 
with TPP (187) on transketolase. I f [1-13C, 2,2-2H2]-glycolaldehyde (182) was then 
assimilated into the pentose phosphate pathway it would deliver [2- l3C, 1,1-2H2]-
fructose-6-phosphate (194), as outlined in Fig. 4.17. 
11 
r = 0 
-OH 
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D 
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HO-
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O 
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D 
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OH 
-O 
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\—OH 
-OH 
OP 
Fig. 4.17: Putative assimilation of [1-13C, 2,2-2H2]-glycolaldehyde (182) into 
[2- ,3C, l,l-2H2]-fructose-6-phosphate (194) and [2- l3C, l,l-2H2]-xylulose-
5-phosphate (193). 
[2-13C, l,l-2H2]-Fructose-6-phosphate (194) would then enter the glycolytic pathway via 
phosphorylation and fission to [2-13C, l,l-2H2]-dihydroxyacetone phosphate (196) and 
glyceraldehyde-3-phosphate (11). The deuterium atoms may be removed from [2- l3C, 
l,l-2H2]-fructose-6-phosphate (194), as their position is highly susceptible to 
enolisation, and would thus exchange with the media. 
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4.4 Conclusions 
To date fluorination activity has not been observed in cell free extracts of Streptomyces 
cattleya. Phosphorylated glycolytic intermediates and glycolaldehyde phosphate (164) 
were selected as candidate substrates on the basis of the minimal mechanism whereby 
phosphate is displaced by fluoride. Studies with different co-factors did not reveal any 
fluorination activity. 
The cell free extract displayed significant phosphatase activity, which may deactivate 
candidate substrates with respect to nucleophilic attack by fluoride. Attempts to 
segregate phosphatase and fluorination activity using ammonium sulphate precipitation 
to partition the protein content of the cell free extract did not prove successful. 
Although the dephosphorylation of the candidate intermediates (glycolytic and 
glycolaldehyde phosphates) proceeds efficiently, the complete absence of any 
fluorination activity perhaps suggests that these were not substrates. 
Fluoroacetaldehyde dehydrogenase activity is high in the cell free extract and if any 
fluoroacetaldehyde (40) formed it would have been rapidly converted to fluoroacetate 
(1). The absence of any fluoroacetate (1) in these cell free incubations suggests that 
either the correct substrate or co-factors were absent from the assays. 
The putative role of glycolaldehyde phosphate (164) as a substrate for fluorination was 
probed in whole cell experiments with [1-13C, 2,2-2H2]-glycolaldehyde (182). Upon 
incubation of resting cells of S. cattleya, 182 did not label the fluorometabolites in a 
manner consistent with direct assimilation into fluoroacetaldehyde (40). Clearly a 
phosphate kinase would have to activate glycolaldehyde (176) to its phosphate (164), so 
that it could undergo nucleophilic attack by fluoride. 
Overall the pivotal role of fluoroacetaldehyde in the biosynthesis of fluoroacetate and 4-
fluorothreonine has been established. Further to that the glycolytic pathway was 
confirmed as the primary metabolic pathway that delivers a substrate for either direct 
fluorination, or bond cleavage followed by fluorination. This chapter has described a 
series of experiments that attempted to demonstrate fluorination activity in cell free 
extracts of S. cattleya that used these facts as starting points for the study. That 
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fluorination activity has not been demonstrated in cell free extracts may suggest that a 
more complex mechanism is operating, other than nucleophilic displacement of 
phosphate by fluoride. 
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?s-... 
Chapter 5 
Experimental 
5.1 Chemical Syntheses 
5.1.1 General Details 
NMR spectra were recorded on Bruker AC-250 (250.133 MHz) and Varian VXR-400S 
(399.958 MHz), Unity (299.908 MHz) and Mercury (199.991 MHz) spectrometers in 
deuteriochloroform solution unless stated otherwise, using the deuterated solvent as a 
lock. Melting points were measured on a Gallenkamp variable heater and are 
uncorrected. IR spectra were recorded with absorption values in cm'1 on a Perkin-Elmer 
257 Spectrometer as a neat film between NaCl plates unless stated otherwise. GCMS 
analysis was performed on a VG TRIO 1000 mass spectrometer equipped with a HP1 
capillary column (25 m long, 0.22 mm i.d., 0.2 um film thickness) connected to a H.P. 
5890 series II oven. 
Reaction glassware was dried in an oven at 120 °C and cooled in a dry atmosphere of 
nitrogen. Reaction solvents were dried and freshly distilled prior to use. Petrol refers to 
the 40-60 °C boiling fraction of petroleum ether. Reactions requiring anhydrous 
conditions were conducted under an atmosphere of dry nitrogen and thin layer 
chromatography was carried out on Merck, Kieselgel 60, F 2 5 4 aluminium and glass 
backed plates. Visualisation of plates was achieved by use of a UV lamp or by use of 
permanganate or phosphomolybdic acid stains. Column chromatography was carried 
out over silica gel Merck, Kieselgel 60, 230-400 mesh. 
5.1.2 Preparation of 3-fluoro-l-hydroxypropanone (133) 
Glycidyl benzyl ether (139)139 
o 
139 
Glycidol (138) (20 ml, 0.3 mol) was dissolved in THF (50 ml) and added dropwise to a 
suspension of NaH (7.6 g, 0.32 mol) in THF (300 ml), that had been cooled to 0 °C. 
The rate of addition was controlled such that the temperature did not rise above 10 °C, 
and the resultant solution was stirred until no further effervescence was observed. A 
solution of benzyl bromide (34 ml, 0.3 mol) in THF (50 ml) was added over one hour to 
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the reaction and left to stir for 16 hours. The resultant precipitate was filtered through a 
hyflo plug and the solvent removed under reduced pressure. The crude product (139) 
was suspended in ether (100 ml), washed with water (3 x 100 ml), and the combined 
aqueous layers were extracted into ether (2 x 100 ml). The organic layers were 
combined, dried and the solvent removed under reduced pressure. Glycidol benzyl ether 
(139) was purified by high vacuum distillation (bp 65 - 69 °C at 0.25 mmHg) to yield a 
colourless oil (11.2 g, 0.07 mol, 22 %). 
Rf (1:3, ethyl acetate : petrol ether): 0.5. 
IR (NaCl): 3087m, 3061J, 3030*, 2999.?, 2922m (shoulder), 28615, 2756w, 1957w, 
1879w, 1815w, \604w, 1586w, 1496m, 1453s, 1386m, 1365m, 1345m, 1337m, 1253m, 
1207m, 1160m, 1133m (sh.), 1096s, 1028m, 910m, 899m, 857m, 847m, 739s, 699s, 
608m. 
NMR (CDC13) 5H (400 MHz) (ppm): 7.3 (5H, m, Ph), 4.59 (2H, dd, J = 24.8 Hz & 11.6 
Hz, PhCH20), 3.77 (1H, dd, J = 8.39 Hz & 2.80 Hz, side chain-OCH,Hb), 3.44 (1H, dd, 
J = 11.6 Hz, J = 6.0 Hz, side chain-OCHJiJ, 3.20 (1H, m, OCH2CH), 2.80 (1H, dd, J = 
4.40 Hz, J = 4.80 Hz, terminal-CH^), 2.62 (1H, dd, J = 4.80 Hz, J = 2.40 Hz, terminal-
CHji b ) . 6C (100 MHz) (ppm): 137.8 (Ph), 128.4 (Ph), 127.7 (Ph), 73.2 (PhCH20), 70.7 
(side chain-OCH2), 50.8 (ring-OCH), 44.2 (terminal-OCH2). 
MS (EI+): 164 (M, 1.4 %), 163 (0.9 %), 108 (PhCH20 + 1, 3.4 %), 107 (PhCH20, 39.1 
%), 106 (4.2 %), 105 (29.3%), 92 (PhCH2 + 1, 10.6 %), 91 (PhCH2, 100 %), 89 (6.5 %), 
79 (24.8), 78 (6.6), 77(18.6). 
3-Fluoro-2-hydroxypropanol benzyl ether (140)'" 
Potassium hydrogen difluoride (38.0 g, 15 mol eq.) was added to a solution of glycidyl 
benzyl ether (139) (11.2 g, 0.07 mmol) in diethylene glycol (200 ml). The resultant 
suspension was heated at 170 °C for 4 hours under N 2 . Water (200 ml) was added to the 
cooled solution and the reaction extracted with diethyl ether (3 x 200 ml) and then with 
ethyl acetate (4 x 100 ml). The organic extracts were combined and concentrated to 
o 
OH 
140 
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~ 300 ml under reduced pressure. The organics were then dried (over MgS04) and the 
remainder of the solvent removed under reduced pressure to yield a yellow oil. 
Purification over silica (ethyl acetate : petrol) yielded 140 as a colourless oil (5.0 g, 0.03 
mol, 40 %). 
IR (NaCl): 3550m (sh.), 3416s (br.), 3088w, 3063w, 303lm, 2953s, 2867s, 1721m, 
1603w, 1496m, 1454s, 1364m, 1328m, 1275m, 1098s, 1019s, 969m, 931m, 740s, 699s. 
NMR § H (200 MHz, CDC13) (ppm): 7.40 - 7.28 (5H, m, Ph), 4.57 (2H, s, 
PhCH2OCH2CH(OH)CH2F), 4.48 (2H, dm, 2 ] m = 47.1 Hz, PhCH2OCH2CH(OH)CH2F), 
4.05 (1H, dm, 33m = 18.6 Hz, PhCH2OCH2CH(OH)CH2F), 3.62 - 3.50 (2H, m, 
PhCH2OCH2CH(OH)CH2F), 2.60 (1H, d, 3JHH = 5.40 Hz, PhCH20CH2CH(0H)CH2F). 
8C (50 MHz, CDC13): 137.56 (Ph), 128.45 (Ph), 127.87 (Ph), 127.72 (Ph), 83.88 (d, ' J C F 
= 169.2 Hz, PhCH2OCH2CH(OH)CH2F), 73.53 (PhCH2OCH2CH(OH)CH2F), 69.99 (d, 
3J C F = 6.99 Hz, PhCH2OCH2CH(OH)CH2F), 69.27 (d, 2J C F = 20.17 Hz, 
PhCHjOCH^O^CH.F) . 5F (235.34 MHz, CDC13): -232.5 (td, 2JH F = 46.4 Hz, 33w = 
17.9 Hz). 
MS (EI+): 184 (M, 7.9 %), 107 (PhCH20, 8.2 %), 105 (3.2 %), 92 (PhCH2 + 1, 25.6 %), 
91 (PhCH2, 00 %), 89 (4.7 %), 79 (5.2 %), 78 (2.3 %), 77 (8.5 %). 
3-Fluoropropan-2-one benzyl ether (136)'" 
A solution of DMSO (0.5 ml, 6.9 mmol) in DCM (10 ml) was added to a solution of 
oxalyl chloride (0.3 ml, 3.3 mmol) in DCM (40 ml) at -60 °C (solid C0 2 / acetone bath). 
Addition was limited to ensure that the temperature did not exceed -55 °C and the 
resultant solution was stirred for 10 minutes. A solution of 3-fluoro-2-hydroxypropanol 
benzyl ether (140) (0.6 g, 3.02 mmol) in DCM (10 ml) was added dropwise to the 
activated DMSO solution and the reaction was stirred for 15 minutes. Triethylamine 
(2.1 ml, 15.1 mmol) was added and the solution was allowed to warm to ambient 
temperature. After a further 15 minutes the reaction was quenched by the addition of 
water (60 ml). The organic layer was separated and the aqueous layer was extracted into 
o 
o 
136 
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DCM (2 x 60 ml). The organics were combined and dried (over MgS0 4) and the 
solvent was removed under reduced pressure to afford a crude oil. Purification by 
column chromatography over silica gel (ethyl acetate : petrol, 1:3) gave a colourless oil 
(136) (0.55 g, 2.8 mmol, 93 % ) . 
IR (golden gate, cm"1): 2870m, 1742s, 1605w, 1496m, 1454m, 1426m, 1100s, 1040s. 
NMR 8H (CDC13, 400 MHz) (ppm): 7.27 - 7.28 (5H, m, aromatic), 4.99 (2H, d, ' J ^ = 
47.2 Hz, OCH2COCH2F), 4.53 (2H, s, ArCH 20), 4.20 (2H, d, *Jm = 1.6 Hz, 
OCH2COCH2F). 8C (100.6 MHz, CDC13) (ppm): 73.1 (ArCH 20), 73.6 (OCH2COCH2F), 
84.5 (d, 'J C F = 182.0 Hz, OCH2COCH2F), 127.9 (o-Ph), 128.2 (p-?h), 128.6 (m-Ph), 
136.6 (Ph), 203.3 (d, 2 J C F = 17.2 Hz, OCH^OCH^) . 5 F (188 MHz, CDC13): -236.11 (t, 
2JFH = 47.1 HZ) . 
MS (CI + , NH 3): 201 (M + N H 4 + +1, 5.0 % ) , 200 (M + NH 4 + , 75.7 % ) , 183 (M + l , 9.1 
% ) , 182 (M, 100 % ) , 166 (8.6 % ) , 108 (55.7 % ) , 91 (22.9 % ) . 
3-Fluoro-l-hydroxypropan-2-one (133) 
A suspension Pd on carbon (50 mg) in a solution of 3-fiuoropropan-2-one benzyl ether 
(136) (0.26 g, 1.4 mmol) in methanol (10 ml) was stirred vigorously under a hydrogen 
atmosphere for 16 hours. The catalyst was filtered through a hyflo plug and the solvent 
removed under reduced pressure, to yield the product (133) as a crude oil (0.15 g). 
I 9F NMR (188 MHz, D 2 0): -225.20 (2 % of F signal, t, J = 47 Hz), -227.30 (13 % of F 
signal, t, J = 47 Hz), -227.53 (10 % of F signal, t, J = 47 Hz), -231.23 (28 % of F signal, 
t, J = 47 Hz), -231.87 (13 % of F signal, t, J = 47 Hz), -232.2 -> -234.8 (28 % of F 
signal, many unresolved triplets, J = 47 Hz), -237.33 (5 % of F signal, t, J = 47 Hz). 
O 
X HO 
133 
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5.1.3 Preparation of fluoroacetaldehyde (40) 
Fluoroacetaldehyde (40) 
2-Fluoroethanol (71) (1 ml, 17.0 mmol) was added to suspension of pyridinium 
dichromate (PDC) (2.00 g, 5.3 mmol) in dichloromethane (30 ml) and the reaction was 
mixture heated under reflux for 16 hours. The reaction vessel was allowed to cool and 
the condenser changed for a vigereux distillation apparatus. The reaction solution was 
distilled into a separating funnel containing water (5 ml). After mixing, the organic 
layer was separated and extracted with a further volume of water (5 ml). The aqueous 
layers were combined and both the organic and aqueous layers analysed by 1 9F NMR 
analysis. Fluoroacetaldehyde hydrate (40) was present in the aqueous layer at a final 
concentration of 40 mM (~ 20 %) The sample also contained residual 2-fluoroethanol 
(71). 
NMR (D 2 0) 5F (376 MHz): -224.5 (80 % of total signal, tt, 2 ] m = 47.6 Hz, 33m = 31.8 
Hz, F-EtOH (71)), 233.5 (20 % of total signal, td, ^ = 46.2 Hz, 3 J H F = 9.4 Hz, 
fluoroacetaldehyde (40)). 
DNP derivative of fluoroacetaldehyde (144) 
NO 
^ 3 
N 
N 
7 - H 8 
F 
144 
A DNP solution was prepared by dissolving 2,4-dinitrophenylhydrazone (0.4 g) in 
concentrated sulphuric acid (2 ml), followed by the slow addition of water (3 ml) and 
then 95 % aqueous ethanol (10 ml). 
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The DNP derivative of fluoroacetaldehyde (144) was prepared by adding the aqueous 
solution of fluoroacetaldehyde (40) to the DNP solution and the resultant precipitate 
filtered and recrystallised from ethanol. 
Melting point: 143-144 °C 
IR(KBr): 3296m, 3107w, 3091w, 2361w, 2343u>, 1617J, 1590m, 151 Is, 1418m, 13235, 
13055, 12665, 1140m, 1124m, 1086m, 924m, 854w, 842w, 831m, 744m, 724m, 606m. 
NMR 5H (400 MHz, CDC13): 11.17 (1H, s, NH), 9.14 (1H, s, (C-3)-H), 8.36 (1H, m (C-
5)-H), 7.98 (1H, m, (C-6)-H), 7.64 (1H, dd, ^ = 5.2 Hz, 33w = 10.4 Hz, (C-7)-H), 5.17 
(2H, dd, 2JHP = 46.4 Hz, 3 J H H = 5.2 Hz, (C-8)-H). 8C (100 MHz, CDC13) (ppm): 80.92 
(C-8, d, 'J C F = 166.4 Hz), 114.6 (C-6), 123.2 (C-3), 130.1 (C-5), 138.9 (C-7), 143.5 (C-
N0 2 ) , 143.7 (C-N0 2), 144.7 (C-l). 8F (376 MHz, CDC13): -222.61 (dt, 2 J r a = 46.4 Hz, 
3JFH = 6.4 Hz). 
HRMS (EI) C 8 H 7 FN 4 0 4 : Calculated (M + ) 242.04513, found 242.0451 
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5.1.4 Preparation of [l-2H]-fluoroacetaldehyde (147) 
para-phenylphenacyl fluoroacetate (102)100 
0 F 
8 V o 
102 
Sodium fluoroacetate (1) (7.27 g, 72.7 mmol) and a catalytic quantity of 18-crown-6 
(0.3 g, 1.1 mmol) were added to a solution of para-phenylphenacyl bromide (101) (20.0 
g, 72.7 mmol) in a 1:1 mixture of acetonitrile and benzene (280 ml) and the reaction was 
heated under reflux for 16 hours. When the reaction vessel had cooled to room 
temperature the organics were washed with water (2 x 100 ml) and then the solvent 
removed under reduced pressure to yield a yellow solid (16.0 g, 88.7 % ) . A small 
quantity was recrystallised from dichloromethane for analytical purposes. 
Melting point: 140 - 142 °C (lit. 138 °C) 1 0 0 
IR (KBr, cm 1): 2930m, 1775s, 1693s, 1601s, 1558m, 1486m, 1440m, 1423s, 1403m, 
1369m, 1284w, 1241m, 1212s, 1187s, 1117m, 1089s, 1046m, 1007m, 965s, 856m, 
834m, 767s, 748m, 730m, 701m. 
NMR 5H (200 MHz, CDC13): 7.99 (2H, d, 3 J M = 8.20 Hz, C4-H), 7.72 (2H, d, 3JHH = 
8.20 Hz, C5-H), 7.66 - 7.58 (2H, m, C9-H), 7.54 - 7.38 (3H, m, C8-H & C10-H), 5.52 
(2H, s, Cl-H), 5.08 (2H, d, 23m = 46.8 Hz). 5C (50 MHz, CDC13): 190.42 (s, C2), 
167.35 (d, 2 J C F = 22.3 Hz, OCOCH2F), 146.87 (s, C6), 139.47 (s, C7), 132.44 (s, C3), 
129.00 (s, Ar), 128.50 (s, Ar), 128.32 (s, Ar), 127.54 (s, Ar), 127.35 (s, Ar), 77.39 (d, 
'J C F = 182.3 Hz, OCOCH2F), 66.41 (s, CI). 8 F (188 MHz, CDC13): -230.63 (t, 2 J F H = 
46.7 Hz). 
MS (EI +): 272 (M, 2.6 % ) , 196 (M - FH 2CC0 2 + 1, 17.5 % ) , 182 (PhPhCO + 1, 13.7 
% ) , 181 (PhPhCO, 100 % ) , 154 (5.3 % ) , 153 (28.3 % ) , 152 (59.8 % ) , 150 (6.4 % ) . 
[l,l-2HJ-2-Fluoroethanol (148) 
para-Phenylphenacyl fluoroacetate (102) (6.8 g, 25.0 mmol) was suspended in 
tetraglyme (20 m l ) and added over 20 minutes to a suspension of L iAlD 4 (1.4 g, 33.3 
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mmol) in tetraglyme (60 ml) at -10 °C (ice / acetone slush bath). The resultant 
suspension was allowed to warm to room temperature and was stirred for a further 4 
hours before the reaction vessel was cooled in ice water. The reaction was quenched by 
the addition of 2-phenoxyethanol (152) (20 ml) and left to stir overnight. [ l , l - 2 H 2 ] - 2 -
Fluoroethanol (148) was then distilled out of the reaction vessel over a vigreux column 
at atmospheric pressure. The reaction vessel was heated to 140 °C and the vigreux 
column heated with a hair dryer to distil over the colourless liquid. The vessel was 
cooled again and DCM (5 ml) was added this was solution distilled along with any 
residual [l,l- 2H 2]-2-fluoroethanol. This process was repeated with two further volumes 
of DCM (5 ml), and all the distillates combined. 
NMR 5 H (200 MHz, CDC13): 4.43 (d, 2 J H F = 47.7 Hz, HOCD 2CH 2F), 4.0 - 2.8 
(tetraglyme), 1.11 (s, AcOH). 5 F (188 MHz, CDC13): -227.4 (tp, 2 J m = 47.6 Hz, 3 J F D -
4.37 Hz) 
[l-2H]-Fluoroacetaldehyde (147) 
Pyridinium dichromate (PDC) (1.0 g, 2.7 mmol) was added to a solution of [ l , l - 2 H 2 ] - 2 -
fluoroethanol (148) in DCM (15 ml) and the reaction was heated under reflux for 18 
hours. After cooling, the condenser was exchanged for a vigreux column and the [1-
2H]-fluoroacetaldehyde (147) and DCM mixture was distilled over into water (2 ml). 
The phases were separated and the organics were extracted with a further volume of 
water (2 ml) and the aqueous layers combined. 
NMR (D 2 0) 8F (188 MHz): -227.6 (80 % of total signal, tm, 2 J m = 47.6 Hz, 
HOCD 2CH 2F), 233.6 (20 % of total signal, t, 2 J H F - 46.1 Hz,). 
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5.1.5 Preparation of potassium aminomalonate (162) 
O O 
Y O 0" K 
+ N H 3 
162 
Potassium hydroxide (4.63 g, 0.0825 mol) was added to an aqueous solution (30 ml) of 
diethyl aminomalonate hydrochloride salt (163) (5.00 g, 0.024 mol) and the reaction 
was heated under reflux for 4 hours. When the reaction mixture had cooled to room 
temperature it was adjusted to pH 4.1 using concentrated aqueous hydrochloric acid and 
stored at 4 °C for 16 hours. The resultant white precipitate was filtered off and washed 
with ice cold water (50 ml) and then ethanol (50 ml), to yield a white amorphous solid 
(2.63 g, 69.7 % ) . 
Melting point: 245 °C (decomposes) (lit. not quoted)129 
IR (KBr): 3067s, 2749s, 2641s, 2168w, 2120w, 1625s, 1531s, 1424s, 1152m, 1081m, 
937m, 929m, 913m, 836m 
NMR 6H (200 MHz, D 2 0): 4.03 (1H, s, 0 2 CCH(NH 3 + )C0 2 K + ) ; 5C (50.3 MHz, D 2 0) : 
59.32 (s, •0 2CCH(NH 3 +)C0 2 'K +), 170.30 (s, 0 2CCH(NH 3 +)C0 2-K +). 
5.1.6 Preparation of glycolaldehydephosphate (164) 
Allylphosphate bis(cyclohexylamine) salt (166)130 
O +NH 
O o \ o-
166 
Trichloroacetonitrile (14.40 g, 100 mmol) was added to a solution of (crystalline) 
phosphoric acid (1.90 g, 19.4 mmol) and triethylamine (4.00 g, 39.6 mmol) in allyl 
alcohol (72) (35 ml, 517 mmol), and the solution became turbid. The mixture was 
heated at 75 °C for 4 hours and the volume then reduced under reduced pressure to 
approximately 15 ml. Water (200 ml) was added to this oily solution and the mixture 
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was extracted into diethyl ether (2 x 150 ml). Cyclohexylamine (15 ml, 130 mmol) was 
added to the resultant aqueous fraction and the solvent was removed under reduced 
pressure. The resultant turbid oil was resuspended in water (50 ml) and acetone was 
added dropwise until the solution became turbid, at which point the solution was stored 
in ice for 3 hours. A white amorphous powder was collected by filtration and washed 
with ice cold acetone (20 ml). The mother liquor was treated with a further volume of 
acetone (20 ml) and the resultant white solid was filtered and washed with acetone. The 
solids were combined to produce a white amorphous solid of 166 (4.8 g, 74 % based on 
phosphoric acid) 
Melting point: 213 - 218 °C (lit. 217-219 °C) 1 3 0 
IR (KBr): 2937s, 2857s, 2566s, 2232m, 1629m, 1560m, 1455m, 1394m, 1070s, 981m, 
915m, 820m 
NMR 5H (200 MHz, D 2 0): 5.8 (1H, m, CH 2CHCH 20), 5.18 (1H, dd, ' J ^ = 17.1 Hz, 3 J m 
= 1.7 Hz, CH 2CHCH 20), 5.02 (1H, dd, ' J ^ = 10.4 Hz, 'J^, = 1.4 Hz, CH 2CHCH 20), 
4.12 (2H, psuedo-X, CH 2CHCH 20), 2.99 (2H, m, H 3N +CH(CH 2R) 2), 1.80-1.95 (4H, m, 
CHxNH 3 +), 1.55-1.75 (4H, m, CHxNH 3 +), 1.45-1.55 (2H, m, CHxNH 3 +), 0.90-1.35 
(10H, m, CHxNH 3 +). 6 C (50.3 MHz, D 2 0) (ppm): 24.03 (CH 2, CHxNH 3 +), 24.53 (CH 2, 
CHxNH 3 +), 30.57 (CH 2, CHxNH 3 +), 50.59 (CH, CHxNH 3 +), 65.55 (CH 2CHCH 20, d, 2J C. P 
= 4.42 Hz), 116.29 (CH 2CHCH 20), 135.61 (CH^HCH.O, d, 3JC. P = 6.99 Hz). 5P 
{'H}(81.0 MHz, D 2 0) : 5.64 (s). 
ESI-MS (ES-): 297 (7 % ) , 275 (4 % ) , 157 (4 % ) , 143 (8 % ) , 137 (M + H, 100 % ) , 115 
(8 % ) , 79 (66 % ) . (ES+): 100 (M, 100 % ) , 83 (M - NH 3 , 33 % ) . 
Allylphosphate mono(triethylamine) salt (167)'30 
Dowex 50X8 (H +) was added to an aqueous solution of allylphosphate 
bis(cyclohexylamine) salt (166) (4.00 g, 11.9 mmol) until the pH remained constant. 
The solution was stirred at room temperature for 20 minutes before the resin was 
removed by filtration, and washed with water (150 ml). The washings were combined 
O 
II 
OH O ^ 
o 
+ 
167 
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in a separating funnel and mixed with a solution of triethylamine (17 ml, 10 mol 
equivalents) in diethyl ether (250 ml). The aqueous layer was separated from the 
organics and the solvent removed under reduced pressure. The product (167) oil, 2.8 g 
(43.9 %) was reacted on immediately due to the potential instability of the product. 
NMR 8H (300 MHz, D 2 0): 5.79 (1H, m, CH 2CHCH 20), 5.17 (1H, d, CH 2CHCH 20, 
trans-3Jm =17.1 Hz), 5.03 (1H, d, CH 2CHCH 20, cis-^ = 10.5 Hz), 4.19 (2H,psuedo-
t, CH 2 CHCtf 2 0), 3.00 (6H, q, CH 3CH 2N, ' J ^ = 7.40 Hz), 1.07 (9H, t, CH 3CH 2N, 3JHH = 
7.35 Hz). 5P {'H}(81.0 MHz, D 2 0): 1.36 (s). 
Glycolaldehyde phosphate, calcium salt (164)130 
A stream of 0 3 (generated from 0 2 @ 60 l.hr"1) was passed through a solution of 
allylphosphate mono(triethylamine) salt (167) (2.8 g, 5.2 mmol) in methanol (150 ml) at 
-78 °C. After 30 minutes the reaction mixture turned light blue indicating ozone 
saturation. The ozone stream was replaced by nitrogen and the reaction vessel was 
allowed to warm to -20 °C. After 10 minutes DMS (5 ml, 13 mol equivalent) was added 
and the resultant solution was stirred for 24 hours whilst maintaining the temperature at 
-20 °C. The reaction vessel was then placed in an ice bath, then iced water (80 ml) and 
Dowex 50 X 8 (H +) were added. The resultant mixture was stirred for 30 minutes and 
the resin removed by filtration and washed with ice-cold water (400 ml). The volume 
was reduced to approximately 50 ml under reduced pressure, keeping the water bath 
temperature below 40 °C. After the reaction mixture was cooled in an ice bath, a 
solution of calcium acetate (1.89 g, 11.9 mmol) in water (25 ml) was added and it was 
left to stir for 1 hour. Acetone (50 ml) was added and a white precipitate formed. The 
mixture was then stored at 4 °C for 16 hours. The precipitate was collected by 
centrifugation (20,000 rpm, 30 minutes, 4 °C), and the supernatant was treated with a 
further volume of acetone (25 ml). This precipitate was collected by centrifugation and 
combined, to yield a white amorphous solid (2.1 g, 71 %) 
Melting point: > 260 °C (lit. not quoted)130 
O 
I I 
O \ o o Ca 2 + O 
H 164 
177 
IR (KBr): 3395s (br.), 3250s (sh.), 3160s (sh.), 1719w, 1654w, 1636w, 1458w, 1137s, 
1091s, 1024s, 913m, 828m (br.) 
NMR 5H (200 MHz, D 2 0 / trace DC1): 4.98 (1H, dt, 3J„„ = 4.90 Hz, OCH2CH(OH)2), 
3.67 (2H, dd, 3 J m = 4.90 Hz, 3 J W = 6.90 Hz, OCH2CH(OH)2); 5 C (50.3 MHz, D 2 0 / trace 
DC1) (ppm): 68.09 (OCHjCH^H), , d, 3 J C P = 5.53 Hz), 88.46 (OCH2CH(OH)2, d, 2 J C P = 
8.75 Hz); 8 P {'H}(81.0 MHz, D 2 0 / trace DC1): 1.00 (s). 
ESI-MS (ES ): 199 (26 % ) , 197 (M + 1, 50 % ) , 195 (M - 1, 38 % ) , 164 (35 % ) , 162 
(100%), 160 (98 % ) . 
5.1.7 Preparation of[l-'3C]- and[l-nC, 2,2-2HJ-glycolaldehyde (179) & (182) 
Isotopically labelled glycolaldehyde was synthesised following modified versions of the 
method of Seranni et al.136140141142 and Thirkettle.137 
Glycolonitrile (178)137 
The pH of a solution of KCN (0.5 g, 7.8 mmol) in H 2 0 (40 ml) was adjusted from 10.5 
to 8.5 with concentrated acetic acid. A solution of formaldehyde (177) (0.23 g, 7.8 
mmol, 0.62 ml of a 37 % aqueous solution) in water (15 ml) was added dropwise and 
the solution was vigorously stirred over 1 hour, maintaining the pH at 8.5 ± 0.2 (with 10 
% aqueous acetic acid or 1 M aqueous NaOH). The resultant solution was stirred for a 
further 40 minutes before the reaction was quenched by the addition of concentrated 
acetic acid, such that the pH was 4.2. Complete reaction was confirmed by TLC 
(acetonitrile : water : acetic acid, 40:10:0.5, glycolonitrile (178) Rf = 0.9), and a negative 
result on a cyanide precipitate test. Glycolonitrile (178) was reacted on immediately 
without further manipulation as it can decompose to yield toxic gases. 
OH 
H CN 
H 
178 
178 
Glycolaldehyde (176)' 
O 
H 
HO 
176 
Solid Pd-BaS04 (0.47 g, 5 %, 60 mg per mmol of nitrile) was suspended in H 2 0 (15 ml) 
and stirred vigorously under a hydrogen atmosphere. After 30 minutes the 
glycolonitrile (178) solution prepared above was added and the pH adjusted to pH 1.7 
with concentrated H 2S0 4 . The resultant solution was then stirred under a hydrogen 
atmosphere for 16 hours before the pH was again returned to pH 1.7 and stirred under a 
hydrogen for a further 24 hours. TLC analysis (acetonitrile : water : acetic acid, 
40:10:0.5) demonstrated complete conversion of glycolonitrile (178) to glycolaldehyde 
(176) (spot at Rf = 0.9 replaced by Rf = 0.6). The catalyst was removed by filtration 
through a hyflo plug and the resultant solution was treated with excess Dowex 50X8 
(H +) until pH = 1.0, was stirred and the resin removed by filtration. Slow and careful 
addition of BaC0 3 to this solution, ensuring that any effervescence ceased before the 
subsequent addition, so that at pH = 4.3 a fine, sticky precipitate formed which was 
removed by centrifugation (20,000 rpm, 10 minutes, 25 °C). The supernatant was 
treated with excess Dowex 2X8 (AcO ), with no change in pH, and the resin removed by 
filtration. The solution was then treated with Dowex 50X8 (H +) until pH = 0.9, the resin 
was removed by filtration and the solvent removed under reduced pressure (ensuring 
that the temperature did not exceed 45 °C). This yielded a colourless syrup of the 
product (176), containing acetic acid and water (0.8 g). 
NMR, 5H (300 MHz, D 2 0): 4.89 (1H, t, 3JHH = 5.25 Hz, HOCH2C(OH)2H), 3.35 (2H, d, 
3JHH = 5.10 Hz, HOCH2C(OH)2H). 
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[l-I3C]-Glycolonitrile 
OH 
H 
H N 
The pH of a solution of [ l 3C]-KCN (0.5 g, 7.8 mmol) in H 2 0 (40 ml) was adjusted from 
10.5 to 8.5 with concentrated acetic acid and reacted with formaldehyde (177) as 
described above for glycolonitrile (178). Complete reaction was confirmed by TLC 
(acetonitrile : water : acetic acid, 40:10:0.5, glycolonitrile R f - 0.9) and a negative result 
on a cyanide precipitate test. [l-1 3C]-Glycolonitrile was reacted on immediately without 
further manipulation as it can decompose to yield toxic gases. 
NMR 8C (50.3 MHz, H 2 0): 119.5 (s). 
[l-13C]-Glycolaldehyde (179) 
Solid Pd-BaS04 (0.47 g, 5 %, 60 mg per mmol of nitrile) was suspended in H 2 0 (15 ml) 
and stirred vigorously under a hydrogen atmosphere. After 30 minutes the [1- I 3C]-
glycolonitrile solution was added and the pH adjusted to pH 1.7 with concentrated 
H 2S0 4 . The resultant solution was then stirred under hydrogen for 16 hours before the 
pH was again returned to pH 1.7 and stirred under hydrogen for a further 24 hours. TLC 
analysis (acetonitrile : water : acetic acid, 40:10:0.5) demonstrated complete conversion 
of [l- l 3C]-glycolonitrile to [l- l3C]-glycolaIdehyde (179) (spot at Rf = 0.9 replaced by Rf 
= 0.6) and so the catalyst was removed by filtration through a hyflo plug. The resultant 
solution was treated with excess Dowex 50X8 (H +) until pH = 1.0, stirred and the resin 
removed by filtration. The solvent was then removed under reduced pressure (ensuring 
that the temperature did not exceed 45 °C). This yielded a dark brown syrup of the 
product (179), containing acetic acid, some water and sulphate (2.2 g). Quantitative 
O 
H 
HO 
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conversion from [ 1 3C]-KCN would generate 0.48 g of product (179) (22 % of the 
recovered mass). The sample was used in biological feeding experiments taking this 
into account. 
NMR 5H (200 MHz, D 2 0): 4.88 (1H, dt, 'J H C = 163.6 Hz, 3 J H H = 5.20 Hz, 
H O C H ^ Q O H ) ^ ) , 3.34 (2H, m, HOCH/QOH^H) . 5 C (50.3 MHz, D 2 0) : 89.8 (s). 
[1- , 3C, 2,2-2H2]-Glycolonitrile (184) 
The pD of a solution of [ l 3C]-KCN (0.52 g, 7.9 mmol) in D 2 0 (40 ml) was adjusted 
from 10.5 to 8.5 with concentrated [l-2H]-acetic acid (CH 3C0 2D). A solution of [ 2 H 2 ] -
formaldehyde (181) (0.25 g, 7.9 mmol, 1.25 ml of a 20 % solution in D 2 0) in D 2 0 (15 
ml) was added to this vigorously stirred solution dropwise over 1 hour, maintaining the 
pD at 8.5 ± 0.2 (with 10 % [l-2H]-acetic acid in D 2 0 or 1 M NaOD in D 2 0) . The 
resultant solution was stirred for a further 40 minutes before the reaction was quenched 
by the addition of concentrated [l-2H]-acetic acid such that the pD was 4.2. Complete 
reaction was confirmed by TLC (acetonitrile : water : acetic acid, 40:10:0.5, 
glycolonitrile Rf = 0.9), and a negative result on a cyanide precipitate test. [1- 1 3C, 2,2-
2H2]-Glycolonitrile (184) was reacted on immediately without further manipulation as it 
can decompose to yield toxic gases. 
OH A. D D N 
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[1- 1 3C, 2,2-2H2]-Glycolaldehyde (182) 
O 
D 
D H 
HO 
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Solid Pd-BaS04 (0.47 g, 5 %, 60 mg per mmol of nitrile) was suspended in D 2 0 (15 ml) 
and stirred vigorously under a hydrogen atmosphere. After 30 minutes the [1- I 3C, 2,2-
2H2]-glycolonitrile (184) solution was added and the pD adjusted to pD 1.7 with 
concentrated D 2S0 4 . The resultant solution was then stirred under hydrogen for 16 
hours before the pD was again returned to pD 1.7 and stirred under hydrogen for a 
further 24 hours. TLC analysis (acetonitrile : water : acetic acid, 40:10:0.5) 
demonstrated complete conversion of [l- l 3C,2,2-2H2]-glycolonitrile (184) to [1- I3C,2,2-
2H2]-glycolaldehyde (182) (spot at Rf = 0.9 replaced by Rf = 0.6) and so the catalyst was 
removed by filtration through a hyflo plug. The resultant solution was treated with 
excess Dowex 50X8 (H +) until pD = 1.0, stirred and the resin removed by filtration. 
Slow and careful addition of BaC0 3 to this solution, so that pD = 4.3, ensuring that any 
effervescence ceased before the subsequent addition. A fine, sticky precipitate formed, 
which was removed by centrifugation (20,000 rpm, 10 minutes, 25 °C). The 
supernatant was treated with excess Dowex 2X8 (AcO ), with no change in pD, and the 
resin removed by filtration. The solution was then treated with Dowex 50X8 (H +) until 
pD = 0.9, the resin was removed by filtration and the solvent removed under reduced 
pressure (ensuring that the temperature did not exceed 45 °C). This yielded a colourless 
syrup of the product (182), containing acetic acid and some D 2 0 (1.0 g). 
NMR 8H (200 MHz, D 2 0): 4.86 (1H, d, 'J H C = 164.0 Hz, HOCD.QOH)^) , 3.47 
(0.187H, "JHC = 142.02 Hz, HOCD 2CH 2NH 2). 8 C (50.3 MHz, D 2 0) : 89.8 (s, 
H O C D ^ O H ^ H ) , 62.5 (s, HOCDzCH.NH,). 
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5.2 Biological Preparations 
5.2.1 General details 
Streptomyces cattleya manipulation was carried out in a Gallenkemp flowhood, with 
surfaces washed with 70 % ethanol (v/v) and all flask rims flame sterilised. Glassware, 
media and consumables were sterilised in a portable universal gas model pressure steam 
steriliser at 121 °C for 20 minutes (50 minutes for liquids greater than 100 ml in 
volume). Cultures were incubated in a temperature controlled Galenkemp orbital 
incubator and resting cells on a temperature controlled Innova 2000 platform shaker. 
Cells were harvested in a Beckman J2-2IM/E centrifuge with a J14 head at 14,000 rpm. 
Other requirements for centrifugation used either the above centrifuge with a J20 head 
(20,000 rpm), an Eppendorf 5415C microcentrifuge or Beckman L-70 ultracentrifuge. 
Cells were disrupted using either a Status S70 homogeniser or a Constant Systems Ltd., 
French Press Cell Disruption Equipment. Aqueous solutions were reduced in vacuo on 
an FTS systems flexi-dry freeze dryer. 
5.2.1.1 19F NMR analysis of resting cell experiments 
Isotope incorporation: Supernatants of resting cell experiments was lyophilised 
(except for 2 ml which was sent to Belfast for GCMS analysis). The residues were 
resuspended in D 2 0 (0.7 ml), and particulate matter was filtered by passing the solutions 
through a cotton wool plug and transferred into an NMR tube. Spectra were recorded 
on a Varian Inova 500 MHz, l 9F NMR spectra were recorded at 375 MHz and "H 
decoupled by irradiating the sample at 500 MHz. Samples were typically analysed for 8 
-10 hours (approximately 20,000 repetitions). 
Fluorometabolite analysis: Supernatants of resting cell or cell free experiments were 
transferred to an NMR tube (0.7 ml) and the spectrometer (Mercury 200 MHz 
spectrometers) locked and shimmed to a external sample of D 2 0 (0.7 ml). The sample 
was irradiated at 188 MHz for 64 repetitions. Spectra were referenced to fluoride (-119 
ppm, i f present) and baseline corrected. 
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5.2.1.2 GCMS analysis of resting cell feeding studies 
Culture supernatants (2 ml) were sent to Belfast for GCMS analysis by Dr J. T. G. 
Hamilton. 
Fluoroacetate (1): Culture supernatants (1 ml) were mixed with an internal standard 
(0.25 ml, sodium propionate, final concentration 1 mM) and lyophilised. The residue 
was resuspended in toluene / acetonitrile (1:1 v/v) (1 ml) and both 18-crown-6 (10 mg) 
and 2-bromo-4'-phenylacetophenone (101) (10 mg) were added. The resultant solution 
was heated to 75 °C for 12 hours and allowed to cool. The sample was then analysed on 
a Hewlett Packard 5890 gas chromatograph with a Hewlett Packard Ultra 2 capillary 
column (12 m x 0.2 mm i.d.), 0.17 urn film thickness and a Hewlett Packard 5970B 
mass selective detector. Helium was used as a carrier gas at 0.8 ml.min"1 and the 
samples (0.1 uT) were injected in the split mode (80:1). The injection port and transfer 
line were maintained at 280 °C. The oven was held at 130 °C for 1 minute was then 
ramped at 10 °C min"1 up to 300 °C, and was held for a further 5 minutes. The 
phenylphenacyl derivatives of fluoroacetate (102) and propionate (103) had retention 
times of 11.8 and 12.1 minutes respectively. Splitless injections were utilised for 
concentrations of less than 0.2 mM fluoroacetate (1). The mass spectrometer operated 
in selected ion monitoring mode to observe mass currents m/z 272 (M, molecular ion), 
273 (M+l) , 274 (M+2), 33 (-CH2F), 34 (-CH2F +1) and 35 (-CH2F +2). Al l values were 
then corrected for natural abundance of stable isotope by comparison with standard 
(unenriched) fluoroacetate (1). 
4-Fluorothreonine (2): Culture supernatants (0.25 ml) were lyophilised and the residue 
derivatised by heating to 100 °C for 1 hour in the presence of N-methyl-N-
(trimethylsilyl)-trifluoroacetamide (MSTFA) (0.25 ml). The GC conditions employed 
were the same as that for the fluoroacetate derivative (102), although a split ratio of 50:1 
was used (splitless injections were used for concentrations less than 0.2 mM). The mass 
spectrometer operated in selected ion monitoring mode to observe mass currents m/z 
218 (C-l and C-2), 219 (as before +1), 219 (as before +2), 236 (C-2, C-3 & C-4), 237 
(as before +1), 238 (as before +2) and 239 (as before +3). Al l values were then 
corrected for natural abundance of stable isotope by comparison with standard 
(unenriched) 4-fluorothreonine (2). 
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5.2.2 Microorganism maintenance and growth 
Streptomyces cattleya NRRL 8057 was obtained from The Queen's University of 
Belfast, Microbial Biochemistry Section, Food Science Department, Belfast (originally 
from United States Department of Agriculture, Agricultural Research Service, Midwest 
Area Northern Regional Research Laboratories, Peoria, Illinois, USA). Cultures were 
maintained on agar slants containing soybean flour (2 % w/v), mannitol (2 % w/v), agar 
(1.5 % w/v) and tap water, grown for 14 days at 28 °C before the static cultures were 
stored at 4 °C. 
Starter and batch cultures are grown on chemically defined media, which was prepared 
by combining previously prepared stock solutions. 
Ion Solution, sterilised by autoclaving 
NFLCl (6.75 g), NaCl (2.25 g), MgS0 4.7H 20 (2.25 g), CaC0 3 (1.13 g), FeS0 4.7H 20 
(0.113 g), CoCl 2.6H 20 (45 mg), ZnS0 4.7H 20 (45 mg) and distilled water (900 ml). 
Carbon Source Solution, sterilised by filtration (Nalgene filter sterilisation units) into 
75 ml portions in presterilised Schott bottles. 
Glycerol (45 g), monosodium glutamate (22.5 g), /wyo-inositol (1.8 g), para-
aminobenzoic acid (450 ul of freshly prepared 1 mg / ml solution) and distilled water 
(450 ml) 
Phosphate Buffer Solution, sterilised by autoclaving. 
KH 2 P0 4 (20 gl"1) pH adjust to 7.0 (± 0.02) with KOH (2 M) 
Fluoride Solution, sterilised by autoclaving. 
NaF (0.5 M) 
The previously prepared solutions were added (ion solution 150 ml, carbon source 
solution 75 ml, phosphate buffer solution 75 ml, fluoride solution 3 ml) to distilled 
water (450 ml) sterilised in a 1 1 Erlenmeyer flask. After mixing 90 ml was decanted 
into a 500 ml Erlenmeyer flask and this was inoculated with a loop of vegetative 
mycelium from the maintenance cultures. The remainder of the medium was stored at 4 
°C until required. The starter culture was incubated for 4 days at 28 °C on an orbital 
shaker at 175 rpm. The sterile defined medium was decanted into 500 ml Erlenmeyer 
flasks (7 x 90 ml) which were inoculated from the starter culture (0.3 ml) and then 
incubated for 8 days at 28 °C on an orbital shaker at 175 rpm. 
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5.2.2.1 Variations ofpH andfluoride uptake during growth ofS. cattleya 
Batch cultures (4 x 90 ml) were each inoculated from a starter culture (0.3 ml) and 
grown under standard conditions. An aliquot (1.0 ml) was removed every 12 hours over 
a period of 14 days and the cells were removed by centrifugation. The supernatant was 
frozen (-10 °C) pending analysis. On thawing the pH of each sample was recorded and 
the fluoride concentration measured by the following method. An aliquot (0.5 ml), 
1.0M H 2 S0 4 (aq) (0.5 ml) and of a solution of 0.5 M K N 0 3 (4.0 ml) and 0.5 M 
trisodium citrate, were mixed by vortexing. The potential difference was then measured 
using a fluoride selective electrode, calibrated to 1.0 mM and 2.0 mM NaF. 
5.2.3 Resting cell experiments with isotopically labelled putative precursors 
Resting cell experiments were carried out under aseptic conditions, with all equipment 
and buffer autoclaved prior to use. Al l manipulations were carried out in a lamina flow 
hood. Cells were harvested by centrifugation (25 minutes, 14,000 rpm, 25 °C) and the 
pellet was washed three times in 50 mM MES buffer pH 6.5 (4-
morpholineethanesulfonic acid monohydrate) using one third of the original culture 
volume, to yield cells (between 10 -15 g wet weight). The bacterial pellet was 
resuspended in 50 mM MES buffer pH 6.5 at a concentration of 0.176 g.ml'1. The cell 
suspension (5 ml) was supplemented with a putative precursor and the total volume 
adjusted to 23 ml with 50 mM MES buffer pH 6.5. Putative precursors were 
administered by filter sterilisation through a nylon membrane. I f there was no 
organically bound fluorine in the administered precursor then fluoride was added (as 
NaF) at a final concentration of 2 mM. Resting cell experiments were incubated for 48 
hours (unless stated otherwise) at 28 °C on an orbital shaker at 180 rpm. Prior to 
analysis the resting cell experiments were stopped by removal of the cells (centrifuge, 
25 minutes, 20,000 rpm, 25 °C) and the supernatants stored at -15 °C. Experiments 
were carried out in duplicate (whenever possible) and 10 mM [2-13C]-glycine (91) 
employed as a control, as the assimilation of this label into the fiuorometabolites is well 
established. The supernatants were then studied by l 9F NMR and GCMS. 
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[6,6-2H2]-Glucose (105) 
Cells (5 ml), 40 raM NaF (1 ml, 2 mM), MES buffer (16.5 ml) and 200 mM [6,6- 2H 2]-
glucose (105) (0.5 ml, 5 mM). 1 9F {'H} NMR (D20, 470 MHz): -218.95 C02CCH2F, 
76.9 % of FAc), -218.97 (0 2CCHDF, 3.3 % of FAc), -219.53 (0 2 CCD 2 F, 19.8 % of 
FAc), -232.71 (RCH(OH)CH2F, 75.6 % of 4-FT), -233.29 (RCH(OH)CHDF, 3.9 % of 
4-FT), -233.88 (RCH(OH)CD2F, 20.6 % of 4-FT). 
GCMS (ion 218, positions 1 & 2 of 4-FT, % corrected for natural abundance): 99.8, 
99.7 (M); 0, 0 (M+l) ; 0.2, 0.3 (M+2). 
GCMS (ion 236, positions 2, 3 & 4 of 4-FT, % corrected for natural abundance): 74.6, 
74.5 (M); 2.7, 3.0 (M+l) ; 22.6, 22.6 (M+2); 0, 0 (M+3). 
D 2 0 
Cells (5 ml), 40 mM NaF (1 ml, 2 mM), MES buffer (12.0 ml) and D 2 0 (5 ml). 1 9F 
{'H} NMR (D 2 0, 470 MHz): -215.47 (0 2 CCH 2 F, 79.4 % of FAc), -216.05 (" 
0 2CCHDF, 19.8 % of FAc), -216.63 (0 2 CCD 2 F, 0.8 % of FAc), -229.89 
(RCH(OH)CH2F, 61.1 % of 4-FT), -230.13 (RCD(OH)CH2F, 16.7 % of 4-FT), -230.47 
(RCH(OH)CHDF, 14.8 % of 4-FT), -230.71 (RCD(OH)CHDF, 5.6 % of 4-FT), -231.05 
(RCH(OH)CD2F, 1.9 % of 4-FT) 
[l-13C]-Acetate (20) 
Cells (5 ml), 40 mM NaF (1 ml, 2 mM), MES buffer (16.0 ml) and 200 mM [1- I 3C]-
acetate (20) (1.0 ml, 10 mM). 1 9F {'H} NMR (D 2 0, 470 MHz): -221.65 ( 0 2CCH 2F, 
94.9 % of FAc), -221.73 (d, 'J C F = 177.4 Hz, -0 2C 1 3CH 2F, 5.1 % of FAc), -235.94 
(RCH(OH)CH2F, 95.0 % of 4-FT), -236.02 (d, 'J C F = 168.0 Hz, RCH(OH) 1 3CH 2F, 5.0 % 
of 4-FT). 
GCMS (ion 33, positions 2 FAc, % corrected for natural abundance): 97.4 (M), 2.6 
(M+l) ; (ion 272, positions 1 & 2 of FAc, % corrected for natural abundance): 94.0 (M), 
5.9 (M+l) , 0.1 (M+2). 
[l,2- l3C2]-Acetate (21) 
Cells (5 ml), 40 mM NaF (1 ml, 2 mM), MES buffer (16.0 ml) and 200 mM [1,2- 1 3C 2]-
acetate (21) (1.0 ml, 10 mM). , 9F {'H} NMR (D 2 0, 470 MHz): -221.64 (" 
02CCH2F,68.9 % of FAc), -221.74 (dd, 'J C F = 177.4 Hz, 2 J C F = 17.4 Hz,-0 2 l 3C 1 3CH 2F, 
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31.1 % of FAc), -235.88 (RCH(OH)CH2F, 75.3 % of 4-FT), -235.97 (dd, 'J C F = 167.0 
Hz, 2 J C F = 17.9 Hz, R l 3CH(OH) 1 3CH 2F, 24.7 % of 4-FT). 
GCMS (ion 33, position 2 of FAc, % corrected for natural abundance): 81.5 (M), 18.5 
(M+l) ; (ion 272, positions 1 & 2 of FAc, % corrected for natural abundance): 73.4 (M), 
11.6(M+1), 15.0 (M+2). 
[2,2,2-2H3]-Acetate (122) 
Cells (5 ml), 40 mM NaF (1 ml, 2 mM), MES buffer (16.0 ml) and 200 mM [2,2,2-2H3]-
acetate (122) (1.0 ml, 10 mM). 1 9F {'H} NMR (D 2 0, 470 MHz): -221.64 (" 
02CCH2F,97.1 % of FAc), -222.23 C02CCHDF, 2.9 % of FAc), -235.91 
(RCH(OH)CH2F, 95.6 % of 4-FT), -236.50 (RCH(OH)CD2F, 4.4 % of 4-FT). 
GCMS (ion 33, position 2 of FAc, % corrected for natural abundance): 97.3 (M), 2.7 
(M+l) ; (ion 272, positions 1 & 2 of FAc, % corrected for natural abundance): 97.4 (M), 
2.6 (M+l) , 0.1 (M+2). 
[2-2H]-Glycerol (128) 
Cells (5 ml), 40 mM NaF (1 ml, 2 mM), MES buffer (16.5 ml) and 200 mM [2- 2H]-
glycerol (128) (0.5 ml, 5 mM): -215.45 (100 % of FAc signal), -229.72 (100 % of 4-FT 
signal). 
[2-2H]-Glycerate (129) 
Cells (5 ml), 40 mM NaF (1 ml, 2 mM), MES buffer (16.0 ml) and 200 mM [2- 2H]-
glycerate (129) (1.0 ml, 10 mM): -215.45 (100 % of FAc signal), -229.72 (100 % of 4-
FT signal). 
GCMS (ion 218, positions 1 & 2 of 4-FT, % corrected for natural abundance): 96.1 
(M), 1.3 (M+l) , 2.6 (M+2); (ion 236, positions 2, 3 & 4 of 4-FT, % corrected for natural 
abundance): 97.9 (M), 1.4 (M+l) , 0.7 (M+2). 
Cells (5 ml), 40 mM NaF (1 ml, 2 mM), MES buffer (16.75 ml) and 200 mM [2- 2H]-
glycerate (129) (0.25 ml, 2.5 mM): -215.45 (100 % of FAc signal), -229.72 (100 % of 
4-FT signal). 
GCMS (ion 218, positions 1 & 2 of 4-FT, % corrected for natural abundance): 100.8 
(M), 1.4 (M+l) , -2.3 (M+2); (ion 236, positions 2, 3 & 4 of 4-FT, % corrected for 
natural abundance): 98.2 (M), 0.9 (M+l) , 0.8 (M+2). 
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Cells (5 ml), 40 mM NaF (1 ml, 2 mM), MES buffer (16.0 ml). After 1 hour 200 mM 
[2-2H]-glycerate (129) (1 ml, 10 mM) was added. 
GCMS (ion 218, positions 1 & 2 of 4-FT, % corrected for natural abundance): 96.0 
(M), 1.3 (M+l) , 2.7 (M+2); (ion 236, positions 2, 3 & 4 of 4-FT, % corrected for natural 
abundance): 97.9 (M), 1.4 (M+l) , 0.7 (M+2). 
Cells (5 ml), 40 mM NaF (1 ml, 2 mM), MES buffer (16.0 ml), 200 mM glycolate (50) 
(1 ml, 10 mM). After 1 hour 200 mM [2-2H]-glycerate (129) (1 ml, 10 mM) and 40 mM 
NaF (1 ml, 2 mM) was added. 
GCMS (ion 218, positions 1 & 2 of 4-FT, % corrected for natural abundance): 95.7 
(M), 1.4 (M+l) , 3.0 (M+2); (ion 236, positions 2, 3 & 4 of 4-FT, % corrected for natural 
abundance): 98.5 (M), 0.7 (M+l) , 0.8 (M+2). 
Cells (5 ml), 40 mM NaF (1 ml, 2 mM), MES buffer (16.0 ml), 200 mM glycerol (87) (1 
ml, 10 mM). After 1 hour 200 mM [2-2H]-glycerate (129) (1 ml, 10 mM) and 40 mM 
NaF (1 ml, 2 mM) was added. 
GCMS (ion 218, positions 1 & 2 of 4-FT, % corrected for natural abundance): 96.0 
(M), 1.4 (M+l) , 2.7 (M+2); (ion 236, positions 2, 3 & 4 of 4-FT, % corrected for natural 
abundance): 97.8 (M), 1.3 (M+l) , 0.9 (M+2). 
3-Fluoro-l-hydroxypropanone (133) 
Cells (5 ml), MES buffer (17 ml) and 3-fluoro-l-hydroxypropanone (1 ml) (133). 
Time = 18 hours, Fluoride release: 0.25 mM. 
1 9F NMR (188 MHz): -119.0 (14.9 % of total signal, F"), -216.25 (4.4 % of total signal, 
t, 2 J F H = 48.6 Hz, FAc), -229.62 (39.4 % of total signal, t, 2 J F H = 46.7 Hz), -231.78 (31.9 
% of total signal, td, 2 J F H = 46.7 Hz, 3 J F H = 21.9 Hz), -235.87 (9.4 % of total signal, t, 2 J F H 
= 46.3 Hz). 
Time = 48 hours, 1 9F NMR (188 MHz): -119.0 (3.1 % of total signal, F ), -216.68 (18.1 
% of total signal, t, 2 J n , = 48.1 Hz, FAc), -228.18 (16.6 % of total signal, t, 2 J m = 46.9 
Hz), -230.10 (19.5 % of total signal, t, 2 J F H = 46.9 Hz), -232.28 (26.9 % of total signal, 
td, 2 J F H = 46.9 Hz, 3 J F H = 22.3 Hz), -236.39 (15.5 % of total signal, t, 2 J m = 46.5 Hz). 
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Cells (5 ml), MES buffer (17.5 ml) and 3-fluoro-l-hydroxypropanone (0.5 ml) (133). 
Time = 18 hours, 1 9F NMR (188 MHz): -119.0 (6.0 % of total signal, F) , -216.59 (30.1 
% of total signal, t, 2 J F H = 47.8 Hz, FAc), -230.00 (37.7 % of total signal, t, 2 J r a = 46.5 
Hz), -232.17 (24.1 % of total signal, td, 2 J m = 47.0 Hz, 3 J m = 22.3 Hz), -236.28 (2.1 % 
of total signal, t, 2 J F H = 46.0 Hz). 
Time = 48 hours, l 9F NMR (188 MHz): -119.0 (13.3 % of total signal, F) , -216.61 
(13.2 % of total signal, t, 2 J F H = 48.3 Hz, FAc), -230.01 (24.0 % of total signal, t, 2 J F H = 
46.3 Hz), -232.25 (40.0 % of total signal, td, 2 J F H = 46.9 Hz, 3 J F H = 22.2 Hz), -236.29 
(9.5 % of total signal, t, 2 J F H = 46.3 Hz). 
[l- ,3C]-GlycoIaldehyde (179) 
Cells (5 ml), MES buffer (16 ml), 40 mM NaF (1 ml, final concentration 2 mM), < 200 
mM [l-13C]-glycolaldehyde (179) (1 ml, < 10 mM). I 9F {'H} NMR (D 2 0, 470 MHz): -
216.46 (100 % of FAc signal), -230.78 (100 % of 4-FT signal). 
GCMS (ion 236, positions 2, 3 & 4 of 4-FT, % corrected for natural abundance): 97.0, 
96.8 (M), 2.8, 2.9 (M+l) , 0.2, 0.3 (M+2). 
Cells (5 ml), MES buffer (16 ml), 40 mM NaF (1 ml, final concentration 2 mM), < 200 
mM [l-13C]-glycolaldehyde (179) (2 ml, < 20 mM). I 9F {'H} NMR (D 2 0, 470 MHz): -
216.53 (100 % of FAc signal), -230.85 (100 % of 4-FT signal). 
GCMS (ion 236, positions 2, 3 & 4 of 4-FT, % corrected for natural abundance): 96.7, 
96.3 (M), 3.1, 3.3 (M+l) , 0.2, 0.3 (M+2). 
Cells (5 ml), MES buffer (16 ml), 40 mM NaF (1 ml, final concentration 2 mM), < 200 
mM [l-13C]-glycolaldehyde (2 ml, < 20 mM). , 9F {'H} NMR (D 2 0, 470 MHz): -
215.95 (100 % of FAc signal), -230.20 (100 % of 4-FT signal). 
GCMS (ion 236, positions 2, 3 & 4 of 4-FT, % corrected for natural abundance): 95.0, 
94.9 (M), 4.9, 4.9 (M+l) , 0.1, 0.2 (M+2). 
[l- ,3C-2,2-2H2]-GIycolaldehyde (182) 
Cells (5 ml), MES buffer (16 ml), 40 mM NaF (1 ml, final concentration 2 mM), < 200 
mM [l- l3C-2,2-2H2]-glycolaldehyde (182) (1 ml, < 10 mM). I 9F { l H} NMR (D 2 0, 470 
MHz): -215.77 (100 % of FAc signal), -230.11 (100 % of 4-FT signal). 
GCMS (ion 33, position 2 of FAc, % corrected for natural abundance): 100 (M). 
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GCMS (ion 272, positions 1 & 2 of FAc, % corrected for natural abundance): 98.8, 
99.2 (M), 1.3, 1.3 (M+l) . 
GCMS (ion 236, positions 2, 3 & 4 of 4-FT, % corrected for natural abundance): 97.0, 
96.6 (M), 3.0, 3.5 (M+l) , 0.0, 0.0 (M+2). 
Cells (5 ml), MES buffer (13.2 ml), 40 mM NaF (1 ml, final concentration 2 mM), < 
200 mM [l-13C-2,2-2H2]-glycolaldehyde (182) (3.8 ml, < 10 mM). 1 9F {'H} NMR (D 2 0, 
470 MHz): -215.39 (100 % of FAc signal), -229.69 (100 % of 4-FT signal). 
GCMS (ion 33, position 2 of FAc, % corrected for natural abundance): 100 (M). 
GCMS (ion 272, positions 1 & 2 of FAc, % corrected for natural abundance): 98.3, 
99.4 (M), 1.7, 1.7 (M+l) . 
GCMS (ion 236, positions 2, 3 & 4 of 4-FT, % corrected for natural abundance): 96.5, 
96.5 (M), 3.2, 3.1 (M+l) , 0.3, 0.3 (M+2). 
5.2.4 Whole cell studies with fluoroacetaldehyde (40) 
Studies on whole cell metabolism of fluoroacetaldehyde (40) were carried out in the 
same manner as the resting cell experiments for isotopically labelled putative 
precursors. 
Fluoroacetaldehyde (40) 
Cells (5 ml), MES buffer (16 ml) and 40 mM fluoroacetaldehyde (40) (1 ml, final 
concentration 2 mM). Aliquots removed (1 ml) and the cells removed by centrifugation 
(microcentrifuge, 14000 rpm, 5 minutes) and stored at 4 °C pending analysis. 
I 9F NMR (376 MHz): Ratio of fluoroacetate (1) vs fluoroacetaldehyde (40) vs 2-
fluoroethanol (71) (which is constant). T = time that aliquot removed. 
T = 0: 0.074, 0.218, 1.00; T = 10 minutes: 0.183, 0.154, 1.00; T= 20 minutes: 
0.228,0.103,1.00; T= 30 minutes: 0.226,0.043,1.00; T= 40 minutes: 0.322,0.00, 
1.00; T= 50 minutes: 0.320,0.00,1.00; T= 60 minutes: 0.327,0.00,1.00; T= 70 
minutes: 0.362, 0.00, 1.00; T= 80 minutes: 0.323, 0.00, 1.00; T= 90 minutes: 
0.329, 0.00, 1.00. 
Fluoroacetaldehyde (40) under nitrogen 
MES buffer was degassed by freezing, subjecting to high vacuum and thawing (this 
cycle was repeated twice). Cells (5 ml), in degassed MES buffer (16 ml) in a 100 ml 
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Erlenmeyer flask were purged with a stream of N 2 for 5 minutes and stoppered with a 
septum seal. Fluoroacetaldehyde (40) (1 ml, 40 mM, final concentration 2 mM) was 
injected into the system and the flask was incubated under standard conditions. 
Aliquots (1 ml) were taken and the cells were removed by microcentrifugation and the 
supernatants frozen pending analysis after 0, 20, 40 and 60 minutes. , 9F NMR analysis 
did not indicate the presence of fluoroacetate (1). 
Fluoroacetaldehyde (40) under l 8 0 2 
MES buffer was degassed by freezing, subjecting to high vacuum and thawing (this 
cycle was repeated twice). Cells (5 ml) and degassed 50 mM MES buffer (17 ml) in a 
stoppered Erlenmeyer flask with a tapped side arm, were purged for 5 minutes under a 
stream of N 2 . The flask was then subjected to a light vacuum (aspirator) and the head 
space above the cells replaced with N 2 / l 8 0 2 (50 ml / 50 ml). Fluoroacetaldehyde (40) 
(40 mM, 1 ml, final concentration 2 mM) was injected into the system and the flask 
incubated for 1 hour. The cells were then removed by centrifugation and the 
supernatant frozen pending analysis. GCMS analysis (ion 272, FAc, % ) : 100.0, 100.0 
(M), 18.2, 18.1 (M+l) , 2.1, 2.0 (M+2). Natural abundance: 100 (M), 18.0 (M+l) & 2.1 
(M+2). 
Fluoroacetaldehyde (40) with amino acids 
DL-Alanine (146): MES buffer was degassed by freezing, subjecting to high vacuum 
and thawing (this cycle was repeated twice). Cells (5 ml), degassed 50 mM MES buffer 
(16 ml) and 200 mM DL-alanine (146) (1 ml, final concentration 10 mM) in a 100 ml 
Erlenmeyer flask were purged with a stream of N 2 for 5 minutes and stoppered with a 
septum seal. Fluoroacetaldehyde (40) (1 ml, 40 mM, final concentration 2 mM) was 
injected into the system and the flask incubated under standard conditions. Aliquots (1 
ml) were taken and the cells removed by microcentrifugation, after 1, 3 and 48 hours. 
The supernatants were frozen pending analysis. 
I 9F NMR (376 MHz): Ratio of fluoroacetate (1) vs fluoroacetaldehyde (40) vs 2-
fluoroethanol (71) (which is constant). T = time that aliquot removed. 
T = 1 hour: 0.079, 0.297, 1.00; T = 3 hours: 0.24, 0.0, 1.00 
Cells (5 ml), 50 mM MES buffer (16 ml) and 200 mM DL-alanine (146) (1 ml, final 
concentration 10 mM) in a 100 ml Erlenmeyer flask were incubated for 2 hours at 28 °C 
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on an orbital shaker. The cells were then purged with a stream of N 2 for 5 minutes and 
stoppered with a septum seal. Fluoroacetaldehyde (40) (1 ml, 40 mM, final 
concentration 2 mM) was injected into the system and the flask incubated under 
standard conditions. Aliquots (1 ml) were taken and the cells were removed by 
microcentrifugation, after 1, 3 and 48 hours. The supernatants were frozen pending 
analysis. 
1 9F NMR (376 MHz): Ratio of fluoroacetate (1) vs fluoroacetaldehyde (40) vs 2-
fluoroethanol (71) (which is constant). T = time that aliquot removed. 
T = lhour: 0.030,0.090,1.00; T = 3 hours: 0.177,0.0,1.00 
DL-Serine (54): MES buffer was degassed by freezing, subjecting to high vacuum and 
thawing (this cycle was repeated twice). Cells (5 ml), degassed 50 mM MES buffer (16 
ml) and 200 mM DL-serine (54) (1 ml, final concentration 10 mM) in a 100 ml 
Erlenmeyer flask were purged with a stream of N 2 for 5 minutes and stoppered with a 
septum seal. Fluoroacetaldehyde (54) (1 ml, 40 mM, final concentration 2 mM) was 
injected into the system and the flask incubated under standard conditions. Aliquots (1 
ml) were taken and the cells removed by microcentrifugation, after 1, 3 and 48 hours. 
The supernatants were frozen pending analysis. 
1 9F NMR (376 MHz): Ratio of fluoroacetate (1) vs fluoroacetaldehyde (40) vs 2-
fluoroethanol (71) (which is constant). T = time that aliquot removed. 
T = lhour: 0.096,0.0,1.00; T = 3 hours: 0.183,0.0,1.00 
Cells (5 ml), 50 mM MES buffer (16 ml) and 200 mM DL-serine (54) (1 ml, final 
concentration 10 mM) in a 100 ml Erlenmeyer flask were incubated for 2 hours at 28 °C 
on an orbital shaker. The cells were then purged with a stream of N 2 for 5 minutes and 
stoppered with a septum seal. Fluoroacetaldehyde (40) (1 ml, 40 mM, final 
concentration 2 mM) was injected into the system and the flask incubated under 
standard conditions. Aliquots (1 ml) were taken and the cells removed by 
microcentrifugation, after 1, 3 and 48 hours. The supernatants were frozen pending 
analysis. 
, 9 F NMR (376 MHz): Ratio of fluoroacetate (1) vs fluoroacetaldehyde (40) vs 2-
fluoroethanol (71) (which is constant). T = time that aliquot removed. 
T = 1 hour: 0.054, 0.060, 1.00; T = 3 hours: 0.066, 0.0, 1.00 
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[l-2H]-Fluoroacetaldehyde (147) 
Cells (5 ml), MES buffer (14 ml), and [l-2H]-fluoroacetaldehyde (147) (4 ml). 
GCMS (T=0, 4-FT): nd 
GCMS (T=l hours, 4-FT): nd 
GCMS (T=2 hours, ion 236, positions 2, 3 & 4 of 4-FT, % corrected for natural 
abundance): 74.8 (M), 39.7 (M+l) , -14.5 (M+2). 
GCMS (T=3 hours, ion 236, positions 2, 3 & 4 of 4-FT, % corrected for natural 
abundance): 63.5 (M), 52.7 (M+l) , -16.1 (M+2). 
GCMS (T=5 hours, ion 236, positions 2, 3 & 4 of 4-FT, % corrected for natural 
abundance): 51.4 (M), 51.8 (M+l) , -3.2 (M+2). 
GCMS (T=7.5 hours, ion 236, positions 2, 3 & 4 of 4-FT, % corrected for natural 
abundance): 41.8 (M), 59.5 (M+l) , -1.3 (M+2). 
GCMS (T=21 hours, ion 236, positions 2, 3 & 4 of 4-FT, % corrected for natural 
abundance): 86.6 (M), 13.7 (M+l) , -0.3 (M+2). 
GCMS (T=48 hours, ion 236, positions 2, 3 & 4 of 4-FT, % corrected for natural 
abundance): 87.6, 87.8 (M), 12.6, 12.6 (M+l) , -0.2, -0.4 (M+2). 
[l-2H]-Fluoroacetaldehyde (147) and [2-,3C]-glycine (91) 
Cells (5 ml), MES buffer (16 ml), 40 mM NaF (1 ml, final concentration 2 mM), 200 
mM [2-13C]-glycine (91) (1 ml, final concentration 10 mM). 
GCMS (ion 218, positions 1 & 2 of 4-FT, % corrected for natural abundance): 98.3, 
98.5 (M), 1.2,1.1 (M+l) , 0.6, 0.4 (M+2). 
GCMS (ion 236, positions 2, 3 & 4 of 4-FT, % corrected for natural abundance): 70.1, 
68.5 (M), 9.1, 9.5 (M+l) , 20.7, 21.6 (M+2), 0.2, 0.4 (M+3). 
Cells (2.5 ml), MES buffer (6.5 ml), 200 mM [2- l3C]-glycine (91) (0.5 ml, final 
concentration 10 mM) and [1-2H]-fluoroacetaldehyde (147) (2 ml). 
GCMS (T=0, 4-FT): nd 
GCMS (T=3 hours, 4-FT): nd 
GCMS (T=6 hours, ion 236, positions 2, 3 & 4 of 4-FT, % corrected for natural 
abundance): 46.8 (M), 29.4 (M+l) , 22.5 (M+2), 1.3 (M+3). 
GCMS (T=9 hours, ion 236, positions 2, 3 & 4 of 4-FT, % corrected for natural 
abundance): 63.5 (M), 18.4 (M+l) , 17.3 (M+2), 0.8 (M+3). 
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GCMS (T=24 hours, ion 236, positions 2, 3 & 4 of 4-FT, % corrected for natural 
abundance): 58.7 (M), 15.9 (M+l) , 24.6 (M+2), 0.8 (M+3). 
GCMS (ion 218): unresolved for all time points. 
Cells (2.5 ml), MES buffer (6.5 ml), 200 mM [2-13C]-glycine (91) (0.05 ml, final 
concentration 1.0 mM) and [l-2H]-fluoroacetaldehyde (147) (2 ml). 
GCMS (T=0, 4-FT): nd 
GCMS (T=3 hours, 4-FT): nd 
GCMS (T=6 hours, ion 236, positions 2, 3 & 4 of 4-FT, % corrected for natural 
abundance): 57.2 (M), 39.0 (M+l) , 3.4 (M+2), 0.3 (M+3). 
GCMS (T=9 hours, ion 236, positions 2, 3 & 4 of 4-FT, % corrected for natural 
abundance): 72.0 (M), 24.9 (M+l) , 2.5 (M+2), 0.6 (M+3). 
GCMS (T=24 hours, ion 236, positions 2, 3 & 4 of 4-FT, % corrected for natural 
abundance): 87.2 (M), 11.1 (M+l) , 1.4 (M+2), 0.3 (M+3). 
GCMS (ion 218): unresolved for all time points. 
Fluoroacetaldehyde (40) with Streptomyces cinnamonensis 
Streptomyces cinnamonensis was grown from a frozen glycerol cell suspension. Once 
thawed this suspension was used to inoculate petri dishes containing (g/1): yeast extract 
(4.0), malt extract (10.0), glucose (4.0) and agar (14.0). This was incubated at 29.5 °C 
for 10 days. Vegetative mycelia from these petri dishes was then used to inoculate 
complex media (70 ml) in 250 ml Erlenmeyer flasks, which were incubated for 10 days 
at 32 °C. The complex media contained (g /1): glucose (24.0), soybean flour (15.0), 
CaC03 (3.0), FeS0 4.7H 20 (5.5) and MgCl 2.6H 20 (0.029). The cells were then 
harvested as for Streptomyces cattleya (section 5.2.3) and suspended in MES buffer at 
0.176 g wet wt. / ml. 
High cell density: 40 mM Fluoroacetaldehyde (1 ml, 2 mM) was added to a cell 
suspension (22 ml) and incubated at 28 °C. Aliquots removed (1 ml) and the cells 
removed by centrifugation (microcentrifuge, 14000 rpm, 5 minutes) and stored at 4 °C 
pending analysis. 
1 9F NMR (376 MHz): Ratio of fluoroacetate (1) vs fluoroacetaldehyde (40) vs 2-
fluoroethanol (71) (assumed to remain constant). T = time that aliquot removed in 
minutes. 
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T = 20: 0.00,0.183, 1.00; T = 40: 0.00, 0.21, 1.00; T = 60: 0.020,0.166,1.00. 
Low cell density: 40 mM Fluoroacetaldehyde (1 ml, 2 mM) was added to a cell 
suspension (5 ml) in MES buffer (17 ml) and incubated at 28 °C. Aliquots removed (1 
ml) and the cells removed by centrifugation (microcentrifuge, 14000 rpm, 5 minutes) 
and stored at 4 °C pending analysis. 
1 9F NMR (376 MHz): Ratio of fluoroacetate (1) vs fluoroacetaldehyde (40) vs 2-
fluoroethanol (71) (assumed to remain constant). T = time that aliquot removed in 
minutes. 
T = 20: 0.00,0.20, 1.00; T = 40: 0.00, 0.23, 1.00; T = 60: 0.00,0.19,1.00. 
5.2.5 Cell free studies 
Cells were harvested by centrifugation (25 minutes, 14,000 rpm, 25 °C) and the pellet 
was washed three times in 50 mM MES buffer pH 6.5 (4-morpholine ethanesulfonic 
acid monohydrate) using one third the original culture volume, to yield cells (between 
10 -15 g wet weight). Al l subsequent steps were carried out in pre-chilled glassware (in 
ice water) and the centrifuge cooled to 4 °C. 
5.2.5.1 Protein concentration determination 
Protein concentration was determined by the Bradford assay.128 The test solution was 
prepared by dissolving Brilliant Blue Dye (50 mg) in 95 % aqueous ethanol (25 ml) and 
left to stir for 3 hours. 85 % H 3 P0 4 aq. (50 ml) was added and the resultant solution was 
then diluted with distilled water so that the final volume was 500 ml. To this solution 
1.00 M NaOH (aq) was added at 50 |xl / ml. The resultant solution was stored at 4 °C 
and warmed thoroughly to room temperature before use. An aliquot (1 ml) was added 
to 20 u.1 of protein solution and mixed thoroughly. After 5 minutes (and no more than 
after 15 minutes) the absorbence at X = 590 nm measured. This was then compared 
with a standard curve derived from known concentrations of bovine serum album 
(BSA). 
5.2.5.2 Cell disruption by sonication 
The bacterial pellet was resuspended in ice cold 50 mM MES buffer pH 6.5 (2 ml of 
buffer per g wet wt. of cells) and the thick slurry placed in a thick glass tube (inner 
diameter 17 mm) suspended in an ice water bath. A sonic probe was lowered into the 
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slurry so that it protruded no more than 5 mm into it. The cells were disrupted to yield 
the maximum concentration of protein, which was 3 bursts of 10 seconds each on 60 % 
power (maximum for probe used). The cell debris was removed by centrifugation 
(20,000 rpm, 20 minutes, 4 °C) and the supernatant decanted. The protein concentration 
determined by the Bradford assay and used in a cell-free study. 
A typical cell free experiment was prepared as follows: Cell free extract (0.625 ml), and 
40 mM fluoroacetaldehyde (40) (2 mM), were added to MES buffer to a final volume of 
5 ml. The MES buffer contained the following co-factors to give the stated final 
concentrations: NAD + (2 mM), NADP + (1 mM), ATP (5 mM), COASH (0.5 mM), DTT 
(2 mM), FAD (2 mM) and FMN (2 mM). The resultant solution were incubated in a 
water bath at 29 °C for 24 hours before being placed in water (> 85 °C) for 5 minutes 
and the protein precipitate removed by centrifugation (20,000 rpm, 10 minutes). The 
supernatants were then frozen pending analysis. 1 9F NMR (376 MHz): In all samples, 
only fluoroacetaldehyde (40) and 2-fluoroethanol (71) resonances observed. 
5.2.5.3 Cell disruption using the French press 
The bacterial pellet was resuspended in ice cold 50 mM MES buffer pH 6.5 containing 2 
mM dithiothreotol (100 ml). The cells were disrupted by passing the slurry once 
through a prechilled (4 °C) French press operating at 26,000 p.s.i. The French press was 
washed through with MES buffer (50 ml) and the fractions combined. After fifteen 
minutes the cell debris was removed by centrifugation (20,000 rpm, 4 °C, 20 minutes) 
and the supernatant decanted. The protein concentration was determined (by the 
Bradford assay) and used in a cell free study. 
Typical examples of cell free experiments were prepared as follows: Cell free extract (5 
ml) and 14 mM fluoroacetaldehyde (40) (1 ml, 2 mM) were added to 50 mM MES 
buffer pH 6.5 (1 ml). The MES buffer contained the following co-factors to give the 
stated final concentrations: NAD + (2.0 mM), NADP + (1.33 mM), FAD (2 mM), FMN 
(2 mM), CoASH (0.5 mM) and ATP (5 mM). The resultant solution were incubated in 
a water bath at 29 °C. Once the time period for that experiment was completed the 
solutions were placed in water (> 85 °C) for 5 minutes and the protein precipitate 
removed by centrifugation (20,000 rpm, 10 minutes). The supernatants were then 
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frozen pending analysis. Specific experiments and results are tabulated in text (chapter 
3). 
In the study of the fluorination of phosphorylated glycolytic intermediates, instead of 
adding 14 mM fluoroacetaldehyde (40) (1 ml), 28 mM of the 'glycolytic intermediate' 
(0.5 ml, 2 mM) and 28 mM NaF (0.5 mM, 2 mM) were added. In order to dissolve 
glycolaldehyde phosphate (164) in 50 mM MES buffer it was necessary to add one drop 
of 1 M HC1 (aq). This did not significantly alter the pH of the overall solution. Specific 
experiments and results are tabulated in text (chapter 4). 
5.2.5.4 Phosphate release assaym 
The phosphate concentration of a cell free experiment was measured by the method of 
Jenkins and Marshall. To an aliquot (1.00 ml) of the solution under analysis was added 
1.00 M perchloric acid (200 ul). After mixing (by vortex), 0.25 M imidazole (100 ul) 
buffered to pH 5.0 with HC1 (aq.) and then 1.5 % (m/v) sodium molybdate (500 ul) 
were added and the resultant solution mixed. Butyl acetate (2.00 ml) was then added 
and, the solution mixed by vortex for 10 seconds. Phase separation was achieved by 
centrifugation (5000 rpm, 2 minutes). An aliquot (1.00 ml) was removed from the 
upper organic layer and the absorbance at X = 310 nm was measured. The phosphate 
concentration was then deterimined against astandard curve (section 4.2, Fig. 4.9). 
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